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Transition metal-catalyzed addition reactions are of great importance in organic synthesis. 
Typically, the rhodium/palladium-catalyzed asymmetric addition reactions have attracted 
great attentions because of their high efficiency, special selectivity and mild reaction 
condition (Chapter 1).  
This thesis mainly focuses on two parts. One part is the development of high efficiency 
chiral diene ligands for rhodium-catalyzed asymmetric 1,4-addition reactions (Chapter 2 and 
3). These easily prepared C1 symmetric chiral diene ligands reveal that the substituents on the 
bicyclo[2.2.2]octa-2,5-diene skeleton are quite important, which can not only influence the 
enantioselectivity by steric interaction or hydrogen bond, but also increase the catalytic 
activity by the liable coordinating property.  
Another part of the thesis describes the application of new substrates or ligands for 
palladium-catalyzed asymmetric arylation reactions (Chapter 4 and 5). The fluoroalkyl 
substituted 2-quinazolinone derivatives are a new class of cyclic imines that are suitable for 
catalytic asymmetric arylation reactions, and excellent enantioselectivity was attained with a 
cationic palladium/(S)-iPr-phox catalyst. In addition, the amino acid-derived phosphine-imine 
ligands were for the first time applied to the palladium-catalyzed asymmetric arylation 
reactions, in which the high catalytic activities, useful level of enantioselectivies, and wide 
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Chapter 1 Introduction 
 
1.1 Rhodium/Palladium Enantioselective Addition Reactions 
Transition metal catalysis is of great importance to both scientific research and industrial 
manufacture for its high efficiency in organic transformations. Their reactivities and 
selectivities can be easily tuned by the modification of ligands. 1  Importantly, the 
rhodium/palladium-catalyzed asymmetric addition reactions to C=X bonds (X=C, O, N) with 
various nucleophiles, typically organoboron reagents, are very efficient methods for 
constructions of carbon-carbon and carbon-heteroatom bonds under mild conditions.2,3 The 
substrates for rhodium/palldium-catalyzed asymmetric addition reactions are mainly divided 
into two types: electron-deficient alkenes (1,4-additions) and aldehyde/imines(1,2-additions). 
The classic rhodium-catalyzed asymmetric addition reactions are well-established, and they 
presented high catalytic activity and enantioselectivity for wide scopes of substrates and 
nucleophiles.2 Compared with rhodium catalysts, the palladium catalysts are relatively lower 
cost. Unfortunately, the palladium(II) catalysts have a chance to undergo -hydride 
elimination to give a catalytic inactive palladium(0) species, which cause some deficiencies in 
the applications.3 In this dissertation, a summary focused on the rhodium-catalyzed 
asymmetric 1,4-additions and palladium-catalyzed asymmetric 1,2-additions will be given. 
                                                             
(1) (a) Comprehensive Organometallic Chemistry III: From Fundamentals to Applications; Crabtree, R. H., 
Mingos, D. M .P., Eds.; Elsevier Ltd.: Oxford, UK, 2007. (b) Steinborn, D.; Harmsen, A. Fundamentals of 
Organometallic Catalysis; Wiley: Hoboken, NJ, 2012. 
(2) For reviews on rhodium-catalyzed addition reactions, see: (a) Heravi, M. M.; Dehghani, M.; Zadsirjan, V. 
Tetrahedron: Asymmetry 2016, 27, 513. (b) Tian, P.; Dong, H,-Q.; Lin, G.-Q. ACS Catal. 2012, 2, 95. (c) Edwards, 
H. J.; Hargrave, J. D.; Penrose, S. D.; Frost, C. G. Chem. Soc. Rev. 2010, 39, 2093. (d) Hayashi, T.; Yamasaki, K. 
Chem. Rev. 2003, 103, 2829. 
(3) For reviews on palladium-catalyzed addition reactions, see: (a) Shockley, S. E.; Holder, J. C.; Stoltzf, B. M. 
Org. Process Res. Dev. 2015, 19, 974. (b) Sun, Y.-W.; Zhu, P.-L.; Xu, Q.; Shi, M. RSC Adv. 2013, 3, 3153. (c) 
Miyaura, N. Synlett 2009, 13, 2039. (d) Gutnov, A. Eur. J. Org. Chem. 2008, 4547. 
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1.2 Rhodium-Catalyzed Asymmetric 1,4-Addition Reactions 
1.2.1 The Development of Rhodium-Catalyzed 1,4-Addition Reactions 
The asymmetric 1,4-addition reactions have captured great attention from synthetic 
chemists because of not only the special reactivity and selectivity compared with other 
metal-catalyzed reactions but also their mild reaction conditions.2 In 1997, Miyaura reported 
the first non-asymmetric rhodium-catalyzed 1,4-addition of aryl- and alkenyl-boronic acids to 
,-unsaturated ketones using a rhodium/phosphine complex as a catalyst.4 Compared to 
other 1,4-addition reactions, rhodium-catalyzed 1,4-additions has several advantages. For 
instance, the organoboron reagents were used in the reaction instead of organometallic 
reagents, which are stable to oxygen and moisture and permit us to carry out the reaction in 
protic solvents or an aqueous solution. Moreover, the organoboron reagents were less reactive 
than other organometallic reagents toward enones where no 1,2-addtion reactions takes place 
in presence or absence of catalyst. However, in this work, high yields were only achieved to 
-unsubstituted enones, while for -substituted enones such as 2-cyclohexenone the yields 
were moderate (Scheme 1.1). It was remained as a challenge to develop an asymmetric 
version reaction under Miyaura’s reaction conditions. In 1998, Hayashi and Miyaura reported 
the first asymmetric rhodium-catalyzed 1,4-addition reactions.5 High catalytic activity and 
high enatioselectivity for -substituted enones were achieved by using Rh(acac)(C2H4) as a 
catalyst precursor and binap as a ligand at high temperature (100 ⁰C). The less reactive 
substrate 2-cyclohexenone gave 93% yield, 97% ee (Scheme 1.2). 
 
                                                             
(4) Sakai, M.; Hayashi, H.; Miyaura, N. Organometallics, 1997, 16, 4229. 
(5) Takaya, Y.; Ogasawara, M.; Hayashi, T. J. Am. Chem. Soc. 1998, 120, 5579. 
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Scheme 1.1 The first rhodium-catalyzed 1,4-additions 
 
 
Scheme 1.2 The first rhodium-catalyzed asymmetric 1,4-additions 
 
The harsh conditions are essential to achieve high catalytic activity for the 
rhodium-catalyzed asymmetric 1,4-additions. The discovery and development of new and 
efficient chiral ligands are of great importance. From 1998 to 2003, besides binap used as 
ligand for the first report, many groups put their efforts on designing or applying new ligands 




Scheme 1.3 Ligands for rhodium-catalyzed asymmetric 1,4-additions from 1998 to 2003 
 
In 2001, Tomioka and co-workers developed a rhodium catalyst coordinating with 
amidomonophosphine ligand which demonstrated excellent catalytic acitivity and 
enantioselectivity for asymmetric 1,4-additions.6a It was mentioned that the bidentate 
amidomonosphosphine behaves as a hemilabile ligand that contains a hard donor site and a 
soft donor site in one molecule. The phosphorus atom in the ligand strongly coordinates to 
rhodium, and the carbonyl oxygen of amide is coordinatively labile.6b At the same year, Reetz 
reported a series of easily prepared binol-based diphosphonites as ligands for asymmetric 
rhodium-catalyzed conjugate additions.7 In 2002, Genêt’s group modified the ligands based 
on the binap scaffold by introducing two hydrophilic groups on it.8 The new type 
                                                             
(6) (a)Kuriyama, M.; Tomioka, K. Tetrahedron Lett. 2001, 42, 921. (b) Kuriyama, M.; Nagai, K.; Yamada, K.; 
Miwa, Y.; Taga, T.; Tomioka, K. J. Am. Chem. Soc. 2002, 124, 8932. 
(7) Reetz, M. T.; Moulin, D.; Gosberg, A. Org. Lett. 2001, 3, 4083. 
(8) Amengual, R.; Michelet, V.; Genêt, J.-P.; Synlett 2002, 1791. 
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(R)-Digm-BINAP ligand revealed high catalytic activity, and the catalyst loading can be 
reduced to 1 mol%. In 2003, monodentate phosphoramidite ligands were used in asymmentric 
1,4-additions by Miyaura9 and Minnaard/Feringa10. At the same year, diphosphine (Li/Chan)11 
and N-heterocyclic carbenes type ligands (Andrus)12 were reported, which also showed great 
catalytic activity and enantioselectivity. Although many types of ligands were developed for 
rhodium-catalyzed asymmetric 1,4-additions, the disadvantage of these ligands is obvious that 
high temperature (usually 100 ⁰C) is required to improve catalytic reactivity. 
The effects of ligands and bases in the rhodium-catalyzed 1,4-addition of arylboronic acids 
to ,-unsaturated carbonyl compounds were investigated by Miyaura’s group in 2003.13 It 
was delight to find that [RhOH(cod)]2 together with KOH exhibited excellent catalytic 
activity compared with those with phosphine ligands. With the superior reaction condition, 
the reaction with 2-cyclohexenone proceeded to give 98% yield at 0 ⁰C in 6 h (Scheme 1.4). 
It is worthwhile to notice that chiral rhodium/diene complex could be a class of highly 
efficient catalyts for the rhodium-catalyzed asymmetric 1,4-addition reactions. 
 
 
Scheme 1.4 1,5-Cyclooctadiene ligand used for rhodium-catalyzed 1,4-additions 
 
Later, in 2003, the C2 symmetric chiral diene ligand based on bicylo[2.2.1]hepta-2,5-diene 
                                                             
(9) Iguchi, Y.; Itooka, R.; Miyaura, N. Synlett 2003, 1040. 
(10) Boiteau, J.-G.; Minnaard, A. J. Feringa, B. L. J. Org. Chem. 2003, 68, 9481. 
(11) Shi, Q.; Xu, L.; Li, X.; Jia, X.; Wang, R.; Au-Yeung, T. T.-L.; Chan, A. S. C.; Hayashi, T.; Cao, R.; Hong, M. 
Tetrahedron Lett. 2003, 44, 6505. 
(12) Ma, Y.; Song, C.; Ma, C.; Sun, Z.; Chai, Q.; Andrus, M. B. Angew. Chem. Int. Ed. 2003, 42, 5871. 
(13) Itooka, R.; Iguchi, Y.; Miyaura, N. J. Org. Chem. 2003, 68, 6000. 
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scaffold was reported by Hayashi and co-workers, which was successfully used for 
rhodium-catalyzed asymmetric conjugated addition reactions. It is a great milestone work that 
the first application of chiral dienes as ligands in asymmetric catalysis (Scheme 1.5).14 
Although chelating dienes such as 1,5-cyclooctadiene and norbornadiene are well known to 
be stable ligands for late transition metal complexes, there is no report about the use of their 
chiral version. This chiral diene ligand demonstrated higher catalytic activity and the reaction 
took place at 20 or 30 ⁰C with higher enatioselectivity for both cyclic and linear enones. At 
the same year, Carreira and co-workers reported their chiral dienes based on the 
bicyclo[2.2.2]octa-2,5-diene skeleton independently, which were effective ligands for 
iridium-catalyzed kinetic resolution of allylic carbonates (Scheme 1.6).15 
 




Scheme 1.6 Carreira’s C2 symmetric bicyclo[2.2.2]octa-2,5-diene ligand and its use for 
iridium-catalyzed kinetic resolution of allylic carbonates 
 
                                                             
(14) Hayashi, T.; Ueyama, K.; Tokunaga, N.; Yoshida, K. J. Am. Chem. Soc. 2003, 125, 11508. 
(15) Fischer, C.; Defieber, C.; Suzuki, T.; Carreira, E. M. J. Am. Chem. Soc. 2004, 126, 1628. 
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Besides bicylo[2.2.1]hepta-2,5-diene16 and bicyclo[2.2.2]octa-2,5-diene,17,23 chiral dienes 
based on different skeletons were appeared, such as bicyclo[3.3.2]decadiene,18 
bicyclo[3.3.1]nona-2,6-diene18,19 bicyclo[3.3.0]octa-2,5-diene,20 cyclooctadiene,21 and 
1,5-hexadiene22 (Figure 1.1). Among all these types of dienes, bicyclo[2.2.2]octa-2,5-diene 
type skeleton was the most commonly used and different variants were synthezied.17,23 
Particularly, the ligand Fc-tfb, which is based on tetrafluorobenzobarrelene skeleton and 
substituted with two ferrocenyl groups, has shown higher catalytic activity and higher 
enatioselectivity than other ligands in some types of rhodium-catalyzed reactions.23 All these 
types of chiral diene ligands have played an important role in metal-catalyzed transformations, 
especially, the rhodium-catalyzed asymmetric 1,4-additions. 
                                                             
(16) (a) Berthon-Gelloz, G.; Hayashi, T. J. Org. Chem. 2006, 71, 8957. (b) Noël, T.; Vandyck, K.; Van der Eycken, 
J. Tetrahedron 2007, 63, 12961. 
(17) (a) Defieber, C.; Paquin, J.-F.; Serna, S.; Carreira, E. M. Org. Lett. 2004, 6, 3873. (b) Tokunaga, N.; Otomaru, 
Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 13584. (c) Otomaru, Y.; 
Okamoto, K.; Shintani, R.; Hayashi, T. J. Org. Chem. 2005, 70, 2503. (d) Okamoto, K.; Hayashi, T.; Rawal, V. 
Chem. Commun. 2009, 4815. (e) Okamoto, K.; Hayashi, T.; Rawal, V. Org. Lett. 2008, 10, 4387. (f) Luo, Y.; 
Carnell, A. J. Angew. Chem. Int. Ed. 2010, 49, 2750. 
(18) Otomaru, Y.; Kina, A.; Shintani, R.; Hayashi, T. Tetrahedron: Asymmetry 2005, 16. 1673. 
(19) Otomaru, Y.; Tokunaga, N.; Shintani, R.; Hayashi. T. Org. Lett. 2005, 7, 307. 
(20) (a) Helbig, S.; Sauer, S.; Cramer, N.; Laschat, S.; Baro, A.; Freya, W. Adv. Synth. Catal. 2007, 349, 2331. (b) 
Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. (c) Feng, C.-G.; Wang, Z.-Q.; 
Shao, C.; Xu, M.-H.; Lin, G.-Q. Org. Lett. 2008, 10, 4101. 
(21) (a) Läng, F.; Breher, F.; Stein, D.; Grützmacher, H. Organometallics 2005, 24, 2997. (b) Kina, A.; Ueyama, 
K.; Hayashi, T. Org. Lett. 2005, 7, 5889. 
(22) (a) Hu, X.; Zhuang, M.; Cao, Z.; Du, H. Org. Lett. 2009, 11, 4744. (b) Wang, Y.; Hu, X.; Du, H. Org. Lett. 
2010, 12, 5482. (c) Hu, X.; Cao, Z.; Liu, Z.; Wang, Y.; Du, H. Adv. Synth. Catal. 2010, 352, 651. 
(23) (a) Nishimura, T.; Nagaosa, M.; Hayashi, T. Chem. Lett. 2008, 37, 860. (b) Nishimura, T.; Yasuhara, Y.; 
Nagaosa, M.; Hayashi, T. Tetrahedron: Asymmetry 2008, 19, 1778. (c) Nishimura, T.; Kumamoto, H.; Nagaosa, M.; 
Hayashi, T. Chem. Commun. 2009, 5713. (d) Nishimura, T.; Kasai, A.; Nagaosa, M.; Hayashi, T. Chem. Commun. 
2011, 47, 10488. (e) Nishimura, T.; Ashouri, A.; Ebe, Y.; Maeda, Y.; Hayashi, T. Tetrahedron: Asymmetry 2012, 23, 
655. (f) Nishimura, T.; Takiguchi, Y.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 9086. (g) Nishimura, T.; Makino, 
H.; Nagaosa, M.; Hayashi, T. J. Am. Chem. Soc. 2010, 132, 12865. (h) Sasaki, K.; Hayashi, T. Tetrahedron: 
Asymmetry 2012, 23, 373. (i) Nishimura, T. ; Ebe, Y.; Fujimoto, H.; Hayashi, T. Chem. Commun. 2013, 49, 5504. (j) 
Nishimura, T.; Noishiki, A.; Ebe, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2013, 52, 1777. (k) Nishimura, T.; 
Takiguchi, Y.; Maeda, Y.; Hayashi, T. Adv. Synth. Catal. 2013, 355, 1374. 
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Figure 1.1 The skeletons for chiral dienes 
 
The widespread application of any new class of ligands is influenced by their stability, wide 
scopes of reactions, and the ease and cost of their synthesis. Developing new ligands for 
transition metal catalysis has been always an essential issue. Nowadays, a various chiral 
ligands have been designed for rhodium-catalyzed 1,4-addition reactions. They can be mainly 
classified into several classes: bidentate or monodentate phosphorus ligands, diene ligands, 
bissulfoxide ligands, and their hybrid ligands (Scheme 1.7).2b No one class of these ligands 
can show impressive results across all scopes of substrates, but the chiral diene ligands have a 
relatively large scope and continue to be applied for reactions of other types of substrates.24 
 
                                                             
(24) For reviews on chiral diene ligands, see: (a) Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. Synlett, 2011, 1345. (b) 
Shintani, R.; Hayashi, T. Aldrichimica Acta, 2009, 42, 31. (c) Defieber, C.; Grützmacher, H.; Carreira, E. M. 
















1.2.2 Mechanism Study of Rhodium-Catalyzed 1,4-Addition Reactions 
 
Figure 1.2 Catalytic cycle of rhodium-catalyzed 1,4-additons 
 
In 2002, Hayashi’s group reported that the catalytic cycle of the rhodium-catalyzed 
asymmetric 1,4-addition reactions was successfully established by using of RhPh(PPh3)(binap) 
as a key intermediate.25 The reaction proceeded through three intermediates, namely, 
phenylrhodium, oxa--allylrhodium, and hydroxorhodium complexes, and all of them were 
observed by NMR spectroscopic methods. Later, in 2006, the kinetic study on 
rhodium/binap-catalyzed asymmetric 1,4-addition reactions was also reported by the same 
group.26 It was found that an inactive dimeric hydroxorhodium complex was a dominant 
species in the rhodium-catalyzed 1,4-additon catalytic cycle (Figure 1.2). The existence of 
inactive dimeric hydroxorhodium complex was further confirmed by investigation of the 
nonlinear effect. The kinetic studies and nonlinear effect analysis determined the rate constant 
k1 for the rate-determining step and the dimerization constant Kdimer. In the 1,4-additions of 
                                                             
(25) Hayashi, T.; Takahashi, M.; Takaya, Y. Ogasawara, M. J. Am. Chem. Soc. 2002, 124, 5052 
(26) Kina, A.; Iwamura, H.; Hayashi, T. J. Am. Chem. Soc. 2006, 128, 3904. 
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organoboronic acid to ,-unsaturated ketones, [Rh(OH)(cod)]2 has a much higher catalytic 
activity than [Rh(OH)(binap)]2 for the reason that [Rh(OH)(cod)]2 has a large rate constant k1 
in the rate-determining transmetalation step and smaller Kdimer (Table 1.1).
27 
 





 binap cod 
k1(M
-1s-1) 0.5 6.7 
Kdimer(M
-1) 8 × 102 3.8 × 102 
 
1.3 Palladium-Catalyzed 1,2-Addition to Imines 
Asymmetric addition of arylboron reagents to carbon–nitrogen double bond catalyzed by 
chiral rhodium and palladium complexes is one of the most efficient approaches to 
                                                             
(27) Kina, A.; Yasuhara, Y.; Nishimura, T.; Iwamura, H.; Hayashi, T. Chem. Asian J. 2006, 1, 707. 
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enantiomerically enriched benzylic amines.28-42 Since 2003, chiral dienes have raised great 
attention in metal-catalyzed asymmetric processes.24 They have been successfully used for 
asymmetric 1,4-addition of organoboronic acids to ,-unsaturated carbonyl compounds, and 
proved to be superior to other types of ligands in terms of selectivity and catalytic activity. 
Rhodium/diene catalysts were also employed to asymmetric arylation of N-tosyl aldimines by 
Hayashi and co-workers in 2004 (Scheme 1.8).17b 
 
 
Scheme 1.8 Rhodium/diene-catalyzed asymmetric arylation of N-tosyl aldimines 
 
Although several examples of the allylation of imines by palladium catalysts have been 
reported since 1998,28 the palladium-catalyzed arylation reaction was reported by Lu in 2007. 
Lu and co-workers developed a cationic palladium complex and it was used in addition of 
arylbornic acids to N-tert-butanesulfinyl iminoacetates. These reactions afforded arylglycine 
derivatives in moderate to good yields and high diastereoselectivities (Scheme 1.9).29 Hu’s 
group also reported a similar work about achiral palladacycle catalyzed addition of 
arylboronic acids to aldimines at the same time (Scheme 1.10).30 
 
                                                             
(28) (a) Nakamura, H.; Nakamura, K.; Yamamoto, Y. J. Am. Chem. Soc. 1998, 120, 4242. (b) Shimizu, M.; Kimura, 
M.; Watanabe, T.; Tamaru, Y. Org. Lett. 2005, 7, 637. (c) Solin, N.; Wallner, O.; Szabo ,´ K. Org. Lett. 2005, 7, 689. 
(29) Dai, H.; Lu, X. Org. Lett. 2007, 9, 3077. 




Scheme 1.9 The first palladium-catalyzed arylation of imines 
 
 
Scheme 1.10 Achiral palladacycle-catalyzed addition of arylboronic acids to aldimines 
 
In 2008, Lu’s group described a chiral Pd(OCOCF3)2/pyridinooxazoline complex which 
performed well in the palladium-catalyzed asymmetric one-pot synthesis of arylglycine with 
fine modified reaction conditions (Scheme 1.11).31 The arylglycine derivatives were obtained 
in low to moderate yields and moderate ees. To design and develop efficient ligands is the key 
issue in the palladium-catalyzed 1,2-addition to imines. Subsequently, different types of chiral 
ligands were emerged for this reaction, such as pyridinooxazoline ligand,32 bis-N-heterocylic 
carbene ligand,33 bisphosphine ligand,34 and bisoxazoline ligand35 (Figure 1.3). While reactive 
aldimines and aldimine esters were used as substrates, high catalytic activity and excellent 
enantioselectivity were obtained by some of these ligands. Nevertheless, the less reactive 
substrates, ketimines, were not mentioned in these reports. 
 
                                                             
(31) Dai, H.; Yang, M.; Lu, X. Adv. Synth. Catal. 2008, 350, 249. 
(32) Dai, H.; Lu, X. Tetrahedron Lett. 2009, 50, 3478. 
(33) (a) Ma, G.-N.; Zhang, T.; Shi, M. Org. Lett. 2009, 11, 875. (b) Liu, Z.; Shi, M. Tetrahedron 2010, 66, 2619. 
(34) Marques, C. S.; Burke, A. J. Eur. J. Org. Chem. 2010, 1639. 
(35) Chen, J.; Lu, X.; Lou, W.; Ye, Y.; Jiang, H.; Zeng, W. J. Org. Chem. 2012, 77, 8541. 
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 Scheme 1.11 Palladium-catalyzed asymmetric one-pot synthesis of arylglycine derivatives 
 
 
Figure 1.3 Chiral ligands for palladium-catalyzed arylation of aldimines or aldimine esters 
 
In the meanwhile, the different types of chiral ligands were applied to the 
rhodium-catalyzed addition of aldimines.18,36 To compared with aldimines, ketimines are more 
difficult substrates as their reactivity are much lower due to the presence of the substituent on 
the azomethine carbon. It was not until 2010 that the first addition of organoboron reagents to 
ketimines was reported by Shintani/Hayashi (Scheme 1.12).37 The rhodium/diene catalyst was 
applied to the addition of sodium tetraaryborates to the N-tosyl ketimines affording products 
in high yields and ees. In this report, methyl aryl ketimines and dialky ketimines are suitable 
substrates for rhodium-catalyzed 1,2-additions, while diaryl ketimines were not mentioned in 
this document.  
                                                             
(36) Selected examples on rhodium-catalyzed asymmetric addition of organoboron reagents to acyclic aldimines. 
see: (a) Tokunaga, N.; Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 
126, 13584. (b) Weix, D. J.; Shi, Y.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 1092. (c) Duan, H.-F.; Jia, Y.-X.; 
Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2006, 8, 2567.(d) Jagt, R. B. C.; Toullec, P. Y. ; Geerdink, D.; de Vries, J. G.; 
Feringa, B. L.; Minnaard, A. J. Angew. Chem. Int. Ed. 2006, 45, 2789. (e) Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; 
Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. 





Scheme 1.12 The first catalytic addition of organoboron reagents to ketimines 
 
The arylation of ketimines derived from diaryl ketones has inherent difficulty in controlling 
the enantioselectivity due to the lack of sufficient steric difference between the two aryl rings. 
In order to solve this problem, cyclic N-sulfonyl ketimines bearing the diaryl-substituted 
azomethine carbon were employed in rhodium-catalyzed 1,2-addition by Nishimura/Hayashi 
in 2012 (Scheme 1.13).38 High yields and ee values were obtained with five-menbered ring 
cyclic N-sulfonyl ketimines. The six-menbered ring cyclic ketimines are relatively less 
reactive than five-menbered ring cyclic ketimines and gave 71% yield, 99% ee. However, the 
1,2-adduct of six-menbered ring cyclic ketimine was easily transformed into corresponding 
chiral (triaryl)methylamine by breaking the cyclic structure without losing any ee value, while 
the breaking of five-menbered ring 1,2-adducts are not easy. Subsequently, different types of 
cyclic imines and various organoboron reagents were used in the rhodium-catalyzed 
1,2-addition reactions.39 
 
                                                             
(38) Nishimura, T.; Noishiki, A.; Tsui, G. C.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 5056. 
(39) (a) Luo, Y.; Carnell, A. J.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 6762. (b) Luo, Y.; Hepburn, H. B.; 
Chotsaeng, N.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 8309. (c) Nishimura, T.; Ebe, Y.; Fujimoto, H.; 
Hayashi, T. Chem. Commun. 2013, 49, 5504. (d) Nishimura, T.; Noishiki, A.; Ebe, Y.; Hayashi, T. Angew. Chem. 
Int. Ed. 2013, 52, 1777. (e) Wang, H.; Xu, M.-H. Synthesis 2013, 45, 2125. (f) Chen, Y.-J.; Chen, Y.-H.; Feng, 
C.-G.; Lin, G.-Q. Org. Lett. 2014, 16, 3400. (g) Wang, H.; Li, Y.; Xu, M.-H. Org. Lett. 2014, 16, 3962. (h) Kong, J.; 
McLaughlin, M.; Belyk, K.; Mondschein, R. Org. Lett. 2015, 17, 5520. (i) Jiang, T.; Wang, Z.; Xu, M.-H. Org. Lett. 
2015, 17, 528. (j) Takechi, R.; Nishimura, T. Org. Biomol. Chem. 2015, 13, 4918. (k) Li, Y.; Yu, Y.-N.; Xu, M.-H. 
ACS Catal. 2016, 6, 661. 
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 Scheme 1.13 Cyclic ketimines were employed to rhodium-catalyzed 1,2-additions 
 
The using of palladium catalysts in the same reaction is an attractive methodology because 
of their lower cost compared with rhodium catalysts. In 2013, palladium-catalyzed system 
was first applied in the addition of arylboronic acid to ketimines by Zhang.40 The 
five-membered cyclic N-sulfonyl ketimines bearing alkyl or aryl substitutes were employed. 
High yields and excellent enantioselectivities were achieved by using 
Pd(OCOCF3)2/pyridinooxazoline catalyst. The six-menbered ring ketimines remained as less 
reactive substrates with this palladium catalyst and only moderated yields but excellent ees 
were given (Scheme 1.14).  
 
                                                             
(40) Yang, G.; Zhang, W. Angew. Chem. Int. Ed. 2013, 52, 7540. 
 17 
 
 Scheme 1.14 The first palladium-catalyzed asymmertic arylation of ketimines 
 
In 2014, Lu/Hayashi reported a more reactive cationic palladium/phosphinooxazoline 
complex for arylation of ketimines.41 Excellent yields and ees were attained with 




Scheme 1.15 A high performance cationic palladium/phosphinooxazoline complex for 
arylation of six-menbered ring cyclic N-sulfonyl ketimines 
 
Various cyclic imine substrates and chiral ligands were explored for the 
                                                             
(41) Jiang, C.; Lu, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2014, 53, 9936. 
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palladium-catalyzed addition reactions. In 2015, the same catalytic system 
Pd(OCOCF3)2/pydinooxazoline was also applied to the palladium-catalyzed asymmetric 
arylation of cyclic N-sulfonyl ketimine esters by Zhang (Scheme 1.16).42 The cyclic -tertiary 
amino ester products were given in excellent yields and enantioselectivities, and these 
products can be easily converted to -tertiary amino alcohol by reduction reaction. 
 
 Scheme 1.16 Ketimine esters as new substrates for palladium-catalyzed addition reactions 
 
In the same year, Peters and co-workers described a planar-chiral ferrocene-derived 
palladacycle complex for asymmetric arylation of imines.
43
 One example of five-menbered ring 
N-sulfonyl ketimine gave quantitative yield and 95% ee (Scheme 1.17). In 2015, the 
pyridine-hydrazone ligands were developed and for the first time be applied to the 
palladium-catalyzed 1,2-addition of arylbornic acids to cyclic ketimines, affording products in 
high yields and ees (Scheme 1.18).
44
 The difficult substrates 3,4-disubstituted 1,2,5-thiadiazole 
1,1-dioxides
39g,40
 also gave arylation products in high yields and ees (>95% ee). 
 
                                                             
(42) Quan, M.; Yang, G.; Xie, F.; Gridnevb, I. D.; Zhang, W. Org. Chem. Front. 2015, 2, 398. 
(43) Schrapel, C.; Peters, R. Angew. Chem. Int. Ed. 2015, 54, 10289. 













Chapter 2 A Chiral Bicyclo[2.2.2]octa-2,5-diene Ligand 
Substituted with the Ferrocenyl Group and Its Use for 
Rhodium-Catalyzed Asymmetric 1,4-Addition Reactions 
 
2.1 Introduction 
Chiral dienes have been developed as a new class of chiral ligands and demonstrate 
high catalytic activity and enantioselectivity in various transition metal-catalyzed 
asymmetric reactions.1 In the first report published in 2003, we synthesized a C2 
symmetric chiral diene based on bicyclo[2.2.1]hepta-2,5-diene skeleton and used it 
successfully for the rhodium-catalyzed asymmetric 1,4-addition reactions.2 Carreira 
also reported their C1 symmetric chiral diene ligands based on 
bicyclo[2.2.2]octa-2,5-diene skeleton. 3  Subsequently, there appeared chiral dienes 
based on different skeletons such as bicyclo[3.3.1]nona-2,6-diene4 and 
bicyclo[3.3.0]octa-2,5-diene.5 Some of the most commonly used 
bicyclo[2.2.2]octa-2,5-diene (bod) ligands are illustrated in Figure 2.1.6-10  
 
                                                             
(1) For reviews on chiral diene ligands, see: (a) Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. Synlett, 2011, 1345. (b) 
Shintani, R.; Hayashi, T. Aldrichimica Acta, 2009, 42, 31. (c) Defieber, C.; Grützmacher, H.; Carreira, E. M. 
Angew. Chem. Int. Ed. 2008, 47, 4482. (d) Johnson, J. B.; Rovis, T. Angew. Chem. Int. Ed. 2008, 47, 840. 
(2) Hayashi, T.; Ueyama, K.; Tokunaga, N.; Yoshida, K. J. Am. Chem. Soc. 2003, 125, 11508. 
(3) Fischer, C.; Defieber, C.; Suzuki. T.; Carreira, E. M. J. Am. Chem. Soc. 2004, 126, 1628. 
(4) (a) Otomaru, Y.; Tokunaga, N.; Shintani, R.; Hayashi, T. Org. Lett. 2005, 7, 307. (b) Otomaru, Y.; Kina, A.; 
Shintani, R.; Hayashi, T. Tetrahedron: Asymmetry, 2005, 16, 1673. 
(5) (a) Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. (b) Helbig, S.; Sauer, 
S.; Cramer, N.; Laschat, S.; Baro, A.; Frey, W. Adv. Synth. Catal. 2007, 349, 2331.(c) Feng, C.-G.; Wang, Z.-Q.; 
Tian, P.; Xu, M.-H.; Lin, G.-Q. Chem. Asian J. 2008, 3, 1511; 
(6) Defieber, C.; Paquin, J.-F.; Serna, S.; Carreira, E. M. Org. Lett. 2004, 6, 3873.  
(7) (a) Tokunaga, N.; Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 
126, 13584. (b) Otomaru, Y.; Okamoto, K.; Shintani, R.; Hayashi, T. J. Org. Chem. 2005, 70, 2503. 
(8) (a) Okamoto, K.; T. Hayashi and V. Rawal, Org. Lett. 2008, 10, 4387. (b) Okamoto, K.; Hayashi, T.; Rawal, V. 
Chem. Commun. 2009, 4815 
(9) Luo, Y.; Carnell, A. J. Angew. Chem. Int. Ed. 2010, 49, 2750. 
(10) (a) Nishimura, T.; Nagaosa, M.; Hayashi, T. Chem. Lett. 2008, 37, 860. (b) Nishimura, T.; Yasuhara, Y.; 
Nagaosa, M.; Hayashi, T. Tetrahedron: Asymmetry 2008, 19, 1778. (c) Nishimura, T.; Kumamoto, H.; Nagaosa , 




Figure 2.1 Some of the chiral diene ligands based on bicyclo[2.2.2]octa-2,5-diene skeleton 
 
It should be noted that the Fc-tfb ligand, one of the bicyclo[2.2.2]octa-2,5-diene 
(bod) type ligand which bears two ferrocenyl (Fc) groups on the tetrafluorobenzo-
barrelene (tfb) skeleton,10c has shown higher catalytic activity and higher 
enantioselectivity than other ligands in several types of rhodium-catalyzed asymmetric 
reactions.10-15 Typically, they are asymmetric addition of organoboron reagents to 
unsaturated compounds, such as aldehydes,10a imines,11 β-alkoxyacrylates,12 
α,β-unsaturated sulfonyl compounds,13 and enynamides14 and some other reactions.15 
However, there are only two pathways to synthesize the most commonly used Pd-bod, 
Bn-bod and Fc-tfb chiral dienes, namely, fraction recrystallization or chiral separation 
by chiral HPLC.7b,10c A straightforward access in terms of scalability and costs to these 
ligands is highly desired. 
Recently, a report by Abele and co-workers described that enantiomerically pure 
5-phenylbicyclo[2.2.2]oct-5-en-2-one 2-1 is readily available in a large scale through 
                                                             
(11) (a) Nishimura, T.; Ebe, Y.; Fujimoto, H.; Hayashi, T. Chem. Commun. 2013, 49, 5504. (b) Nishimura, T.; 
Noishiki, A.; Ebe, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2013, 52, 1777. (c) Nishimura, T.; Ashouri, A.; Ebe, Y.; 
Maeda, Y. Hayashi, T. Tetrahedron: Asymmetry 2012, 23, 655. 
(12) Nishimura, T.; Kasai, A.; Nagaosa, M.; Hayashi, T. Chem. Commun. 2011, 47, 10488. 
(13) Nishimura, T.; Takiguchi, Y.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 9086. 
(14) Nishimura, T.; Makino, H.; Nagaosa, M.; Hayashi, T. J. Am. Chem. Soc. 2010, 132, 12865. 
(15) (a) Sasaki, K.; Hayashi, T. Tetrahedron: Asymmetry, 2012, 23, 373. (b) Nishimura, T.; Takiguchi, Y.; Maeda, 
Y.; Hayashi, T. Adv. Synth. Catal. 2013, 355, 1374. 
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an organocatalytic one-pot Michael addition–aldol reaction.16 The ketone 2-1 is a key 
intermediate for the synthesis of 2,5-diphenylbicyclo[2.2.2]octa-2,5-diene (Ph-bod) 
and its C1 symmetric analogs substituted with aryl and alkyl groups (Scheme 2.1). 
They were used as ligands for the rhodium-catalyzed asymmetric addition of 
arylboronic acids to enones and N-sulfonylimines.17 
 
Scheme 2.1 Synthesis of chiral bicyclo[2.2.2]octa-2,5-diene ligands by Abele 
 
In this chapter, we introduce a ferrocenyl group onto the bod skeleton based on the 
Abele’s procedure.16 The C1 symmetric chiral diene ligand (Fc,Ph-bod) was obtained. 
The new chiral diene ligand is examined as ligand in rhodium-catalyzed asymmetric 
1,4-addition of aryl- and alkenylboronic acids to α,β-unsaturated ketones.18 The 
                                                             
(16) Abele, S.; Inauen, R.; Spielvogel, D.; Moessner, C. J. Org. Chem. 2012, 77, 4765. 
(17) Brönnimann, R.; Chun, S.; Marti, R.; Abele, S. Helv. Chim. Acta 2012, 95, 1809. 
(18) For reviews on rhodium-catalyzed asymmetric conjugate addition, see: (a) Tian, P.; Dong, H.-Q.; Lin, G.-Q.; 
ACS Catal. 2012, 2, 95. (b) Partyka, D. V. Chem. Rev. 2011, 111, 1529. (c) Berthon, G.; Hayashi, T. Rhodium- and 
Palladium-Catalyzed Asymmetric Conjugate Additions. In Catalytic Asymmetric Conjugate Reactions; Córdova, 
A., Eds.; Wiley-VCH: Weinheim, Germany, 2010; pp 1. (d) Edwards, H. J.; Hargrave, J. D.; Penrose, S. D.; Frost, 
C. G. Chem. Soc. Rev. 2010, 39, 2093. (e) Johnson, J. B.; Rovis, T. Angew. Chem. Int. Ed. 2008, 47, 840. (f) 
Hayashi, T. Pure Appl. Chem. 2004, 76, 465. (g) Darses, S.; Genet, J.-P. Eur. J. Org. Chem. 2003, 4313. (h) 
Hayashi, T.; Yamasaki, K. Chem. Rev. 2003, 103, 2829. (i) Fagnou, K.; Lautens, M. Chem. Rev. 2003, 103, 169. (j) 
Bolm, C.; Hildebrand, J. P.; Muñiz, K.; Hermanns, N. Angew. Chem. Int. Ed. 2001, 40, 3284. 
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enantioselectivity is compared with that observed with Ph-bod and Fc-tfb to study the 
effects of the ferrocenyl group. 
2.2 Result and Discussion 
2.2.1 Synthesis of 2-Ferrocenyl-5-phenylbicyclo[2.2.2]octa-2,5-diene (Fc,Ph-bod) 
 
 Scheme 2.2 Synthesis of 2-ferrocenyl-5-phenylbicyclo[2.2.2]octa-2,5-diene (Fc,Ph-bod) 
 
For the synthesis of (R,R)-Fc,Ph-bod ligand, we have designed two synthetic pathways 
(Scheme 2.2). In the method A, the intermediate ketone 2-1 was converted to compound 2-2 
in 34% yield by the addition of FcLi reagent. One reason for the low yield is the high basicity 
of FcLi reagent, which will deprotonate the -proton of ketone 2-1 resulting in a self-addition 
product. Subsequently, the compound 2-2 was treated with MsCl and Et3N to form a double 
bond and gave (R,R)-Fc,Ph-bod ligand in 60% yield. The method B is following the 
procedures reported by Abele.16 The ketone 2-1 was transformed into alkenyl triflate 2-3, and 
the triflate was subjected to the palladium-catalyzed cross-coupling reaction with 
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ferrocenylzinc reagent. An excess amount of FcZnCl was allowed to react with triflate 2-3 in 
the presence of 10 mol% Pd(PPh3)4 in refluxing THF for 16 h. Aqueous work-up followed by 
silica gel column chromatography gave the diene, (R,R)-Fc,Ph-bod, in 72% yield. Although 
the method A is relative lower yield, 20% overall yield from ketone 2-1, the cost of method A 
is lower compared with method B in which expensive reagent 2-PyNTf2 and Pd(PPh3)4 were 
used. This diene was used for the preparation of rhodium complex, [RhCl((R,R)-Fc,Ph-bod)]2, 
by the ligand exchange reaction with [RhCl(coe)2]2 in dichloromethane. 
 
2.2.2 Asymmetric 1,4-Addition Catalyzed by Rhodium Complexes Coordinated With 
(R,R)-Fc,Ph-bod and its Related Chiral Dienes 






entry 2-4 2-5 time (h) ligand product 2-6 yield (%)b ee (%)c 
1d 2-4a 2-5m 1 (R,R)-Fc,Ph-bod  2-6am 99 98 (R) 
2   1 (R,R)-Fc,Ph-bod 2-6am 93 98 (R) 
3d   1 (R,R)-Ph-bod  2-6am 93 97 (R) 
4   1 (R,R)-Ph-bod 2-6am 95 97 (R) 
5 2-4a 2-5n 3 (R,R)-Fc,Ph-bod 2-6an 89 95 (R) 
6   3 (R,R)-Ph-bod 2-6an 90 93 (R) 
7d   3 (R,R)-Ph-tfbe 2-6an 87 93 (R) 
8d   3 (S,S)-Fc-tfb 2-6an 99 98 (R) 
9 2-4b 2-5m 1 (R,R)-Fc,Ph-bod 2-6bm 90 90 (S) 
10   1 (R,R)-Ph-bod 2-6bm 97 83 (S) 
11d   1 (R,R)-Ph-tfb
e 2-6bm 85 85 (S) 
12d   1 (S,S)-Fc-tfb
e 2-6bm 92 98 (S) 
13 2-4b 2-5o 1 (R,R)-Fc,Ph-bod 2-6bo 95 95 (S) 
14   1 (R,R)-Ph-bod 2-6bo 96 89 (S) 
15 2-4b 2-5p 2 (R,R)-Fc,Ph-bod 2-6bp 81 92 (S) 
16   2 (R,R)-Ph-bod 2-6bp 76 89 (S) 
17 2-4b 2-5q 2 (R,R)-Fc,Ph-bod 2-6bq 99 93 (S) 
18   2 (R,R)-Ph-bod 2-6bq 96 87 (S) 
19 2-4c 2-5m 1 (R,R)-Fc,Ph-bod 2-6cm 91 88 (R) 
20   1 (R,R)-Ph-bod 2-6cm 84 84 (R) 
21 2-4c 2-5o 1 (R,R)-Fc,Ph-bod 2-6co 96 92 (R) 
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22   1 (R,R)-Ph-bod 2-6co 98 89 (R) 
23 2-4c 2-5p 1 (R,R)-Fc,Ph-bod 2-6cp 88 94 (R) 
24   1 (R,R)-Ph-bod 2-6cp 93 92 (R) 
25 2-4c 2-5q 1 (R,R)-Fc,Ph-bod 2-6cq 99 92 (R) 
26   1 (R,R)-Ph-bod 2-6cq 99 90 (R) 
aEnone 2-4 (0.30 mmol), boronic acid 2-5 (0.60 mmol), [RhCl(coe)2]2 (9.0 μmol of Rh), 
diene ligand (9.9 μmol), and KOH (0.15 mmol) in dioxane/H2O (1.0/0.1 mL). 
bIsolated 
yield. cThe % ee was determined by chiral HPLC. The absolute configurations of known 
compounds were determined by comparison of their optical rotations with those reported, 
and the absolute configurations of new compounds, 2-6bq, 2-6cp, and 2-6cq are estimated 
by similarity of the stereochemical pathway. dIsolated rhodium complex [RhCl(diene)]2 
was used in place of in situ generation from [RhCl(coe)2]2 and the diene ligand. 
eIn the 
experiment of entries 7 and 11, (S,S) isomer of Ph-tfb ligand was used. For easier 
understanding of the stereochemical outcome, it is shown as if (R,R) isomer is used. In 
entry 12, (R,R)-Fc-tfb was used in the experiment. 
 
Table 2.1 summarizes the results of asymmetric 1,4-addition of organoboronic acids 
to ,-unsaturated cyclic ketones in the presence of a rhodium catalyst coordinated 
with (R,R)-Fc,Ph-bod obtained above. For comparison, this table also contains the 
results of reactions in the presence of other related rhodium/chiral diene complexes, 
which have been previously reported as effective catalysts for the asymmetric 
1,4-addition. First, (R,R)-Fc,Ph-bod was examined for the addition of phenylboronic 
acid to 2-cyclohexenone, which is one of the benchmark reactions to demonstrate high 
efficiency of newly developed chiral rhodium catalysts.1 Thus, the reaction of 
2-cyclohexenone 2-4a with phenylboronic acid 2-5m (2 equiv) was carried out in the 
presence of [RhCl((R,R)-Fc,Ph-bod)]2 (3 mol% Rh) and KOH (50 mol%) in 
dioxane/H2O (10/1) at 30 °C for 1 h to give a high yield (99%) of 
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(R)-3-phenylcyclohexanone 2-6am with 98% ee (entry 1). In situ generation of the 
rhodium/chiral diene catalyst from [RhCl(coe)2]2 and (R,R)-Fc,Ph-bod gave the 
addition product 2-6am of the same 98% ee (entry 2). This enantioselectivity is 
slightly higher than that observed with (R,R)-Ph-bod under the same condition (entries 
3 and 4). The higher enantioselectivity of (R,R)-Fc,Ph-bod (95% ee) than (R,R)-Ph-bod 
(93% ee) was also observed in the addition of alkenylboronic acid 2-5n to 2-4a (entries 
5 and 6). For comparison, (R,R)-Ph-tfb and (S,S)-Fc-tfb gave the product 2-6an with 
93% and 98% ee, respectively (entries 7 and 8). In the addition of phenylboronic acid 
2-5m to acyclic enone, (E)-non-3-en-2-one 2-4b, which is known to be a difficult 
substrate to achieve high enantioselectivity in the rhodium-catalyzed conjugate 
addition, Fc,Ph-bod gave the product 2-6bm of 90% ee (entry 9). Although this 
enantioselectivity is lower than that with Fc-tfb (98% ee, entry 12), it is higher than 
that with Ph-bod (83% ee, entry 10) and Ph-tfb (85% ee, entry 11). The higher 
enantioselectivity of Fc,Ph-bod than Ph-bod was also observed in the reaction of enone 
2-4b with phenylboronic acids substituted with 4-methoxy 2-5o, 4-chloro 2-5p, and 
4-methoxycarbonyl 2-5q groups (entries 13-18). Similarly, the reaction of another 
acyclic enone, (E)-5-methylhex-3-en-2-one (2-4c), with arylboronic acids, 2-5m, 2-5o, 
2-5p and 2-5q, proceeded with higer enantioselectivity in the presence of Fc,Ph-bod 
than Ph-bod (entries 19-26). 
In all the reactions shown in Table 2.1, Fc,Ph-bod ligand showed higher 
enantioselectivity than Ph-bod and Ph-tfb, but it was less enantioselective than Fc-tfb. 
It follows that Fc (ferrocenyl) group brings about higher enantioselectivity than Ph 
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group and two Fc groups are better than one Fc group in the present 1,4-addition 
reactions (Figure 2.2). 
Figure 2.2 Higher enantioselectivity after introducing the Fc (ferrocenyl) group 
 
2.3 Conclusions  
We have synthesized a chiral diene, (R,R)-Fc,Ph-bod, which is C1 symmetric 
substituted with ferrocenyl group and phenyl group on each of the two double bonds. 
Its rhodium complex, [RhCl((R,R)-Fc,Ph-bod)]2 was used as a catalyst for the 
asymmetric 1,4-addition of arylboronic acids to α,β-unsaturated ketones to show 
higher enantioselectivity than the Ph-bod catalyst. Through these studies, it has been 
demonstrated that the ferrocenyl (Fc) group on the bod ligand contributes to the higher 
enantioselectivity. 
 
2.4 Experimental Section 
2.4.1 General 
All air- and moisture-sensitive manipulations were carried out with standard 
Schlenk techniques under argon. The starting materials were obtained from 
commercial sources and used without further purification. THF and dioxane were 
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distilled over benzophenone ketyl under argon. CH2Cl2 was distilled over CaH2 under 
argon. [RhCl(coe)2]2 was prepared following the literature procedures.
19 
 
2.4.2 Preparation of (R,R)-Fc,Ph-bod and [RhCl((R,R)-Fc,Ph-bod)]2 
The alkenyl triflate 2-3 was prepared from enantiomerically pure ketone, 5-phenyl-
bicyclo[2.2.2]oct-5-en-2-one (2-1), according to the reported procedures.16  
To a solution of ferrocene (259 mg, 1.39 mmol) in THF (2.5 mL), t-BuLi (1.5 M in 
pentane, 0.85 mL, 1.27 mmol) was slowly added at 78 °C, and the mixture was 
allowed to warm to room temperature and stirred for 2 h. ZnCl2 (173 mg, 1.27 mmol) 
in THF (1.5 mL) was added and the mixture was stirred at room temperature for 0.5 h 
to form FcZnCl solution. The FcZnCl solution was added dropwise to a solution of 2-3 
(100 mg, 0.30 mmol) and Pd(PPh3)4 (35 mg, 0.030 mmol) in THF (1.0 mL), and the 
mixture was refluxed for 16 h. Water was added to quench the reaction, and the 
mixture was extracted with Et2O. The organic layer was washed with brine, dried over 
Na2SO4, and evaporated under vacuum. The residue was subjected to column 
chromatography on silica gel with hexane/ethyl acetate (49/1) to give the orange solid 
(R,R)-Fc,Ph-bod (79.5 mg, 0.22 mmol, 72% yield). The diene ligand was allowed to 
react with [RhCl(coe)2]2 (95 mg, 0.26 mmol) in CH2Cl2 (5 mL) to give dark-red solid 
[RhCl((R,R)-Fc,Ph-bod)]2 (100 mg, 0.20 mmol, 91% yield). The NMR spectrum of 
[RhCl((R,R)-Fc,Ph-bod)]2 is hard to be analyzed due to the stereoisomers.  
                                                             
(19) Van Der Ent, A.; Onderdelinden, A. L.; Schunn, R. A. Chlorobis(Cyclooctene)Rhodium(I) and–Iridium(I) 




(R,R)-Fc,Ph-bod. [α]22D +71 (c 0.99, CHCl3). 
1H NMR (CDCl3) 7.46 (dd, J = 8.4,1.3 
Hz, 2H), 7.34 (t, J = 7.5 Hz, 2H), 7.23 (tt, J = 7.4, 1.1 Hz, 1H), 6.67 (dd, J = 6.4, 2.0 
Hz, 1H), 6.30 (dd, J = 6.4, 2.0 Hz, 1H), 4.36-4.37 (m, 1H), 4.34-4.35 (m, 1H), 
4.20-4.22 (m, 2H), 4.13 (s, 5H), 4.08-4.10 (m, 1H), 3.93-3.94 (m, 1H), 1.52-1.56 (m, 
4H). 13C NMR (CDCl3) 146.8, 144.6, 138.3, 129.1, 128.4, 126.7, 125.1, 124.7, 83.7, 
68.6, 68.5, 68.4, 65.5, 64.5, 40.8, 39.6, 26.4, 25.8. HRMS (ESI) m/z calcd for 
C24H22Fe
+ M+ 366.1065, found 366.1060. 
 
2.4.3 Procedures for Rhodium-Catalyzed 1,4-Additions 
General Procedure for Asymmetric 1,4-Addition Catalyzed by the Rhodium Complex in 
situ Generated from [RhCl(coe)2]2 and Chiral Diene 
A solution of [RhCl(coe)2]2 (9.0 μmol Rh), chiral diene ligand (9.9 μmol), and 
boronic acid (0.60 mmol) in 1.0 mL of dioxane was stirred at room temperature for 5 
min. To this mixture was added aqueous KOH (0.10 mL, 1.5 M, 0.15 mmol), and the 
mixture was stirred at room temperature for another 5 min. Enone (0.30 mmol) was 
added, and the mixture was stirred at 30 °C for 1 h or 3 h. The mixture was passed 
through a short silica gel column (eluent: diethyl ether) and the solvent was removed 
under vacuum. The residue was subjected to column chromatography on silica gel with 
hexane/ethyl acetae to give the 1,4-addition product. 
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General Procedure for Asymmetric 1,4-Addition Catalyzed by Isolated Rhodium 
Complex [RhCl(diene)]2  
To a solution of [RhCl(diene)]2 complex (9.0 μmol Rh) and bornic acid (0.60 mmol) 
in 1.0 mL of dioxane was added aqueous KOH (0.10 mL, 1.5 M, 0.15 mmol), and the 
mixture was stirred at room temperature for 5 min. Enone (0.30 mmol) was added, and 
the mixture was stirred at 30 °C for 1 h or 3 h. The mixture was passed through a short 
silica gel column (eluent: diethyl ether) and the solvent was removed under vacuum. 
The residue was subjected to column chromatography on silica gel with hexane/ethyl 
acetae to give the 1,4-addition product. 
 
2.4.4 Characterization Data for the Addition Products   
 
Compound 2-6am: (CAS 34993-51-6, R configuration) Colorless oil. 99% yield. 
[]25D +20 (c 1.00, CHCl3), R configuration. The ee value was 98%, tR (minor) = 10.0 
min, tR (major) = 12.3 min (Chiralpak AD-H, λ = 254 nm, hexane/iPrOH = 99/1, flow 
rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3)  7.33 (t, J = 7.5 Hz, 2H), 7.25-7.21 
(m, 3H), 3.01 (tt, J = 11.9, 3.9 Hz, 1H), 2.60 (ddt, J = 14.0, 4.4, 1.9 Hz, 1H), 2.53 (ddd, 
J = 13.8, 12.5, 0.9 Hz, 1H), 2.50-2.43 (m, 1H), 2.38 (dddd, J = 14.3, 12.6, 6.1, 0.9 Hz, 





Compound 2-6an: (CAS 1063949-45-0, R configuration) Colorless oil. 89% yield. 
[]25D –8.9 (c 1.01, CHCl3), R configuration. The ee value was 95%, tR (minor) = 15.1 
min, tR (major) = 17.2 min (Chiralcel OD-H, λ = 254 nm, hexane/iPrOH = 98/2, flow 
rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3)  7.35 (d, J = 7.2 Hz, 2H), 7.30 (t, J = 
7.6 Hz, 2H), 7.22 (t, J = 7.2 Hz, 1H), 6.39 (d, J = 15.9 Hz, 1H), 6.16 (dd, J = 15.9, 6.9 
Hz, 1H), 2.73-2.62 (m, 1H), 2.57-2.48 (m, 1H), 2.44-2.37 (m, 1H), 2.36-2.27 (m, 2H), 
2.15-2.06 (m, 1H), 2.05-1.98 (m, 1H), 1.81-1.69 (m, 1H), 1.67-1.57 (m, 1H). 
 
 
Compound 2-6bm: (CAS 501919-45-5, S configuration) Colorless oil. 90% yield. 
[]25D +18 (c 1.00, CHCl3), S configuration. The ee value was 90%, tR (major) = 12.0 
min, tR (minor) = 15.8 min (Chiralcel OB-H, λ = 254 nm, hexane/iPrOH = 99/1, flow 
rate = 0.5 mL/min). 1H NMR (500 MHz, CDCl3)  7.28 (t, J = 7.5 Hz, 2H), 7.21-7.15 
(m, 3H), 3.15-3.06 (m, 1H), 2.73 (dd, J  = 16.1, 7.4 Hz, 1H), 2.69 (dd, J = 16.1, 7.0 Hz, 





Compound 2-6bo: (CAS 850409-87-9, S configuration) Colorless oil. 95% yield. 
[]25D +18 (c 1.02, CHCl3), S configuration. The ee value was 95%, tR (major) = 36.2 
min, tR (minor) = 39.9 min (Chiralcel OJ-H, λ = 254 nm, hexane/iPrOH = 99/1, flow 
rate = 0.5 mL/min). 1H NMR (500 MHz, CDCl3)  7.08 (d, J = 8.6 Hz, 2H), 6.82 (d, J 
= 8.6 Hz, 2H), 3.78 (s, 3H), 3.10-2.99 (m, 1H), 2.71-2.63 (m, 2H), 2.00 (s, 3H), 
1.62-1.45 (m, 2H), 1.29-1.05 (m, 6H), 0.82 (t, J =6.9 Hz, 3H). 
 
 
Compound 2-6bp: (CAS 1346758-81-3, S configuration) Colorless oil. 81% yield. 
[]25D +13 (c 0.73, CHCl3), S configuration. The ee value was 92%, tR (major) = 21.4 
min, tR (minor) = 22.6 min (Chiralcel OJ-H, λ = 254 nm, hexane/iPrOH = 99/1, flow 
rate = 0.5 mL/min). 1H NMR (500 MHz, CDCl3) 7.25 (d, J = 8.3 Hz, 2H), 7.10 (d, J 
= 8.3 Hz, 2H), 3.14-3.05 (m, 1H), 2.68 (d, J = 7.2 Hz, 2H), 2.02 (s, 3H), 1.62-1.45 (m, 





Compound 2-6bq: Colorless oil. 99% yield. []25D +11 (c 0.87, CHCl3), S 
configuration. The ee value was 93%, tR (major) = 23.2 min, tR (minor) = 24.8 min 
(Chiralcel OJ-H, λ = 254 nm, hexane/iPrOH = 98/2, flow rate = 1.0 mL/min). 1H NMR 
(500 MHz, CDCl3)  7.95 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 3.89 (s, 3H), 
3.21-3.16 (m, 1H), 2.73 (d, J = 7.1 Hz, 2H), 2.02 (s, 3H), 1.65-1.50 (m, 2H), 1.27-1.01 
(m, 6H), 0.82 (t, J= 6.9 Hz, 3H). 13C NMR (125 MHz, CDCl3): 207.3, 167.0, 150.2, 
129.8, 128.3, 127.5, 52.0, 50.5, 41.1, 36.2, 31.6, 30.6, 26.9, 22.4, 14.0. HRMS (ESI) 
m/z calcd for C17H24O3Na (M+Na
+) 299.1618, found 299.1628. 
 
 
Compound 2-6cm: (CAS 162239-77-2, R configuration) Colorless oil. 91% yield. 
[]25D +23 (c 0.88, CHCl3), R configuration. The ee value was 88%, tR (major) = 12.6 
min, tR (minor) = 13.9 min (Chiralcel OD-H + Chiralpak ID, λ = 254 nm, 
hexane/iPrOH = 99/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3)  7.27 (t, 
J = 7.5 Hz, 2H), 7.18 (t, J = 7.3 Hz, 1H), 7.14 (d, J = 7.4 Hz, 2H), 2.94-2.88 (m, 1H), 
2.84-2.7 (m, 2H), 1.97 (s, 3H), 1.83 (octet, J = 6.8 Hz, 1H), 0.93 (d, J = 6.7 Hz, 3H), 





Compound 2-6co: (CAS 1346758-78-8, R configuration) Colorless oil. 96% yield. 
[]25D +29 (c 1.00, CHCl3), R configuration. The ee value was 92%, tR (major) = 10.2 
min, tR (minor) = 11.1 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 99/1, flow rate 
= 1.0 mL/min). 1H NMR (500 MHz, CDCl3)  7.06 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.5 
Hz, 2H), 3.77 (s, 3H), 2.88-2.84 (m, 1H), 2.80-2.71 (m, 2H), 1.97 (s, 3H), 1.78 (octet, 
J = 6.8 Hz, 1H), 0.91 (d, J = 6.7 Hz, 3H), 0.72 (d, J = 6.7 Hz, 3H). 
 
 
Compound 2-6cp: Colorless oil. 88% yield. []25D +23 (c 0.85, CHCl3), R 
configuration. The ee value was 94%, tR (major) = 14.9 min, tR (minor) = 17.4 min 
(two Chiralcel OJ-H, λ = 254 nm, hexane/iPrOH = 199/1, flow rate = 1.0 mL/min). 1H 
NMR (500 MHz, CDCl3)  7.24 (d, J = 8.6 Hz, 2H), 7.07 (d, J = 8.4 Hz, 2H), 
2.93-2.88 (m, 1H), 2.80 (dd, J =16.2, 5.0 Hz, 1H), 2.74 (dd, J =16.2, 9.5 Hz, 1H), 1.99 
(s, 3H), 1.84-1.74 (m, 1H), 0.92 (d, J = 6.7 Hz, 3H), 0.73 (d, J = 6.7 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) 207.8, 141.8, 131.9, 129.6, 128.3, 47.5, 47.3, 33.2, 30.6, 20.6, 
20.2. HRMS (ESI) m/z calcd for C13H16ClO (M-H





Compound 2-6cq: Pale yellow oil. 99% yield. []25D +21 (c 0.94, CHCl3), R configuration. 
The ee value was 92%, tR (major) = 14.4 min, tR (minor) = 16.2 min (Chiralpak IF, λ = 254 
nm, hexane/iPrOH = 19/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3)  7.94 (d, J 
= 8.3 Hz, 2H), 7.22 (d, J = 8.3 Hz, 2H), 3.89 (s, 3H), 3.02-2.97 (m, 1H), 2.86-2.77 (m, 2H), 
1.99 (s, 3H), 1.89-1.79 (m, 1H), 0.93 (d, J = 6.7 Hz, 3H), 0.73 (d, J = 6.7 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) 207.5, 167.0, 149.0, 129.5, 128.3, 128.3, 51.9, 47.8, 47.3, 33.1, 30.6, 
20.6, 20.3. HRMS (ESI) m/z calcd for C15H20O3Na (M+Na




Chapter 3 High Efficiency Chiral Dienes with Liable 
Intramolecularly Coordinating Functional Groups for 
Rhodium-Catalyzed Asymmetirc 1,4-Additions 
 
3.1. Introduction 
Chiral dienes have been proved to be efficient chiral ligands for transition metal-catalyzed 
asymmetric reaction.1 A variety of useful transformations have been achieved in excellent 
yield and enantioselectivity with chiral diene ligands,1 especially, the rhodium-catalyzed 
asymmetric 1,4-addition reactions.2 In 2003, Hayashi reported a C2 symmetric chiral diene 
base on bicyclo[2.2.1]hepta-2,5-diene scaffold which was successfully used in the 
rhodium-catalyzed asymmetric 1,4-addition of aryl- or alkenylbonronic acids to , 
unsaturated ketones.3 Compared with phosphorus ligand, the chiral diene ligand revealed 
higher catalytic activity and allowed the reaction to proceed smoothly under mild condition.2 
The catalytic cycle of rhodium-catalyzed asymmetric 1,4-addition of phenylboronic acid to 
methyl vinyl ketone was established (Figure 3.1).4 Kinetic studies on both rhodium/binap and 
rhodium/diene catalyst revealed that the significantly high catalytic activity of rhodium/diene 
catalyst is attributed to a large rate constant in the rate-determining transmetalation step.5 In 
addition, the equilibrium between the catalytic inactive dimeric hydroxorhodium complex and 
the active monomeric complex was discovered in the catalytic cycle.5 
                                                             
(1) For reviews on chiral diene ligands, see: (a) Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. Synlett 2011, 1345. (b) 
Shintani, R.; Hayashi, T. Aldrichimica Acta, 2009, 42, 31. (c) Defieber, C.; Grützmacher, H.; Carreira, E. M. 
Angew. Chem. Int. Ed. 2008, 47, 4482. (d) Johnson, J. B.; Rovis, T. Angew. Chem. Int. Ed. 2008, 47, 840. 
(2) For reviews on rhodium-catalyzed asymmetric 1,4-additions, see: (a) Heravi, M. M.; Dehghani, M.; Zadsirjan, 
V. Tetrahedron: Asymmetry 2016, 27, 513. (b) Tian, P.; Dong, H.-Q.; Lin,G.-Q. ACS Catal. 2012, 2, 95. (c) 
Edwards, H. J.; Hargrave, J. D.; Penrose, S. D.; Frost, C. G. Chem. Soc. Rev. 2010, 39, 2093. (d) Hayashi, T.; 
Yamasaki, K. Chem. Rev. 2003, 103, 2829. 
(3) Hayashi, T.; Ueyama, K.; Tokunaga, N.; Yoshida, K. J. Am. Chem. Soc. 2003, 125, 11508. 
(4) Hayashi, T.; Takahashi, M.; Takaya, Y.; Ogasawara, M. J. Am. Chem. Soc. 2002, 124, 5052. 
(5) (a) Kina, A.; Iwamura, H.; Hayashi, T. J. Am. Chem. Soc. 2006, 128, 3904. (b) Kina, A.; Yasuhara, Y.; 





Figure 3.1 Catalytic cycle of rhodium-catalyzed 1,4-additons 
 
Chiral diene ligands with different bicyclic structures have been reported subsequently, 
such as bicyclo[2.2.2]octa-2,5-diene,6 bicyclo[3.3.2]decadiene,7 
bicyclo[3.3.1]nona-2,6-diene,7,8 and bicyclo[3.3.0]octa-2,5-diene.9 Although the bicyclic 
structures of these ligands play a crucial role in the asymmetric reactions, they partially result 
in some difficulties in ligand synthesis and modification. For instance, there are two pathways 
to synthesize the most widely used C2 symmetric Hayashi’s Ph-bod ligand, namely HPLC 
resolution and fractional recrystallization, which is still lack of concise and scalable 
approaches.6c Hence, exploring novel, effective, and easily accessible chiral dienes is still one 
                                                             
(6) (a) Defieber, C.; Paquin, J.-F.; Serna, S.; Carreira, E. M. Org. Lett. 2004, 6, 3873. (b) Tokunaga, N.; Otomaru, 
Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 13584. (c) Otomaru, Y.; 
Okamoto, K.; Shintani, R.; Hayashi, T. J. Org. Chem. 2005, 70, 2503. (d) Okamoto, K.; Hayashi, T.; Rawal, V. Org. 
Lett. 2008, 10, 4387. (e) Nishimura, T.; Nagaosa, M.; Hayashi, T. Chem. Lett. 2008, 37, 860. (f) Okamoto, K.; 
Hayashi, T.; Rawal, V. Chem. Commun. 2009, 4815. (g) Nishimura, T.; Kumamoto, H.; Nagaosa, M.; Hayashi, T. 
Chem. Commun. 2009, 5713. (h) Luo, Y.; Carnell, A. J. Angew. Chem. Int. Ed. 2010, 49, 2750  
(7) Otomaru, Y.; Kina, A.; Shintani, R.; Hayashi, T. Tetrahedron: Asymmetry 2005, 16. 1673. 
(8) Otomaru, Y.; Tokunaga, N.; Shintani, R.; Hayashi. T. Org. Lett. 2005, 7, 307. 
(9) (a) Helbig, S.; Sauer, S.; Cramer, N.; Laschat, S.; Baro, A.; Freya, W. Adv. Synth. Catal. 2007, 349, 2331. (b) 
Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. (c) Feng, C.-G.; Wang, Z.-Q.; 
Shao, C.; Xu, M.-H.; Lin, G.-Q. Org. Lett. 2008, 10, 4101. 
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of the most important issues in this field.  
The application of chiral diene ligands in rhodium-catalyzed asymmetric cyclopropanation 
of alkenes with dimethyl diazomalonate was introduced by Hayashi and co-workers in 2010.10 
The newly designed rhodium catalyst involves a chelating chiral diene moiety and a carbonyl 
oxygen as an intramolecularly coordinating functional group，the rhodium catalyst have a 
single coordination site for the decomposition of dimethyl diazomalonate to generate the 
rhodiumcarbene in the asymmetric cyclopropanation of alkenes (Scheme 3.1a). Unfortunately, 
only a single coordination site is not enough for rhodium-catalyzed 1,4-addition reactions 
where two coordination sites are essential for transmetalation of boronic acid and insertion of 
alkene.4  
 
Scheme 3.1 Chiral tridenetate diene and labile tridentate diene 
 
In order to weaken the coordinating ability of the functional group, we change the distance 
                                                             
(10) Nishimura, T.; Maeda, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2010, 49, 7324. 
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of the functional group from 4 bonds away from diene moiety to 3 bonds. We here design a 
series of new diene ligands with a liable intramolecularly coordinating group by using Abele’s 
5-phenylbicyclo[2.2.2]oct-5-en-2-one as starting material.11 This labile coordinating ability is 
expected to go against the dimeric rhodium catalyst formation, while the labile coordination 
site will not influence the alkene insertion step. Due to the amount of inactive dimeric 
hydroxorhodium complex is reduced, these chiral diene ligands are expected to have higher 
catalytic activity in rhodium-catalyzed asymmetric 1,4-addition reactions (Scheme 3.1b). 
 
3.2 Result and Discussion 
3.2.1 Synthesis of C1 Symmetric Labile Tridentate Dienes 
The synthetic routes of the C1 symmetric bicyclo[2.2.2]octa-2,5-dienes with liable 
intramolecularly coordinating group are shown in Scheme 3.2. The ketone 3-1 was converted 
to diene 3-2, which is a mixture of E and Z isomer, in quantitative yield by Horner–
Wadsworth–Emmons reaction. The diene 3-2 was subjected to kinetic protonation to give a 
mixture of double bond moved products 3-4e and 3-2. Then the unseparatable mixture was 
hydrolyzed by LiOH in THF/H2O, in which diene 3-4e was converted to diene acid 3-3 and 
the low reactive conjugated diene ester 3-2 will not be hydrolyzed. This diene acid 3-3 was 
used as a synthetic intermediate for synthesis of other chiral dienes. Diene 3-4a was derived 
from diene 3-3 by reduction reaction. The diene 3-4a was subjected to deprotonate by NaH 
and reacted with MeI to give 3-4b. Diene 3-4c was obtained in moderate yield through amide 
coupling reaction from diene 3-3. Diene 3-3 was converted to carbonyl chloride, and reacted 
                                                             
(11) Abele, S.; Inauen, R.; Spielvogel, D.; Moessner, C. J. Org. Chem. 2012, 77, 4765 
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with PhNH2 and EtOH respectively to give diene 3-4d and 3-4e in moderate yields.  
 
 
Scheme 3.2 Synthesis of C1 symmetric labile tridentate dienes 
 
3.2.2 Asymmetric 1,4-Additions by [RhCl(coe)2]2/Dienes 
The enantioselectivity and catalytic activity of these C1 symmetric labile tridentate dienes 
3-4 were examined in the rhodium-catalyzed asymmetric 1,4-addition of phenylboronic acid 
3-6m to 2-cyclohexenone 3-5a (Table 3.1). The 1,4-addition reactions proceeded smoothly at 
40⁰C with all of the chiral diene ligands to give high yields and high ee values. Highest 
enantioselectivity (98% ee) was obtained with CH2CH2OH,Ph-bod 3-4a (enrty 1). The 
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replacement of -OH group (3-4a) to –OMe group (3-4b) caused the loss of enantioselectivity, 
which may be rationalized by the –OH hydrogen bond of 3-4a play a role in the chirality 
introduction (entry 2). Other dienes with amide groups (3-4c, 3-4d) or an ester group (3-4e) 
revealed moderate catalytic activities but high enantioselectivities (entries 3-5). Low yields 
are mainly due to the relatively strong coordinating ability of the carbonyl group, where the 
single coordination site of a catalyst is not enough to catalyzed the 1.4-addition reactions. 12 
 
Table 3.1 Asymmetric 1,4-Addition of Phenylboronic Acid (3-6m) to 2-Cyclohexenone (3-5a) 





entry ligand time (h) yield (%)b ee (%)c 
1 3-4a 1 h 98 98 (R) 
2 3-4b 1 h 94 86 (R) 
3 3-4c 12 h 54 96 (R) 
4 3-4d 3 h 89 96 (R) 
5 3-4e 3 h 76 94 (R) 
aEnone 3-5a (0.30 mmol), phenylboronic acid 3-6m (0.60 mmol), [RhCl(coe)2]2 (9.0 μmol 
of Rh), diene ligand (9.9 μmol), and KOH (0.15 mmol) in dioxane/H2O (1.0/0.1 mL). 
bIsolated yield. cThe ee values were determined by chiral HPLC. The absolute 
configuration of 3-7am was determined by comparison of its optical rotation with literature 
report. 
 
                                                             




3.2.3 Nonlinear Effect Analysis 














1 17.4 (R,R) 91 14.8 (R) 17.0 27 
2 29.5 (R,R) 95 25.6 (R) 28.9 23 
3 38.7 (R,R) 94 33.9 (R) 38.0 23 
4 59.1 (R,R) 89 53.3 (R) 57.9 21 
5 79.0 (R,R) 99 73.0 (R) 77.4 27 
6 100 (R,R) 98 98.0 (R) 98.0  
aEnone 3-5a (0.30 mmol), boronic acid 6m (0.60 mmol), [RhCl(coe)2]2 (9.0 μmol of Rh), 
diene ligand 3-4a (9.9 μmol), and KOH (0.15 mmol) in dioxane/H2O (1.0/0.1 mL) at 40 ⁰C 
for 1 h. bThe ee values of enantioenriched ligand 3-4a were determined by chiral HPLC. 
cIsolated yield. dThe product ee was determined by chiral HPLC. The absolute 
configuration of 3-7am was determined by comparison of its optical rotation with literature 
report  
 
The new C1 symmetric dienes with liable intramolecularly cooridinating functional groups, 
which can go against the inactive dimeric rhodium complex formation, were synthesized. The 
chiral diene 3-4a revealed the best catalytic activity and enantioselectivity. The equilibrium 
between its monomeric and dimeric species will be studied by nonlinear effect analysis. The 
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non-optical pure diene 3-4a was used as ligands in rhodium-catalyzed asymmetric 1,4-addtion 
of phenybornic acid (3-6m) to 2-cyclohexenone (3-5a) (Table 3.2). A weak negative NLE was 
obtained (Figure 3.2). The dimerization constant was calculated to be Kdimer = 24.2 which is 
much smaller than Kdimer = 360 of Rh/Ph-bod
13 or Kdimer =380 of Rh/cod
5 system. It was 
indicated that larger amount of monomeric species of diene 3-4a will existed in the reaction 
than standard chiral dienes. The results may be caused by the liable intramolecularly 
coordinating group –OH. In addition, we would like to further confirmed the labile 
coordinating ability in diene 3-4a by X-ray analysis. Unfortunately, it is not easy to get the 
crystal due to the diene 3-4a is relatively unstable in a solution for a long time. 
 



























Figure 3.2 Observation of nonlinear effect (blue dot) and simulation Kdimer = 380 (purple line) 
 
                                                             
(13) Dou, X.; Huang, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2016, 55, 1133. 
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The study on the nonlinear effect gave us significant information about the rhodium/3-4a 
complex. It was demonstrated that a large amount of active monomeric rhodium complex 
existed in the reaction. Thus, we test the competitive reactions with diene 3-4mix (Scheme 3.3). 
The diene 3-4mix is a mixture of (R,R)-3-4a and (S,S)-Ph-bod in 1:1 ratio. With this “racemic” 
diene 3-4mix, we get products R-7am with 54% ee and S-7bm with 36% ee, respectively. The 
results revealed that the liable tridentated chiral diene 3-4a had higher catalytic activity than 
Ph-bod ligand. Moreover, the diene 3-4a gave much higher ee value (96% ee) in the reaction 
with linear enone 3-5b compared with Ph-bod (83% ee). In addition, the reaction with less 
reactive substrate ,-disubstituted enones 3-5c aslo proceeded well by Rh/3-4a (89% yield, 
95% ee), while gave low yield by Rh/Ph-bod (49% yield, 95% ee). 
 





Scheme 3.4 Reaction with less reactive substrate -disubstituted enones 3-5c 
 
3.3 Conclusions 
C1 symmetric chiral diene ligands involved an intramolecularly coordinating functional 
group were synthesized and successfully applied to the rhodium-catalyzed asymmetric 
1,4-addition reactions. The Ph-CH2CH2OH-bod (3-4a) gave the best result in addition of 
phenylboronic acid to cyclic and linear enones. The nonlinear effect analysis revealed that the 
functional group of diene 3-4a works as a labile coordinating group which can go against the 
formation of inactive dimeric catalyst. The smaller Kdimer =24.2 was obtained. Compared with 
Ph-bod, Ph-CH2CH2OH-bod (3-4a) showed higher catalytic activities in the rhodium-catlyzed 
asymmetric 1,4-addition reactions. 
 
3.4 Experimental Section 
3.4.1. General 
All air- and moisture-sensitive manipulations were carried out with standard Schlenk 
techniques under argon. NMR spectra were recorded on Bruker AMX-500 spectrometer or 
Bruker AMX300 spectrometer. Chemical shifts were reported in δ (ppm) referenced to the 
residual solvent peak of CDCl3 (δ 7.26) for 




Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br (broad). Coupling constants were reported in Hertz (Hz). Optical rotations were 
measured on an Anton Paar MCP 200 machine. High resolution mass spectra (HRMS) (ESI) 
were obtained on a Bruker micrOTOF-Q II spectrometer. Enantiomeric excesses (ee) were 
determined by HPLC analysis on Shimadzu HPLC.  
THF was distilled over benzophenone ketyl under argon. Dichloromethane and 
1,2-dichloroethane were distilled over CaH2 under argon. Enones and Boronic acids are 
commercial available and used as received. [RhCl(coe)2]2 were synthesized following the 
literature procedures.14 Enantiomerically pure 5-phenylbicyclo[2.2.2]oct-5-en-2-one (3-1) was 
received from Dr. Stefan Abele, Actelion Pharmaceuticals Ltd., as a gift. 
 
3.4.2. Preparation of Chiral Diene Ligands 
 
To a solution of NaH (1.00 g, 25.2 mmol, 60% in mineral oil) in THF (20.0 mL), triethyl 
phosphonoacetate (5.0 mL, 25.2 mmol) was added dropwise at 0 ⁰C. The mixture was stirred 
at room temperature until the bubble subsided. To this mixture, the solution of ketone 3-1 
(2.00 g, 10.1 mmol) in THF (10.0 mL) was added. The mixture was allowed to stir at room 
temperature for 2 h, and then it was quenched with water at 0 ⁰C. The mixture was extracted 
with Et2O (30 mL × 3). The organic layer was washed with brine, dried over Na2SO4, and 
                                                             
(14) Van Der Ent, A.; Onderdelinden, A. L.; Schunn, R. A. Chlorobis(Cyclooctene)Rhodium(I) and–Iridium(I) 
Complexes. In Inorganic Syntheses; Angelici, R. J., Eds.; Wiley: New York, 1990; Vol. 28, pp 90. 
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evaporated under vacuum. The residue was subjected to column chromatography on silica gel 
with hexane/ethyl acetate (10/1) to give the colorless oil 3-2 (2.72 g, 10.1 mmol, quant. yield). 
 
 
The 3-2 (2.72 g, 10.1 mmol) was dissolved in THF (25.0 mL) and cooled at 78 ⁰C for 10 
min. A solution of LDA (2.0 M in THF, 7.6 mL, 15.2 mmol) was added slowly at this 
temperature. The mixture was allowed to warm at room temperature and stirred for 15 min, 
then cooled back at 78 ⁰C and stirred for 1 h. The mixture was quenched by water very 
slowly at 78 ⁰C and stirred for 1 h. Then the mixture was warm to room temperature slowly, 
and extracted with Et2O (30 mL × 3). The organic layer was combined, dried over Na2SO4, 
and evaporated under vacuum. The crude product was subjected to column chromatography 
on silica gel with hexane/ethyl acetate (20/1) to give product as yellow oil (2.09 g, 7.79 mmol, 





To a solution of diene mixture 3-2 and 3-4e (2.09 g, 7.79 mmol) in THF/ H2O (15.0/15.0 
mL), LiOH (15.6 mmol, 373 mg) was added. The mixture was stirred at room temperature for 
12 h. The mixture was extracted with Et2O (20 mL × 3) to remove unreactive ester 3-2. Then 
the aqueous layer was acidified with 1.0 M HCl until no more white precipitate formed. The 
suspension was exacted with Et2O (20 mL × 3). The organic layer was dried under vacuum to 
give the diene acid as white solid (1.18 g, 4.91 mmol, 63% yield). Compound 3-3: []25D 
+0.80 (c 1.00, CHCl3). 
1H NMR(CDCl3) 7.41 (d, J = 8.2 Hz, 2H), 7.31 (t, J = 7.6 Hz, 2H), 
7.22-7.19 (m, 1H), 6.57 (d, J = 6.3 Hz, 1H), 6.22 (d, J = 6.3 Hz, 1H), 4.08 (dd, J = 5.8, 1.9Hz, 
1H), 3.67-3.65 (m, 1H), 3.24 (s, 2H), 1.53-1.42 (m, 4H). 13C NMR (CDCl3)  177.2, 146.4, 
139.9, 138.1, 131.6 129.1, 128.4, 126.7, 124.7, 41.7, 39.7, 39.0, 25.6, 25.3. HRMS (ESI) m/z 
calcd for C16H15O2
 (M-H+) 239.1078, found 239.1072. 
 
 
To a solution of diene acid 3-3 (150.0 mg, 0.62 mmol) in THF (2.0 mL), LiAlH4 (1.0 M in 
THF, 0.81 mL, 0.81 mmol) was added slowly at 0 ⁰C. The mixture was warmed at room 
temperature and stirred for 30 min. The reaction was monitored by TLC. After the reaction 
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completed, the reaction mixture was quenched by fieser workup. The mixture was subjected 
to filtration, extracted with Et2O, dried over Na2SO4 and dried under vacuum. The crude 
product was subjected to column chromatography on silica gel with hexane/ethyl acetate (5/1) 
to give colorless oil (134.2 mg, 0.59 mmol, 95% yield). Compound 3-4a: []25D 26 (c 1.00, 
CHCl3). 
1H NMR(CDCl3) 7.44-7.40 (m, 2H), 7.33 (t, J = 7.7 Hz, 2H), 7.22 (tt, J = 7.3, 1.1 
Hz, 1H), 6.54 (dd, J = 6.3, 2.1 Hz, 1H), 6.13 (ddd, J = 6.1, 3.1, 1.4 Hz, 1H), 4.10-4.06 (m, 
2H), 3.74 (dd, J = 6.3, 2.5 Hz, 1H), 3.73 (dd, J = 6.3, 2.2 Hz, 1H), 3.58-3.54 (m, 1H), 
2.50-2.41 (m, 2H), 1.50-1.38 (m, 4H). 13C NMR (CDCl3) 147.3, 144.7, 138.1, 129.7, 128.8, 
128.4, 126.8, 124.7, 60.2, 41.6, 39.5, 37.0, 25.8, 25.4. HRMS (ESI) m/z calcd for C16H18ONa
+ 
(M+Na+) 249.1250, found 249.1247. 
 
 
To a solution of NaH (24.0 mg, 0.60 mmol, 60% in mineral oil) in THF (3.0 mL), diene 
alcohol 3-4a (67.9 mg, 0.30 mmol) and iodomethane (73.7 μL, 1.20 mmol) was added. Then 
the mixture was reflux for 4 h. The mixture was quenched with 1 drop of H2O. The mixture 
was dried with Na2SO4, filtered, and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel with hexane/ethyl acetate (10/1) to give 
colorless liquid (64.3 mg, 0.12 mmol, 89% yield). Compound 3-4b: []25D 8.4 (c 1.02, 
CHCl3). 
1H NMR(CDCl3)  7.41 (d, J = 8.2 Hz, 2H), 7.31 (t, J = 7.7 Hz, 2H), 7.21-7.18 (m, 
1H), 6.52 (dd, J = 6.3, 1.9 Hz, 1H), 6.03 (dd, J = 6.2, 1.4 Hz, 1H), 4.04-4.02 (m, 1H), 3.55 
(dd, J = 6.2, 1.3 Hz, 1H), 3.51-3.47 (m, 2H), 3.35 (s, 3H), 2.46 (t, J = 7.0 Hz, 2H), 1.44-1.40 
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(m, 4H). 13C NMR (CDCl3)  146.9, 145.1, 138.3, 129.0, 128.4, 127.7, 126.6, 124.7, 71.3, 
58.6, 41.9, 39.4, 34.0, 25.8, 25.3. HRMS (ESI) m/z calcd for C17H21O
+ (M+H+) 241.1587, 
found 241.1584.  
 
 
The flask was charged with diene acid 3-3 (48.0 mg, 0.20 mmol), 
N,N'-dicyclohexylcarbodiimide (57.8 mg, 0.28 mmol) and 4-dimethylaminopyridine (7.3 mg, 
0.06 mmol). The mixture was dissolved in CH2Cl2 (2.0 mL) and stirred for 30 min at room 
temperature. Benzylamine (26 μL, 0.24 mmol) was added to the mixture. After stirred at room 
temperature for 12 h, the mixture was dried under vacuum and subject to column 
chromatography on silica gel with hexane/ ethyl acetate (10/1 to 5/1) to give white solid (34.6 
mg, 0.11mmol, 53% yield). Compound 3-4c: []25D +15 (c 0.60, CHCl3). 
1H NMR(CDCl3)  
7.31-7.26 (m, 5H), 7.23-7.19 (m, 5H), 6.36 (dd, J = 6.2, 2.0 Hz, 1H), 6.20 (d, J = 6.0 Hz, 1H), 
5.72 (br, 1H), 4.56 (dd, J = 14.6, 6.5 Hz, 1H), 4.23 (dd, J = 14.6, 4.7 Hz, 1H), 4.07 (dd, J = 
6.2, 2.2Hz, 1H), 3.54 (dd, J = 6.1, 2.1 Hz, 1H), 3.21 (d, J = 16.1 Hz, 1H), 3.17 (d, J = 16.1 Hz, 
1H), 1.46-1.41 (m, 4H). 13C NMR (CDCl3)  170.2, 147.4, 142.6, 138.1, 137.8, 132.4, 129.0, 
128.7, 128.4, 127.8, 127.5, 126.9, 124.7, 43.7, 41.9, 41.7, 39.8, 25.6, 25.2. HRMS (ESI) m/z 
C23H23NONa





To a solution of diene acid 3-3 (50.0 mg, 0.21 mmol) in CH2Cl2 (4.0 mL), one drop of 
DMF and oxalyl chloride (36 μL, 0.42 mmol) were added dropwise. After the solution was 
stirred at room temperature for 3 h, aniline (36 μL, 0.42 mmol) was added and the mixture 
was stirred at room temperature for another 1 h. The it was quenched by one drop of water. 
The mixture was dried by Na2SO4, filtered and concentrated under vacuum. The crude 
product was subjected to column chromatography on silica gel with hexane/ether (10/1 to 5/1) 
to give product as white solid (30.9 mg, 0.10 mmol, 47% yield). Compound 3-4d: []25D +39 
(c 0.50, CHCl3). 
1H NMR(CDCl3)  7.44 (d, J =7.6 Hz, 2H), 7.41 (d, J = 7.9 Hz, 2H), 7.36 (t, 
J = 7.7 Hz, 2H), 7.30-7.25 (m, 3H), 7.23 (br, 1H), 7.08 (t, J = 7.4 Hz, 1H), 6.64 (dd, J = 6.2, 
1.7 Hz, 1H), 6.35 (d, J = 6.2 Hz, 1H), 4.20 (dd, J = 5.9, 1.9 Hz, 1H), 3.63 (dd, J = 6.0, 1.9 Hz, 
1H), 3.35 (d, J = 16.2 Hz, 1H), 3.27 (d, J = 16.4 Hz, 1H) 1.52-1.46 (m, 4H). 13C NMR (CDCl3) 
 168.5, 147.6, 142.6, 137.8, 133.3, 129.0, 128.9, 128.6, 127.2, 124.7, 124.2, 119.4, 105.0, 
42.9, 42.0, 40.0, 25.6, 25.3. HRMS (ESI) m/z C22H20NO
 (M-H+) 314.1550, found 314.1556. 
 
 
To a solution of diene acid 3-3 (100.0 mg, 0.42 mmol) in CH2Cl 2 (5.0 mL), one drop of 
DMF and oxalyl chloride (72 μL, 0.84 mmol) were added dropwise. The mixture was stirred 
at room temperature for 3 h. Ethanol (49 μL, 0.84 mmol) was added, and the result mixture 
was stirred at room temperature for another 1 h. The reaction was quenched by one drop of 
water. It was dried by Na2SO4, filtered and concentrated under vacuum. The crude product 
was subjected to column chromatography on silica gel with hexane/ ether (20:1) to give diene 
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ester as colorless oil (58.3 mg, 0.22 mmol, 52% yield). Compound 3-4e: []25D 5.0 (c 0.98, 
CHCl3). 
1H NMR(CDCl3):  7.40 (d, J = 7.9 Hz, 2H), 7.31 (t, J = 7.7 Hz, 2H), 7.20 (t, J = 7.3 
Hz, 1H), 6.56 (dd, J = 6.3, 1.9 Hz, 1H), 6.17 (d, J = 6.2, 1H), 4.16 (q, J = 7.1 Hz, 2H), 4.07 
(dd, J = 6.2, 2.1 Hz, 1H), 3.64 (dd, J = 6.2, 2.0 Hz, 1H), 3.19 (s, 2H), 1.52-1.41 (m, 4H), 1.28 
(t, J = 7.1 Hz, 3H). 13C NMR (CDCl3):  171.3, 146.5, 140.7, 138.2, 130.8, 129.1, 128.4, 
126.7, 124.7, 60.5, 41.7, 39.6, 39.4, 25.7, 25.3, 14.2. HRMS (ESI) m/z calcd for C18H20O2Na
+ 
(M+Na+) 291.1356, found 291.1363. 
 
3.4.3. General Procedure for Rhodium-Catalyzed Asymmetric 1,4-Additions  
General Procedure for Rhodium-Catalyzed Asymmetric Addition of Phenylboronic 
Acid to Enonoes 
 
A Schlenk tube was charged with [RhCl(coe)2]2 (3.2 mg, 9.0 μmol Rh), phenylboronic acid 
(73.2 mg, 0.60 mmol) and chiral diene ligand 4 (9.9 μmol). The mixture was dissolved in 
dioxane (1,0 mL) and stirred at room temperature for 10 min. Then aqueous KOH (0.10 mL, 
1.5 M, 0.15 mmol) was added, and it was stirred at room temperature for another 5 min. 
Subsequently, enone (0.30 mmol) was added and the mixture was heat at 40 ⁰C. After the 
reaction was compeleted, the mixture was passed through a short silica gel column (eluent: 
diethyl ether) and the solvent was removed under vacuum. The residue was subjected to 
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Compound 3-7am: (CAS 34993-51-6) Colorless oil. 98% yield. []25D +20 (c 1.00, CHCl3), 
R configuration. The ee value was 98%, tR (minor) = 10.0 min, tR (major) = 12.3 min 
(Chiralpak AD-H, λ = 254 nm, hexane/iPrOH = 99/1, flow rate = 1.0 mL/min). 1H NMR (500 
MHz, CDCl3)  7.33 (t, J = 7.5 Hz, 2H), 7.25-7.21 (m, 3H), 3.01 (tt, J = 11.9, 3.9 Hz, 1H), 
2.60 (ddt, J = 14.0, 4.4, 1.9 Hz, 1H), 2.53 (ddd, J = 13.8, 12.5, 0.9 Hz, 1H), 2.50-2.43 (m, 1H), 
2.38 (dddd, J = 14.3, 12.6, 6.1, 0.9 Hz, 1H), 2.15 (ddt, J= 13.0, 6.6, 3.2Hz, 1H), 2.12-2.06 (m, 
1H), 1.91-1.73 (m, 2H). 
 
 
Compound 3-7bm: (CAS 501919-45-5) Colorless oil. 99% yield. []25D +20 (c 1.00, 
CHCl3), S configuration. The ee value was 96%, tR (major) = 12.0 min, tR (minor) = 
15.8 min (Chiralcel OB-H, λ = 254 nm, hexane/iPrOH = 99/1, flow rate = 0.5 mL/min). 
1H NMR (500 MHz, CDCl3)  7.28 (t, J = 7.5 Hz, 2H), 7.21-7.15 (m, 3H), 3.15-3.06 
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(m, 1H), 2.73 (dd, J  = 16.1, 7.4 Hz, 1H), 2.69 (dd, J = 16.1, 7.0 Hz, 1H), 2.00 (s, 3H), 
1.65-1.50 (m, 2H), 1.30-1.06 (m, 6H), 0.82 (t, J = 6.9 Hz, 3H). 
 
Competitive Reaction with [RhCl(coe)2]2/3-4mix 
The reactions were carried out with diene mixture 3-4mix, which is a mixture of (R,R)-3-4a 
and (S,S)- Ph-bod in 1:1 ratio (determined by 1H NMR, Figure 3.3). The same procedure as 
above to give 1,4-addition products. 
 
 







General Procedure for Rhodium-Catalyzed Asymmetric Addition of NaBPh4 to 
,-Disubstituted Enones 
 
[RhCl(coe)2]2 (3.6 mg, 10 µmol Rh), diene (11 µmol), enone 3-5c (22.0 mg,0.20 mmol) 
and NaBPh4 (136.9 mg, 0.40 mmol) in a Schlenk tube was dissolved in dioxane (1.0 mL). 
After the mixture was stirred at room temperature for 10 min, MeOH (81.0 µL, 2.00 mmol) 
was added. The resulting solution was stirred at 70 °C for 24 h. The reaction mixture was 
passed through a pad of silica gel with Et2O as eluent and the solvent was removed under 
vacuum. The residue was subjected to column chromatography on silica gel with hexane/ethyl 
acetate (10/1) to afford 1,4-adduct. 
 
 
Compound 3-7cm: (CAS 905832-87-3) Colorless oil. 89% yield. []25D 71 (c 1.00, CHCl3), 
R configuration. The ee value was 96%, tR (major) = 17.0 min, tR (minor) = 20.1 min 
(Chiralcel OJ-H, λ = 254 nm, hexane/iPrOH = 95/5, flow rate = 0.5 mL/min). 1H NMR 
(CDCl3): δ 7.36-7.30 (m, 4H), 7.24-7.18 (m, 1H), 2.89 (d, J = 14.1 Hz, 1H), 2.45 (d, J = 14.2 
Hz, 1H), 2.34 (dd, J = 15.7, 6.4 Hz, 1H), 2.29 (dd, J = 15.3, 6.6 Hz, 1H), 2.19 (dddd, J = 13.6, 




3.4.4. Nonlinear Effect Analysis 
The reactions were carried out with enantioenriched chiral diene 3-4a, which ee value was 
determined by chiral HPLC analysis. [HPLC condition for diene 3-4a: Chiralpak IA, λ = 254 
nm, hexane/ iPrOH = 99/1, flow = 1.0 mL/min. Retention times: tR (minor) = 24.0 min, tR 




Scheme 3.5 The equilibrium between inactive dimeric complex and active monomeric complex 
 
We assume that the monomeric rhodium species R-3-4a and S-3-4a give identical reaction 
rate and the opposite enantioselectivities as active species. The enantiomeric purity of the 
product eeprod with non-enantiopure catalyst will be calculated by concentrations of monomers, 
[R] and [S], where eemax is the ee value of product by the enantiopure catalyst RR-3-4: 
𝑒𝑒pro =  𝑒𝑒max
[𝑅] − [𝑆]
[𝑅] + [𝑆]




The equilibrium constant Kdimer is defined as association constant. The homochiral dimer is 
overwhelmingly more stable than the heterochiral dimer. The formation of heterochiral dimer 
is considered to be negligible.5  







     (3) 
 
The total R or S catalyst concentrations are given by:  
[𝑅]𝑡𝑜𝑡𝑎𝑙 = 2[𝑅𝑅] + [𝑅] 
[𝑆]𝑡𝑜𝑡𝑎𝑙 = 2[𝑆𝑆] + [𝑆]     (4)   
 
The overall catalyst ee value based on total ligand concentrations is given by 
𝑒𝑒𝑐𝑎𝑡 =  
[𝑅]total  −  [𝑆]total
[𝑅]total  +  [𝑆]total
     (5) 
 








1 + (1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑆]𝑡𝑜𝑡𝑎𝑙)0.5
     (6) 
 
From the equation (1) and (6), we get: 
𝑒𝑒𝑝𝑟𝑜 = 𝑒𝑒𝑚𝑎𝑥 × [
2[𝑅]𝑡𝑜𝑡𝑎𝑙
1 + (1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑅]𝑡𝑜𝑡𝑎𝑙)0.5
−
2[𝑆]𝑡𝑜𝑡𝑎𝑙
1 + (1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑆]𝑡𝑜𝑡𝑎𝑙)0.5
2[𝑅]𝑡𝑜𝑡𝑎𝑙
1 + (1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑅]𝑡𝑜𝑡𝑎𝑙)0.5
+
2[𝑆]𝑡𝑜𝑡𝑎𝑙





𝑒𝑒𝑝𝑟𝑜 = 𝑒𝑒𝑚𝑎𝑥 × [
(1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑅]𝑡𝑜𝑡𝑎𝑙)
0.5 − (1 + 8𝐾𝑑𝑖𝑚𝑒𝑟[𝑆]𝑡𝑜𝑡𝑎𝑙)
0.5














= 0     (7) 
 
𝑒𝑒𝑚𝑎𝑥 = 98% 
𝑒𝑒𝑝𝑟𝑜 was determine by HPLC analysis  
[𝑅ℎ]𝑡𝑜𝑡𝑎𝑙 = 8.182 × 10
−3𝑀 [3 mol% Rh in 1.1 ml (dioxane+H2O)] 











Form the equation (7), the Kdimer values can be calculated. The experimental results and Kdimer 
were shown in Table 3.3. 
 

















1 3-4a 17.4 (R,R) 91 14.8 (R) 17.0 27 
2 3-4a 29.5 (R,R) 95 25.6 (R) 28.9 23 
3 3-4a 38.7 (R,R) 94 33.9 (R) 38.0 23 
4 3-4a 59.1 (R,R) 89 53.3 (R) 57.9 21 
5 3-4a 79.0 (R,R) 99 73.0 (R) 77.4 27 
6 3-4a 100 (R,R) 98 98.0 (R) 98.0  
7e 3-4e 41.4 (R,R) 86 37.4 (R) 38.7 6 
8e 3-4e 61.2 (R,R) 88 57.2 (R) 57.2 0 
9f 3-4e 100 (R,R) 78 93.5 (R) 93.5  
aEnone 3-5a (0.30 mmol), boronic acid 3-6m (0.60 mmol), [RhCl(coe)2]2 (9.0 μmol of Rh), 
diene ligand 3-4a or 3-4e (9.9 ümol), and KOH (0.15 mmol) in dioxane/H2O (1.0/0.1 mL) at 40 
⁰C for 1 h. bThe ee values of enantioenriched ligand 3-4a or 3-4e were determined by chiral 
HPLC. cIsolated yield. dThe product ee was determined by chiral HPLC. The absolute 
configuration of 3-7am was determined by comparison of its optical rotation with literature 





Chapter 4 Palladium-Catalyzed Asymmetric Arylation of 
Trifluoromethylated/Perfluoroalkylated 2-Quinazolinones 
with High Enantioselectivity 
 
4.1 Introduction 
Significant efforts have been made for the enantioselective synthesis of benzylic amines 
which are important structural motifs of biologically active compounds. In complement of 
enzymatic approaches by transamination of ketones,1 the rhodium- or palladium-catalyzed 
asymmetric addition of arylboron reagents to aldimines and ketimines is one of the most 
efficient methods to construct enantiomerically enriched benzylic amines.2,3 Compared with 
aldimines, ketimines are more changeling substrates as their reactivity is much lower due to 
the presence of the substituent on the azomethine carbon.3h,4f,4g Recently, the cyclic ketimines 
have attracted considerable attention in asymmetric arylation reactions. The enantioselectivity 
of the substrates with the cyclic structures is generally higher, in which syn-anti isomerization 
of the carbon–nitrogen double bond does not take place. Most of the cyclic imines previous 
used for the catalytic asymmetric arylation are those bearing an N-sulfonyl imine moiety, 
                                                             
(1) For reviews on biocatalytic transamination, see: (a) Xie, Y.; Pan, H.; Liu, M.; Xiao, X.; Shi, Y. Chem. Soc. Rev. 
2015, 44, 1740. (b) Fuchs, M.; Farnberger, J. E.; Kroutil, W. Eur. J. Org. Chem. 2015, 6965. 
(2) For reviews on the transition metal-catalyzed asymmetric addition of organometallic reagents to imines, see: (a) 
Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter, M. M. Chem. Rev. 2011, 111, 2626. (b) Marques, C. S.; Burke, A. J. 
ChemCatChem 2011, 3, 635. (c) Yamada, K.; Tomioka, K. Chem. Rev. 2008, 108, 2874. (d) Friestad, G. K.; 
Mathies, A. K. Tetrahedron 2007, 63, 2541. 
(3) Selected examples on asymmetric addition of organoboron reagents to acyclic imines; for Rh catalysis, see: (a) 
Kuriyama, M.; Soeta, T.; Hao, X.; Chen, Q.; Tomioka, K. J. Am. Chem. Soc. 2004, 126, 8128. (b) Tokunaga, N. ; 
Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 13584. (c) Weix, 
D. J.; Shi, Y.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 1092. (d) Otomaru, Y.; Kina, A.; Shintani, R.; Hayashi, T. 
Tetrahedron: Asymmetry 2005, 16, 1673. (e) Duan, H.-F.; Jia, Y.-X.; Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2006, 8, 
2567. (f) Jagt, R. B. C.; Toullec, P. Y.; Geerdink, D.; de Vries, J. G.; Feringa, B. L.; Minnaard, A. J. Angew. Chem. 
Int. Ed. 2006, 45, 2789. (g) Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. 
(h) Shintani, R.; Takeda, M.; Tsuji, T.; Hayashi, T. J. Am. Chem. Soc. 2010, 132, 13168. (i) Yang, H.-Y.; Xu, M.-H. 
Chem. Commun. 2010, 46, 9223. (j) Luo, Y.; Carnell, A. J. Angew. Chem. Int. Ed. 2010, 49, 2750. (k) Chen, C.-C.; 
Gopula, B.; Syu, J.-F.; Pan, J.-H.; Kuo, T.-S.; Wu, P.-Y.; Henschke, J. P.; Wu, H.-L. J. Org. Chem. 2014, 79, 8077. 
for Pd catalysis, see: (l) Dai, H.; Lu, X. Org. Lett. 2007, 9, 3077. (m) Dai, H.; Yang, M.; Lu, X. Adv. Synth. Catal. 
2008, 350, 249. (n) Dai, H.; Lu, X. Tetrahedron Lett. 2009, 50, 3478. (o) Ma, G.-N.; Zhang, T.; Shi, M. Org. Lett. 
2009, 11, 875. (p) Marques, C. S.; Burke, A. J. Eur. J. Org. Chem. 2010, 1639. (q) Chen, J.; Lu, X.; Lou, W.; Ye, Y.; 
Jiang, H.; Zeng, W. J. Org. Chem. 2012, 77, 8541. 
 62 
 
including: benzo[d]isothiazole 1,1-dioxide A, benzo[e][1,2,3]oxathiazine 2,2-dioxide B,4 and 
some other cyclic sulfonyl imines lacking the benzo-fusion C-F5 (Scheme 4.1a). One example 
of cyclic imine G which has N-acyl imine moiety instead of N-sulfonyl imine has also been 
reported.6 In this communication we wish to report that 2-quinazolinone derivatives 
substituted with fluoroalkyl groups 4-1 are a new class of cyclic imines suitable for the 
palladium-catalyzed asymmetric arylation reactions (Scheme 4.1b) 
Molecules substituted with trifluoromethyl or perfluoralkyl groups are of great importance 
in medicinal chemistry. The asymmetric approaches for the direct introduction of fluoroalkyl 
groups are important synthetic challenges.7 Alternatively, the employment of fluoroalkyl 
substrates would allow for easy access to chiral fluoroalkylated molecules. 
Dihydroquinazolinones containing trifluoromethyl group at the 4-position are known to be 
biologically active.8 Several reports have appeared on their catalytic asymmetric synthesis by 
enantioselective addition to 4-trifluoromethyl-2-quinazolinone derivatives,9-13 where high 
enantioselectivity has been realized in the addition of ketone enolates,9 nitroalkanes,10 
                                                             
(4) For Rh catalysis, see: (a) Nishimura, T.; Noishiki, A.; Tsui, G. C.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 
5056. (b) Luo, Y.; Carnell, A. J.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 6762. (c) Wang, H.; Xu, M.-H. 
Synthesis 2013, 2125. (d) Jiang, T.; Wang, Z.; Xu, M.-H. Org. Lett. 2015, 17, 528. (e) Takechi, R.; Nishimura, T. 
Org. Biomol. Chem. 2015, 13, 4918. For Pd catalysis, see: (f) Yang, G.; Zhang, W. Angew. Chem. Int. Ed. 2013, 52, 
7540. (g) Jiang, C.; Lu, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2014, 53, 9936. (h) Schrapel, C.; Peters, R. Angew. 
Chem. Int. Ed. 2015, 54, 10289. (i) Quan, M., Yang, G.; Xie, F.; Gridnev, I. D.; Zhang, W. Org. Chem. Front. 2015, 
2, 398. (j) Álvarez-Casao, Y.; Monge, D.; Álvarez, E.; Fernández, R.; Lassaletta, J. M. Org. Lett. 2015, 17, 5104. 
(5) (a) Luo, Y.; Hepburn, H. B.; Chotsaeng, N.; Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 8309. (b) Nishimura, 
T.; Ebe, Y.; Fujimoto, H.; Hayashi, T. Chem. Commun. 2013, 49, 5504. (c) Wang, H.; Li, Y.; Xu, M.-H. Org. Lett. 
2014, 16, 3962. (d) Kong, J.; McLaughlin, M.; Belyk, K.; Mondschein, R. Org. Lett. 2015, 17, 5520. (e) Li, Y.; Yu, 
Y.-N.; Xu, M.-H. ACS Catal. 2016, 6, 661. 
(6) Nishimura, T.; Noishiki, A.; Ebe, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2013, 52, 1777. 
(7) For selected reviews on asymmetric trifluoromethylation and perfluoroalkylation reactions, see: (a) Yang, X.; 
Wu, T.; Phipps, R. J.; Toste, F. D. Chem. Rev. 2015, 115, 826. (b) Dilman, A. D.; Levin, V. V. Eur. J. Org. Chem. 
2011, 831. (c) Ma, J.-A.; Cahard, D. Chem. Rev. 2008, 108, PR1. 
(8) Corbett, J. W.; Ko, S. S.; Rodgers, J. D.; Gearhart, L. A.; Magnus, N. A.; Bacheler, L. T.; Diamond, S.; Jeffrey, 
S.; Klabe, R. M.; Cordova, B. C.; Garber, S.; Logue, K.; Trainor, G. L.; Anderson, P. S.; Erickson-Viitanen, S. K. J. 
Med. Chem. 2000, 43, 2019. 
(9) (a) Jiang, B.; Dong, J. J.; Si, Y. G.; Zhao, X. L.; Huang, Z. G.; Xu, M. Adv. Synth. Catal. 2008, 350, 1360. (b) 
Yuan, H.-N.; Wang, S.; Nie, J.; Meng, W.; Yao, Q.; Ma, J.-A. Angew. Chem. Int. Ed. 2013, 52, 3869.  
(10) Xie, H.; Zhang, Y.; Zhang, S.; Chen, X.; Wang, W. Angew. Chem. Int. Ed. 2011, 50, 11773. 
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cyanide,11 indoles,12 and isocyanoacetates.13 However, there have been no reports on the 
catalytic asymmetric arylation of the 2-quinazolinone derivatives with arylboron reagents, to 
the best of our knowledge. 
 
 
Scheme 4.1 Catalytic asymmetric addition of arylboron reagents to cyclic imines 
 
                                                             
(11) Zhang, F.-G.; Zhu, X.-Y.; Li, S.; Nie, J.; Ma, J.-A. Chem. Commun. 2012, 48, 11552. 
(12) Zhang, K.-F.; Nie, J.; Guo, R.; Zheng, Y.; Ma, J.-A. Adv. Synth. Catal. 2013, 355, 3497. 
(13) Zhao, M.-X.; Bi, H.-L.; Jiang, R.-H.; Xu, X.-W.; Shi, M. Org. Lett. 2014, 16, 4566. 
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4.2 Result and Discussion 
4.2.1 Screening of Reaction Conditions 
Table 4.1 Catalytic Asymmetric Phenylation of 4-Trifluoromethyl-2-quinazolinone (4-1a) 




entry catalyst (5 mol%) additive (15 mol%) yield (%)b ee (%)c 
1 PdCl2[(S)-iPr-phox] AgBF4 97 99.8 (R) 
2 PdCl2[(S)-iPr-phox] AgOTf 90 99.7 (R) 
3 PdCl2[(S)-iPr-phox]  0  
4 PdCl2[(S)-Me-phox] AgBF4 97 99.3 (R) 
5 PdCl2[(S)-tBu-phox] AgBF4 93 99.9 (R) 
6 PdCl2[(S)-iPr-pyrox] AgBF4 42 89 (R) 
7 PdCl2[(S)-binap] AgBF4 0  
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8d [RhCl(R,R)-Ph-bod]2 K3PO4 67 93 (R) 
9e PdCl2[(S)-iPr-phox] AgBF4 97 99.8 (R) 
10e,f PdCl2[(S)-iPr-phox] AgBF4 96 99.8 (R) 
11g PdCl2[(S)-iPr-phox] AgBF4 88 99.8 (R) 
12g,h PdCl2[(S)-iPr-phox] AgBF4 95 99.8 (R) 
aReaction conditions unless otherwise noted: 4-1a (0.10 mmol), 4-3a (0.20 mmol), catalyst (5 
mol%), additive (15 mol%), 1,2-dichloroethane (1.0 mL), 65-70 ⁰C, 12 h. bIsolated yield of 4-4a. 
cDetermined by HPLC analysis with a chiral stationary phase column. The absolute configuration 
of 4-4a was determined by X-ray crystallographic analysis. dPerformed in 1,4-dioxane at 60 ⁰C, 12 
h. eWith PdCl2[(S)-iPr-phox] (1 mol%) and AgBF4 (3 mol%). 
fA larger scale reaction with 4-1a 
(2.50 mmol), 4-3a (7.50 mmol). gSemiaminal 4-2a in place of imine 4-1a. hPhenylboroxine 
(PhBO)3 (0.20 mmol of boron) in place of phenylboronic acid 4-3a. 
 
The results are summarized in Table 4.1. A cationic palladium complex coordinated with a 
chiral phosphine-oxazoline ligand (S)-iPr-phox,14 which has been reported to be effective as a 
catalyst for the asymmetric arylation of sulfonyl imines,4g was also found to be effective in 
this study. The reaction of 4-1a with 2 equiv of phenylboronic acid (4-3a) in the presence of 5 
mol% of a cationic palladium catalyst generated in situ from PdCl2[(S)-iPr-phox]
15 (5 mol%) 
and AgBF4 (15 mol%) in 1,2-dichloroethane at 65–70 °C for 12 h gave 97% yield of the 
phenylation product 4-4a, which was determined to be an R isomer of 99.8% ee by its X-ray 
crystal structure analysis16 and HPLC analysis with a chiral column (entry 1). The generation 
of a cationic palladium complex is essential for the high catalytic activity. The cationic 
complex generated with AgOTf in place of AgBF4 is also catalytically active to give 90% 
                                                             
(14) (a) von Matt, P.; Pfaltz, A. Angew. Chem. Int. Ed. 1993, 32, 566. (b) Sprinz, J.; Helmchen, G. Tetrahedron Lett. 
1993, 34, 1769. (c) Dawson, G. J.; Frost, C. G.; Williams, J. M. J.; Coote, S. J. Tetrahedron Lett. 1993, 34, 3149. 
(15) (a) Uozumi, Y.; Kato, K.; Hayashi, T. Tetrahedron: Asymmetry 1998, 9, 1065. (b) Blacker, A. J.; Clarke, M. L.; 
Loft, M. S.; Mahon, M. F.; Humphries, M. E.; Williams, J. M. J. Chem. Eur. J. 2000, 6, 353.  
(16) CCDC 1412243 [(R)-4-4a] contains the supplementary crystallographic data for this paper. These data are 
provided free of charge by The Cambridge Crystallographic Data Centre. 
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yield of (R)-4-4a (99.7% ee) (entry 2), but the addition reaction did not take place in the 
absence of the silver salts (entry 3). Phosphine-oxazoline ligands with methyl and t-butyl 
substituents at the stereogenic center, (S)-Me-phox and (S)-tBu-phox,14 were as good as the 
isopropyl analogue in terms of both catalytic activity and enantioselectivity (entries 4 and 5). 
The cationic palladium complex with pyridine-oxazoline ligand, (S)-iPr-pyrox,17 also 
catalyzed the reaction albeit with lower activity and enantioselectivity (entry 6). The binap 
complex was ineffective (entry 7). For comparison, the chiral diene–rhodium complex 
[RhCl((R,R)-Ph-bod)]3b,18 was examined for its performance (entry 8). Although the 
enantioselectivity was high (93% ee), the catalytic activity was lower than that of cationic 
palladium/phosphine-oxazoline complexes (entry 8). The cationic palladium complex was so 
catalytically active that we succeeded in reducing the amount of catalyst from 5 mol% to 1 
mol% without loss of yield or % ee (entry 9). A larger scale reaction giving a gram of product 
4-4a was successful with 1 mol% of the palladium catalyst (entry 10). 
The hemiaminal 4-2a, a synthetic precursor of 2-quinazolinone 4-1a, could be used as a 
substrate for the reaction. The yield of 4-4a was slightly lower (88%) when 4-2a was 
employed instead of 4-1a under identical conditions (entries 1 vs 11). The use of 
phenylboroxine (PhBO)3 in place of phenylboronic acid (4-3a) improved the yield to 95% 
(entry 12). The higher yield with boroxine may be ascribed to the dehydration of 4-2a into 
4-1a under the reaction conditions where the boroxine works as a dehydrating reagent 
generating imine 4-1a and boronic acid 4-3a in situ.6 Given the fact that synthesis and 
                                                             
(17) For references regarding (S)-iPr-pyrox, see: (a) Brunner, H.; Obermann, U.; Wimmer, P. J. Organomet. Chem. 
1986, 316, C1; for PdCl2[(S)-iPr-pyrox], see: (b) Dodd, D. W.; Toews, H. E.; Carneiro, F. d. S.; Jennings, M. C.; 
Jones, N. D. Inorg. Chim. Acta 2006, 359, 2850. 
(18) (a) Otomaru, Y.; Okamoto, K.; Shintani, R., Hayashi, T. J. Org. Chem. 2005, 70, 2503. (b) Abele, S.; Inauen, 
R.; Spielvogel, D.; Moessner, C. J. Org. Chem. 2012, 77, 4765. 
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isolation of imine 4-1a by dehydration of 4-2a is not always trivial, the asymmetric arylation 
with direct employment of hemiaminal 4-2a has advantages over the procedures of using 4-1a 
as a substrate. 
 
4.2.2 Scope of Arylboronic Acid and Substrates 






entry ArB(OH)2 (4-3) product 4-4 yield (%)
b ee (%)c 
1 PhB(OH)2 (4-3a) 4-4a 97 99.8 (R) 
2 4-MeC6H4B(OH)2 (4-3b) 4-4b 99 99.5 (R) 
3 4-MeOC6H4B(OH)2 (4-3c) 4-4c 99 99.9 (R) 
4 4-PhC6H4B(OH)2 (4-3d) 4-4d 82 99.9 (R) 
5 4-PhOC6H4B(OH)2 (4-3e) 4-4e 87 99.7 (R) 
6 3-MeC6H4B(OH)2 (4-3f) 4-4f 99 99.9 (R) 
7 3-PhC6H4B(OH)2 (4-3g) 4-4g 90 99.7 (R) 
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8 3,4-OCH2OC6H3B(OH)2 (4-3h) 4-4h 97 99.5 (R) 
9 4-FC6H4B(OH)2 (4-3i) 4-4i 87 99.9 (R) 
10 4-ClC6H4B(OH)2 (4-3j) 4-4j 22 99.9 (R) 
11d 4-3j 4-4j 62 99.9 (R) 
12d,e 4-3j 4-4j 65 99.9 (R) 
13 4-BrC6H4B(OH)2 (4-3k) 4-4k 19 99.8 (R) 
14d,e 4-3k 4-4k 48 99.8 (R) 
15 2-MeC6H4B(OH)2 (4-3l) 4-4l 53 99.8 (R) 
16 2-MeOC6H4B(OH)2 (4-3m) 4-4m 78 99.4 (S) 
aReaction conditions unless otherwise noted: 4-1a (0.10 mmol), 4-3 (0.20 mmol), 
PdCl2[(S)-iPr-phox] (1 mol%), AgBF4 (3 mol%), 1,2-dichloroethane (1.0 mL), 65–70 °C, 12 h. 
bIsolated yield of 4-4. cDetermined by HPLC analysis with chiral stationary phase columns. The 
absolute configurations were estimated based on stereochemical similarity to 4-4a. dWith 
boroxine (ArBO)3 (0.20 mmol boron). 
eWith PdCl2[(S)-iPr-phox] (5 mol%) and AgBF4 (15 
mol%). 
 
The cationic palladium catalyst generated from PdCl2[(S)-iPr-phox] and AgBF4 was found 
to be highly enantioselective for the asymmetric arylation with various types of arylboronic 
acids, and the enantioselectivity ranging between 99.4% and 99.9% ee in the arylation of 
2-quinazolinone 4-1a (Table 4.2). The catalytic activity was high even with 1 mol% of the 
palladium catalyst for the arylboronic acids 4-3b to 4-3i bearing methyl, phenyl, fluoro, and 
alkoxy groups at para- and/or meta- positions (entries 2-9). For the introduction of 4-Cl 
phenyl group, the yield of the arylation product was low (22%) under the standard conditions 
(2 equiv of arylboronic acids and 1 mol% of the Pd catalyst) although the enantioselectivity 
was high (entry 10). The low yield is attributed at least in part to the low solubility of boronic 
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acid 4-3j. The use of boroxine ((ArBO)3), which is more soluble than the boronic acid, 
improved the yield to 62% (entry 11). A larger amount of the catalyst (5 mol%) slightly 
improved the yield (entry 12). Similar results were obtained when the 4-Br phenyl group was 
introduced (entries 13 and 14). The enantioselectivity remained high for ortho-substituted 
boronic acids, although the yields were lower than para/meta-substituted substrates (entries 
15 and 16). 
 











1 F CF3 4-5a 98 99.9 (R) 
2 CF3 CF3 4-5b 96 99.4 (R) 
3 OMe CF3 4-5c 97 99.8 (R) 
4 Cl CF2CF3 4-5d 92 99.8 (R) 
5 Cl CF2CF2CF3 4-5e 92 99.9 (R) 
6 F CF2CF3 4-5f 70 99.2 (R) 
7 F CF2CF2CF3 4-5g 62 99.5 (R) 
8 Cl Me  0  
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9 Cl Ph  0  
aReaction conditions: 4-1 (0.10 mmol), 4-3a (0.20 mmol), PdCl2[(S)-iPr-phox] (1 mol%), 
AgBF4 (3 mol%), 1,2-dichloroethane (1.0 mL), 65–70 °C, 12 h. 
bIsolated yield of 4-5. 
cDetermined by HPLC analysis with chiral stationary phase columns. The absolute 
configurations were estimated based on stereochemical similarity to 4-4a. 
The substrate scope of the 2-quinazolinone derivatives is shown in Table 4.3. Replacement 
of Cl at 6 position of 4-1a by F, CF3, and OMe groups did not have any effect on the high 
catalytic activity or high enantioselectivity of the present system (entries 1-3). The 
2-quinazolinone derivatives with longer perfluoroalkyl groups, CF2CF3 and CF2CF2CF3, were 
also applicable, giving the corresponding phenylation products with high enantioselectivity 
(entries 4-7). The phenylation did not take place for those lacking the perfluoroalkyl group at 
the imine carbon (entries 8 and 9), suggesting that the electron withdrawing perfluoroalkyl 
group is essential for the activation of the imino group towards the addition of an 
aryl-palladium intermediate.2,3 
 
4.2.3 Derivatizations of (R)-4-4a and Stereochemical Model 




The asymmetric phenylation product (R)-4-4a was readily converted into its related 
compounds, 4-6, 4-7, and 4-8, by removal of the PMB group with trifluoroacetic acid, LiAlH4 
reduction into tetrahydroquinazoline, and nickel-catalyzed cross-coupling with MeMgBr, 
respectively, without erosion of enantiomeric purity (Scheme 4.2) 
Scheme 4.3 Stereochemical pathway giving (R)-4-4a with the Pd/(S)-iPr-phox catalyst; 
phenyl rings on the phosphorus are omitted for clarity 
 
The high enantioselectivity (>99% ee) of the reaction may be rationalized by the 
stereochemical model shown in Scheme 4.3, where the conformation of (S)-iPr-phox on 
palladium was drawn based on X-ray crystal structure reported for PdCl2[(S)-iPr-phox].
15b 
Thus, imine 4-1a coordinates to a phenyl-palladium intermediate with its si-face, leading to 
(R)-4-4a through migratory insertion into the phenyl–palladium bond. The coordination with 
the other face (re-face) would suffer from a serious steric interaction between the 
2-quinazolinone ring of 4-1a and the bulky isopropyl group on the (S)-iPr-phox ligand. 
 
4.3 Conclusions 
In summary, 2-quinazolinone derivatives substituted with fluoroalky groups at imine 
carbon were found to be reactive ketimine substrates for palladium-catalyzed asymmetric 
arylation with arylboronic acids. The enantioselectivity with a cationic 
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palladium/(S)-iPr-phox catalyst was very high (>99% ee) for all the 2-quinazolinone 
substrates and substituted arylboronic acids. The reported method allows for ready 
enantioselective synthesis of chiral trifluoromethylated and perfluoroalkylated 
2-quinazolinones, their potential biological activities are currently being evaluated. 
4.4 Experimental Section 
4.4.1 General 
All air- and moisture-sensitive manipulations were carried out with standard Schlenk 
techniques under argon. NMR spectra were recorded on Bruker AMX-500 spectrometer or 
Bruker AMX300 spectrometer. Chemical shifts were reported in δ (ppm) referenced to the 
residual solvent peak of CDCl3 (δ 7.26) or (CD3)2CO (δ 2.05) for 
1H NMR and CDCl3 (δ 77.0) 
or (CD3)2CO (δ 29.84) for 
13C NMR. Multiplicity was indicated as follows: s (singlet), d 
(doublet), t (triplet), q (quartet), m (multiplet), br (broad). Coupling constants were reported 
in Hertz (Hz). Optical rotations were measured on an Anton Paar MCP 200 machine. High 
resolution mass spectra (HRMS) (ESI) were obtained on a Bruker micrOTOF-Q II 
spectrometer. Enantiomeric excesses (ee) were determined by HPLC analysis on Shimadzu 
HPLC. 
THF was distilled over benzophenone ketyl under argon. Dichloromethane and 
1,2-dichloroethane were distilled over CaH2 under argon. Boronic acids and AgBF4 are 
commercial available and used as received. Boroxines,19 2-quinazolinone,10,20 phox ligands,14c 
                                                             
(19) So, C. M.; Kume, S.; Hayashi, T. J. Am. Chem. Soc. 2013, 135, 10990. 
(20) (a) Pierce, M. E.; Parsons, Jr., R. L.; Radesca, L. A.; Lo, Y. S.; Silverman, S.; Moore, J. R.; Islam, Q.; 
Choudhury, A.; Fortunak, J. M. D.; Nguyen, D.; Luo, C.; Morgan, S. J.; Davis, W. P.; Confalone, P. N. J. Org. 
Chem. 1998, 63, 8536. (b) Magnus, N. A.; Confalone, P. N.; Storace, L.; Patel, M.; Wood, C. C.; Davis, W. P.; 









prepared from PdCl2(MeCN)2 with the corresponding ligands in benzene according to the 
reported procedures. 
 
4.4.2 Experimental Procedures and Characterization Data 
Synthesis of 2-Quinazolinones 
The synthetic route of 4-1c is given as an example for synthesis of the 2-quinazolinones. 
The characterization data of new compounds are giving below. 
 
 
To a solution of 4-1c1 (3.00 g, 12.2 mmol) and TMEDA (2.19 mL, 14.7 mmol) in 
anhydrous THF (30.0 mL), n-BuLi (2.5 M in hexane, 10.2 mL, 26 mmol) was added dropwise 
at 78 ⁰C. The mixture was warmed to 0 ⁰C and it was stirred for 2 h. Then it was cooled to 
20 ⁰C, and ethyl trifluoroacetate (1.89 mL, 15.9 mmol) was added dropwise. The mixture 
was warm at 0 ⁰C for 2 h, iced H2O was added to quench the reaction, and it was extracted 
with ethyl acetate. The organic extract was dried over Na2SO4 and evaporated under vacuum. 
The crude product 4-1c2 was directly used for next step. 
 
                                                             




The crude product 4-1c2 was suspended in 37% HCl/dioxane (15.0 mL/5.0 mL) at room 
temperature, and the mixture was heated to 80 ⁰C. After 12 h, the reaction mixture was cooled 
to 0 ⁰C, and NaOH (50%, aq.) was added slowly to make the mixture pH > 12. The mixture 
was extracted with ethyl acetate. The organic extract was dried over Na2SO4 and evaporated 
under vacuum. The residue was subjected to silica gel column chromatography with 




To a solution of 4-1c3 (1.98 g, 7.70 mmol) in acetonitrile (25.0 mL), was added a solution 
of 4-methoxybenzyl alcohol (1.05 mL, 8.47 mmol) in acetonitrile (25.0 mL) at 70 ⁰C over 2 h. 
The mixture was stirred for another 2 h at this temperature. The solvent was removed under 
vacuum. The residue was subjected to silica gel column chromatography with hexane/ethyl 





Compound 4-1c4 (2.24 g, 5.92 mmol) and KOCN (1.44 g, 17.8 mmol) was suspended in 
AcOH/H2O (11.8 mL/1.18 mL) in a 50 mL flask, and the mixture was heated at 60 ⁰C for 4 h. 
It was diluted with H2O (15.0 mL) and cooled to 0 ⁰C. The precipitates formed were collected 
by filtration, rinsed with H2O (3×5.0 mL), washed with hexane (3×5.0 mL), and dry under 
vacuum at 80 ⁰C to give 4-1c5 as yellow solid (2.16 g, 87% yield). 
 
 
Compound 4-1c5 (2.16 g, 5.14 mmol) was dissolved in xylene (25.0 mL) in a 50 mL flask 
with Dean-Stark trap. After the solution was heated to reflux for 4 h, the solvent was removed 
under vacuum to give 4-1c as yellow solid (2.16 g, >99% yield). 
 
 
Yellow solid. 1H NMR (500 MHz, (CD3)2CO) δ 8.24 (s, 1H), 8.15 (d, J = 9.1 Hz, 1H), 7.89 (d, 
J = 9.0 Hz, 1H), 7.35 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.8 Hz, 2H), 5.59 (s, 2H), 3.76 (s, 3H). 
13C NMR (125 MHz, (CD3)2CO) δ 160.7 (q, J = 34.7 Hz), 160.3, 154.6, 147.9, 133.2 (q, J = 
3.0 Hz), 129.3, 128.7, 128.0, 125.5 (q, J = 269.6 Hz), 124.4 (t, J = 3.6 Hz), 120.9 (q, J = 
277.1 Hz), 118.4, 115.1, 112.4, 55.6, 48.3. 19F NMR (376 MHz, (CD3)2CO) δ 63.07, 66.94. 
HRMS (ESI) m/z calcd for C18H13F6N2O2





Yellow solid. 1H NMR (500 MHz, (CD3)2CO) δ 8.07 (d, J = 2.0 Hz, 1H), 7.88 (dd, J = 9.3, 
2.3 Hz, 1H), 7.72 (d, J = 9.3 Hz, 1H), 7.33 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.54 
(s, 2H), 3.76 (s, 3H). 13C NMR (125 MHz, (CD3)2CO) δ 160.5 (t, J = 27.1 Hz), 160.3, 153.9, 
144.7, 137.3, 129.3, 128.9, 128.1, 126.0 (t, J = 6.4 Hz), 119.4 (qt, J = 284.7, 34.4 Hz), 119.1, 
115.1, 114.4, 112.8 (tq, J =257.4, 36.7 Hz), 55.5, 48.2. 19F NMR (376 MHz, (CD3)2CO) δ 
81.30 (s, CF3), 110.71 (s, CF2). HRMS (ESI) m/z calcd for C18H12ClF5N2NaO2
+ (M+Na+) 
441.0400, found 441.0393. 
 
 
Yellow foam. 1H NMR (500 MHz, (CD3)2CO) δ 8.05 (s, 1H), 7.89 (dd, J = 9.3, 2.2 Hz, 1H), 
7.73 (d, J = 9.3 Hz, 1H), 7.32 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.55 (s, 2H), 3.76 
(s, 3H). 13C NMR (125 MHz, (CD3)2CO) δ 160.6 (t, J = 25.4 Hz), 160.3, 153.9, 144.7, 137.4, 
129.3, 129.0, 128.1, 126.2 (t, J = 7.2 Hz), 119.1, 118.8 (qt, J = 286.1, 33.4 Hz), 115.1, 114.9, 
114.0 (tt, J = 258.8, 30.7 Hz), 110.0 (tqt, J = 266.0, 37.9, 34.8 Hz), 55.6, 48.2. 19F NMR (376 
MHz, (CD3)2CO) δ 80.40 (t, J = 9.9 Hz, CF2CF2CF3), 109.35 (sextet, J = 9.5 Hz, 
CF2CF2CF3), 124.90 (t, J = 7.6 Hz, CF2CF2CF3). HRMS (ESI) m/z calcd for 
C19H12ClF7N2NaO2





Yellow solid. 1H NMR (500 MHz, (CD3)2CO) δ 7.82 (d, J = 8.8, 1H), 7.76-7.70 (m, 2H), 7.33 
(d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.55 (s, 2H), 3.76 (s, 3H). 13C NMR (125 MHz, 
(CD3)2CO) δ 160.8 (td, J = 26.9, 3.0 Hz), 160.2, 158.2 (d, J = 242.2 Hz), 154.1, 142.8, 129.3, 
128.3, 126.0 (d, J = 24.5 Hz), 119.5 (d, J = 8.1 Hz), 119.4 (qt, J = 284.5, 33.6 Hz), 115.1, 
113.9 (d, J = 8.0 Hz), 112.8 (tq, J = 257.4, 36.6 Hz), 112.0 (dt, J = 24.8, 6.3 Hz), 55.5, 48.3. 
19F NMR (376 MHz, (CD3)2CO) δ 81.35 (s, CF2CF3), 111.10 (s, CF2CF3), 119.61 (dt, J = 
8.8, 6.3 Hz, Ar-F). HRMS (ESI) m/z calcd for C18H12F6N2NaO2




Yellow solid. 1H NMR (500 MHz, (CD3)2CO) δ 7.80 (d, J = 9.1, 1H), 7.77-7.70 (m, 2H), 7.33 
(d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.56 (s, 2H), 3.75 (s, 3H). 13C NMR (125 MHz, 
(CD3)2CO) δ 160.8 (td, J = 24.9, 1.7 Hz), 160.3, 158.2 (d, J = 242.1 Hz), 154.1, 142.9, 129.3, 
128.3, 126.0 (d, J = 24.5 Hz), 119.5 (d, J = 8.2 Hz), 118.8 (qt, J = 285.9, 33.5 Hz), 115.1, 
114.4. (d, J = 8.5 Hz), 114.0 (tt, J = 258.8, 30.7 Hz), 112.0 (dt, J = 25.1, 7.0 Hz), 110.0 (tqt, J 
= 265.7, 38.0, 34.8 Hz), 55.6, 48.3. 19F NMR (376 MHz, (CD3)2CO) δ 80.42 (t, J = 9.9 Hz, 
CF2CF2CF3), 109.71 (sextet, J = 8.7 Hz, CF2CF2CF3), 119.55 (dt, J = 9.2, 6.3 Hz, Ar-F), 






475.0663, found 475.0664. 
 
Palladium-Catalyzed Asymmetric Arylation Reaction 
General Procedure for Palladium-Catalyzed Asymmetric Arylation of 2-Quinazolinones. 
  PdCl2[(S)-iPr-phox] (0.6 mg, 0.001 mmol), 2-quinazolinone (0.10 mmol), and boronic acid 
(0.20 mmol) were placed in a Schlenk tube. To the tube, 1,2-dichloroethane (0.5 mL) was 
added, and then AgBF4 (0.6 mg, 0.003 mmol) in 1,2-dichloroethane (0.5 mL) was added. The 
mixture was stirred at 65-70 °C for 12 h, and it was directly subjected to flash 
chromatography on silica gel using hexane/ethyl acetate (4:1) as an eluent to give adduct as a 
colorless solid. 
 
A Large Scale Procedure for Palladium-Catalyzed Asymmetric Phenylation of 
2-Quinazolinone 4-1a  
A Schlenk tube was charged with PdCl2[(S)-iPr-phox] (13.8 mg, 0.025 mmol), 
2-quinazolinone 4-1a (921.8 mg, 2.50 mmol), and benzeneboronic acid (4-3a) (914.5 mg, 
7.50 mmol). The mixture was dissolved in 1,2-dichloroethane (24.0 mL), and AgBF4 (14.6 
mg, 0.075 mmol) in 1,2-dichloroethane (1.0 mL) was added. The mixture was stirred at 
65-70 °C for 12 h, and it was directly subjected to silica gel column chromatography using 





General Procedure for Palladium-Catalyzed Asymmetric Arylation of Hemiaminal 4-2a 
  PdCl2[(S)-iPr-phox] (2.8 mg, 0.005 mmol), hemiaminal 4-2a (38.6 mg, 0.10 mmol), and 
boroxine (0.20 mmol B) were placed in a Schlenk tube under argon. To the tube, 
1,2-dichloroethane (0.5 mL) was added, and then AgBF4 (2.9 mg, 0.015 mmol) in 
1,2-dichloroethane (0.5 mL) was added. The mixture was stirred at 65-70 °C for 12 h, and it 
was directly subjected to flash chromatography on silica gel using hexane/ethyl acetate (4:1) 
as an eluent to give adduct as a colorless solid. 
 
 
Compound 4-4a: Colorless solid. 97% yield. []25D 19 (c 1.00, CHCl3). The ee value was 
99.8%, tR (major) = 10.3 min, tR (minor) = 12.2 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.58 (d, J = 6.9 
Hz, 2H), 7.46–7.39 (m, 3H), 7.15 (m, 3H), 6.84 (m, 4H), 5.95 (s, 1H), 5.20 (d, J = 16.3 Hz, 
1H), 5.04 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 152.3, 
137.8, 136.6, 130.1, 129.2, 129.1, 128.9, 128.1, 127.8 (q, J = 1.8 Hz), 127.7, 127.5, 125.2 (q, 
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J = 288.4 Hz), 120.8, 116.0, 114.3, 65.9 (q, J = 28.7 Hz), 55.2, 45.5. 19F NMR (282 MHz, 
CDCl3) δ 74.94 (s, CF3). HRMS (ESI) m/z calcd for C23H18ClF3N2O2Na




Compound 4-4b: Colorless solid. 99% yield. []25D 14 (c 1.02, CHCl3). The ee value was 
99.5%, tR (minor) = 20.0 min, tR (major) = 21.6 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 7.9 
Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 7.18-7.11 (m, 3H), 6.88-6.83 (m, 3H), 6.81 (d, J = 8.9 Hz, 
1H), 5.94 (s, 1H), 5.21 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H), 2.38 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 158.8, 152.4, 139.2, 136.6, 134.8, 130.0, 129.5, 129.2, 
128.2, 127.7 (q, J = 1.3 Hz), 127.6, 127.4, 125.3 (q, J = 288.4 Hz), 120.9, 115.9, 114.2, 65.7 
(q, J = 28.8 Hz), 55.2, 45.5, 21.0. 19F NMR (282 MHz, CDCl3) δ 75.07 (s, CF3). HRMS (ESI) 
m/z calcd for C24H20ClF3N2O2Na
+ (M+Na+) 483.1058, found 483.1061. 
 
 
Compound 4-4c: Colorless solid. 99% yield. []25D 9.1 (c 0.98, CHCl3). The ee value was 
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99.9%, tR (major) = 20.2 min, tR (minor) = 32.3 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.48 (d, J = 8.6 
Hz, 2H), 7.18-7.11 (m, 3H), 6.93 (d, J = 8.9 Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H), 6.83 (s, 1H), 
6.80 (d, J = 8.9 Hz, 1H), 5.88 (s, 1H), 5.20 (d, J = 16.2 Hz, 1H), 5.03 (d, J = 16.2 Hz, 1H), 
3.83 (s, 3H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 159.9, 158.8, 152.4, 136.6, 130.0, 
129.7, 129.2, 128.2, 127.6, 127.5, 125.3 (q, J = 288.5 Hz), 121.1, 115.9, 114.2, 114.1, 65.5 (q, 
J = 29.0 Hz), 55.3, 55.2, 45.5. 19F NMR (282 MHz, CDCl3) δ 75.20 (s, CF3). HRMS (ESI) 
m/z calcd for C24H20ClF3N2O3Na
+ (M+Na+) 499.1007, found 499.1013. 
 
 
Compound 4-4d: Colorless solid. 82% yield. []25D +9.2 (c 1.02, CHCl3). The ee value was 
99.9%, tR (major) = 18.2 min, tR (minor) = 44.0 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.69–7.63 (m, 
4H), 7.61 (d, J = 7.4 Hz, 2H), 7.47 (t, J = 7.6 Hz, 2H), 7.40 (t, J = 7.4 Hz, 1H), 7.19-7.13 (m, 
3H), 6.90 (s, 1H), 6.85 (d, J = 7.1 Hz, 2H), 6.83 (d, J = 7.5 Hz, 1H), 5.77 (s, 1H), 5.22 (d, J = 
16.2 Hz, 1H), 5.07 (d, J = 16.3 Hz, 1H), 3.77 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 
152.3, 142.1, 139.7, 136.6, 136.6, 130.2, 129.2, 128.9, 128.3 (q, J = 1.3 Hz), 128.1, 128.0, 
127.7, 127.6, 127.5, 127.1, 125.3 (q, J = 288.5 Hz), 120.7, 116.1, 114.3, 65.8 (q, J = 29.0 Hz), 
55.2, 45.6. 19F NMR (282 MHz, CDCl3) δ 74.93 (s, CF3). HRMS (ESI) m/z calcd for 
C29H22ClF3N2O2Na





Compound 4-4e: Colorless solid. 87% yield. []25D +5.2 (c 1.00, CHCl3). The ee value was 
99.7%, tR (major) = 15.6 min, tR (minor) = 49.9 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 8.7 
Hz, 2H), 7.42 -7.35 (m, 2H), 7.21-7.13 (m, 4H), 7.08 (dd, J = 8.5, 0.9 Hz, 2H), 7.02 (d, J = 
8.9 Hz, 2H), 6.886.83 (m, 3H), 6.82(d, J = 8.9 Hz, 1H), 5.72 (s, 1H), 5.21 (d, J = 16.4 Hz, 
1H), 5.05 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 158.4, 
155.9, 152.2, 136.6, 131.9, 130.2, 130.0, 129.5 (q, J = 1.7 Hz), 129.1, 128.1, 127.7, 127.6, 
125.2 (q, J = 288.6 Hz), 124.3, 120.8, 119.8, 118.1, 116.1, 114.3, 65.6 (q, J = 29.0 Hz), 55.3, 
45.6. 19F NMR (282 MHz, CDCl3) δ 75.10 (s, CF3). HRMS (ESI) m/z calcd for 
C29H22ClF3N2O3Na
+ (M+Na+) 561.1163, found 561.1163. 
 
 
Compound 4-4f:Colorless solid. 99% yield. []25D 25 (c 1.00, CHCl3) The ee value was 
99.9 %, tR (major) = 19.4 min, tR (minor) = 21.7 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.41-7.35 (m, 
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2H), 7.31 (t, J = 7.6 Hz, 1H), 7.22 (d, J = 7.4 Hz, 1H), 7.17 (d, J = 8.8 Hz, 2H), 7.15 (dd, J = 
9.3, 2.6 Hz, 1H), 6.88-6.83 (m, 3H), 6.82 (d, J = 8.9 Hz, 1H), 5.91 (s, 1H), 5.23 (d, J = 16.2 
Hz, 1H), 5.03 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H), 2.38 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
158.8, 152.3, 138.7, 137.7, 136.5, 130.1, 130.0, 129.2, 128.6, 128.5, 128.2, 127.7, 127.5, 
125.3 (q, J = 288.7 Hz), 124.8 (q, J = 1.7 Hz), 120.8, 115.9, 114.2, 65.8 (q, J = 28.8 Hz), 55.2, 
45.5, 21.6. 19F NMR (282 MHz, CDCl3) δ 74.90 (s, CF3). HRMS (ESI) m/z calcd for 
C24H20ClF3N2O2Na
+ (M+Na+) 483.1058, found 483.1062. 
 
 
Compound 4-4g: Colorless solid. 90% yield. []25D 11 (c 0.98, CHCl3). The ee value was 
99.7%, tR (major) = 8.6 min, tR (minor) = 9.5 min (Chiralpak IB, λ = 254 nm, hexane/iPrOH = 
9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.78 (s, 1H), 7.65 (d, J = 7.5 Hz, 
1H), 7.59–7.54 (m, 3H), 7.51 (t, J = 7.8 Hz, 1H), 7.46 (t, J = 7.6 Hz, 2H), 7.38 (t, J = 7.3 Hz, 
1H), 7.197.13 (m, 3H), 6.89 (s, 1H), 6.86-6.81 (m, 3H), 5.84 (s, 1H), 5.25 (d, J = 16.3 Hz, 
1H), 5.03 (d, J = 16.3 Hz, 1H), 3.77 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 152.4, 
142.1, 140.2, 138.4, 136.6, 130.2, 129.3, 129.2, 128.9, 128.1, 128.1, 127.9, 127.7, 127.6, 
127.3, 126.7, 126.6, 125.3 (q, J = 288.3 Hz), 120.6, 116.1, 114.3, 66.0 (q, J = 28.8 Hz), 55.2, 
45.6. 19F NMR (282 MHz, CDCl3) δ 74.73 (s, CF3). HRMS (ESI) m/z calcd for 
C29H22ClF3N2O2Na





Compound 4-4h: Pale yellow solid. 97% yield. []25D 6.2 (c 0.99, CHCl3) The ee value was 
99.5%, tR (major) = 19.9 min, tR (minor) = 25.9 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.18-7.12 (m, 
3H), 7.08 (d, J = 8.2 Hz, 1H), 7.00 (s, 1H), 6.88 (s, 1H), 6.85 (d, J = 8.6 Hz, 2H), 6.83-6.78 
(m, 2H), 6.03-5.97 (m, 3H), 5.19 (d, J = 16.2 Hz, 1H), 5.02 (d, J = 16.3 Hz, 1H), 3.77 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 158.8, 152.3, 148.2, 148.2, 136.5, 131.3, 130.1, 129.0, 128.1, 
127.6, 127.5, 125.2 (q, J = 288.4 Hz), 121.5, 120.8, 116.0, 114.2, 108.7, 108.0, 101.7, 65.7 (q, 
J = 29.0 Hz), 55.2, 45.5. 19F NMR (282 MHz, CDCl3) δ 75.02 (s, CF3). HRMS (ESI) m/z 
calcd for C24H17ClF3N2O4
- (M-H+) 489.0834, found 489.0842. 
 
 
Compound 4-4i: Colorless solid. 87% yield. []25D 19 (c 0.98, CHCl3). The ee value was 
99.9%, tR (major) = 12.1 min, tR (minor) = 81.5 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min) 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.3 
Hz, 1H), 7.56 (d, J = 8.2 Hz, 1H), 7.16 (dd, J = 9.1, 2.4 Hz, 1H), 7.15-7.08 (m, 4H), 6.85 (d, J 
= 8.7 Hz, 2H), 6.82 (d, J = 9.1 Hz, 1H), 6.79 (s, 1H), 6.13 (s, 1H), 5.18 (d, J = 16.2 Hz, 1H), 
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5.02 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 162.8 (d, J = 250.4 
Hz), 158.9, 152.3, 136.6, 133.7 (d, J = 3.4 Hz), 130.3, 130.0 (dq, J = 8.3, 1.7 Hz), 129.0, 
128.0, 127.7, 125.2 (q, J = 288.6 Hz), 120.6, 116.1, 115.9 (d, J = 21.7 Hz), 114.3, 65.5 (q, J = 
29.1 Hz), 55.2, 45.5. 19F NMR (282 MHz, CDCl3) δ 75.11 (s, 3F, CF3), 111.38 (tt, J = 8.0, 
4.9 Hz, 1F, Ph-F). HRMS (ESI) m/z calcd for C23H17ClF4N2O2Na




Compound 4-4j: Colorless solid. 65% yield. []25D +4.9 (c 1.00, CHCl3). The ee value was 
99.9%, tR (major) = 13.1 min, tR (minor) = 31.6 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.5 
Hz, 2H), 7.40 (d, J = 8.8 Hz, 2H), 7.17 (dd, J = 8.9, 2.4 Hz, 1H), 7.13 (d, J = 8.6 Hz, 2H), 
6.86-6.81 (m, 3H), 6.80 (d, J = 1.5 Hz, 1H), 6.07 (s, 1H), 5.18 (d, J = 16.3 Hz, 1H), 5.02 (d, J 
= 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 152.3, 136.6, 136.3, 135.5, 
130.4, 129.3 (q, J = 1.9 Hz ), 129.1, 129.0, 128.0, 127.7, 127.7, 125.1 (q, J = 288.5 Hz), 120.3, 
116.2, 114.3, 65.6 (q, J = 29.1 Hz), 55.3, 45.6. 19F NMR (282 MHz, CDCl3) δ 75.02 (s, CF3). 
HRMS (ESI) m/z calcd for C23H17Cl2F3N2O2Na





Compound 4-4k: Colorless solid. 48% yield. []25D 2.3 (c 1.02, CHCl3). The ee value was 
99.8%, tR (major) = 12.3 min, tR (minor) = 22.0 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.8 
Hz, 2H), 7.45(d, J = 8.5 Hz, 2H), 7.17 (dd, J = 8.9, 2.4 Hz, 1H), 7.13 (d, J = 8.6 Hz, 2H), 
6.87-6.81 (m, 3H), 6.80 (d, J = 1.6 Hz, 1H), 5.90 (s, 1H), 5.19 (d, J = 16.3 Hz, 1H), 5.03 (d, J 
= 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 152.2, 136.8, 136.6, 132.1, 
130.4, 129.6, 128.9, 128,0, 127.7, 127.7, 125.0 (q, J = 288.2 Hz), 123.8, 120.3, 116.2, 114.3, 
65.7 (q, J = 29.1 Hz), 55.3, 45.6. 19F NMR (282 MHz, CDCl3) δ 75.02 (s, CF3). HRMS (ESI) 
m/z calcd for C23H17BrClF3N2O2Na
+ (M+Na+) 547.0006, found 547.0002. 
 
 
Compound 4-4l: Colorless solid. 53% yield. []25D 35 (c 0.99, CHCl3). The ee value was 
99.8%, tR (major) = 15.2 min, tR (minor) = 25.2 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.1 
Hz, 1H), 7.34 (t, J = 7.1 Hz, 1H), 7.28 (t, J = 7.5 Hz, 1H), 7.24-7.18 (m, 3H), 7.16 (dd, J = 8.9, 
2.3 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 8.9 Hz, 1H), 6.72 (s, 1H), 5.63 (s, 1H), 5.21 
(d, J = 16.1 Hz, 1H), 5.10 (d, J = 16.2 Hz, 1H), 3.78 (s, 3H), 2.05 (s, 3H). 13C NMR (125 
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MHz, CDCl3) δ 158.9, 151.9, 138.4, 137.1, 134.6, 134.1, 130.3, 129.6, 128.3, 128.2, 127.6, 
127.6, 126.9 (q, J = 4.0 Hz), 125.8, 125.5 (q, J = 289.1 Hz), 119.5, 115.6, 114.3, 66.2 (q, J = 
27.9 Hz), 55.2, 45.6, 21.5. 19F NMR (282 MHz, CDCl3) δ -75.07 (br, CF3). HRMS (ESI) m/z 
calcd for C24H20ClF3N2O2Na
+ (M+Na+) 483.1058, found 483.1063. 
 
 
Compound 4-4m: White solid. 78% yield. []25D +8.4 (c 0.99, CHCl3). The ee value was 
99.4%, tR (major) = 13.1 min, tR (minor) = 22.0 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.52 (dt, J = 7.8, 
1.9 Hz, 1H), 7.41 (td, J = 7.9, 1.5 Hz, 1H), 7.22 (d, J = 8.7 Hz, 2H), 7.10 (dd, J = 8.8, 2.4 Hz, 
1H), 7.00 (td, J = 7.8, 1.1 Hz, 1H), 6.94 (d, J = 8.3 Hz, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.83 (s, 
1H), 6.76 (d, J = 8.9 Hz, 1H), 5.60 (s, 1H), 5.24 (d, J = 16.1 Hz, 1H), 5.03 (d, J = 15.3 Hz, 
1H), 3.78 (s, 3H), 3.48 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.8, 158.0, 151.9, 136.7, 
131.1, 129.3, 128.6, 127.6, 127.1 (q, J = 3.4 Hz), 126.8, 126.7, 125.8, 125.0 (q, J = 287.7 Hz), 
120.5, 120.1, 115.1, 114.2, 113.6, 64.7 (q, J = 28.3 Hz), 55.7, 55.2, 45.5. 19F NMR (282 MHz, 
CDCl3) δ 75.12 (s, CF3). HRMS (ESI) m/z calcd for C24H20ClF3N2O3Na






Compound 4-5a: Colorless solid. 98% yield. []25D 66 (c 1.02, CHCl3). The ee value was 
99.9%, tR (major) = 11.0 min, tR (minor) = 12.3 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min).1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 7.0 
Hz, 2H), 7.46-7.40 (m, 3H), 7.16 (d, J = 8.7 Hz, 2H), 6.90 (ddd, J = 9.2, 7.6, 2.9 Hz, 1H), 
6.87-6.81 (m, 3H), 6.60 (dd, J = 8.7, 2.5Hz, 1H), 5.69 (s, 1H), 5.20 (d, J = 16.3 Hz, 1H), 5.07 
(d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 157.8 (d, J = 242.8 
Hz), 152.4, 137.9, 134.2, 129.3, 128.9, 128.3, 127.8 (q, J = 1.9 Hz), 127.7, 125.3 (q, J = 288.5 
Hz), 120.7 (d, J = 7.3 Hz), 117.0 (d, J = 22.5 Hz), 116.3 (d, J = 25.3 Hz), 116.0 (d, J = 7.8 Hz), 
114.3, 65.9 (q, J = 28.6 Hz), 55.3, 45.7.19F NMR (282 MHz, CDCl3) δ 74.85 (s, 3F, CF3), 
120.47 (ddd, J = 8.6, 7.7, 4.7 Hz, 1F, Ar-F). HRMS (ESI) m/z calcd for C23H18F4N2O2Na
+ 
(M+Na+) 453.1197, found 453.1195. 
 
 
Compound 4-5b: Colorless solid. 96% yield. []25D 43 (c 0.98, CHCl3). The ee value was 
99.4%, tR (major) = 7.3 min, tR (minor) = 8.6 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 
9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.58 (d, J = 6.3 Hz, 2H), 7.48–
7.40 (m, 4H), 7.17 (d, J = 8.4 Hz, 2H), 7.09 (s, 1H), 6.99 (d, J = 8.7 Hz, 1H), 6.86 (d, J = 8.5 
 89 
 
Hz, 2H), 6.03 (br, 1H), 5.24 (d, J = 16.2 Hz, 1H), 5.10 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 159.0, 152.2, 140.8, 137.6, 129.4, 129.0, 128.65, 127.8, 127.7, 
127.3 (q, J = 3.5 Hz), 126.5 (q, J = 2.4 Hz), 125.2 (q, J = 288.6 Hz), 124.4 (q, J = 33.3 Hz), 
123.6 (q, J = 271.7 Hz), 119.6, 114.9, 114.4, 66.0 (q, J = 28.8 Hz), 55.2, 45.7. 19F NMR (282 
MHz, CDCl3) δ 62.15 (s, 3F, Ar-CF3), 75.07 (s, 3F, R-CF3). HRMS (ESI) m/z calcd for 
C24H18F6N2O2Na
+ (M+Na+) 503.1165, found 503.1172. 
 
 
Compound 4-5c: Colorless solid. 97% yield. []25D 16 (c 1.00, CHCl3). The ee value was 
99.8%, tR (major) = 18.4 min, tR (minor) = 20.6 min (Chiralpak IC, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.2 
Hz, 2H), 7.45–7.37 (m, 3H), 7.17 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 6.81 (d, J = 
9.1 Hz, 1H), 6.74 (dd, J = 9.0, 2.8 Hz, 1H), 6.43 (s, 1H), 5.54 (s, 1H), 5.19 (d, J = 16.3 Hz, 
1H), 5.06 (d, J = 16.4 Hz, 1H), 3.78 (s, 3H), 3.60 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 
158.7, 154.6, 152.6, 138.4, 131.5, 129.0, 128.8, 128.7, 127.9, 127.8, 127.7, 125.5 (q, J = 
288.5 Hz), 120.4, 115.6, 114.8, 114.2, 66.1 (q, J = 28.7 Hz), 55.4, 55.2, 45.5. 19F NMR (282 
MHz, CDCl3) δ 74.67 (s, CF3). HRMS (ESI) m/z calcd for C24H21F3N2O3Na
+ (M+Na+) 





Compound 4-5d: Colorless solid. 92% yield. []25D +5.0 (c 1.01, CHCl3). The ee value was 
99.8%, tR (major) = 7.1 min, tR (minor) = 10.3 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH 
= 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.4 Hz, 2H), 7.47–
7.36 (m, 3H), 7.14 (dd, J = 8.9, 2.4 Hz, 1H), 7.10 (d, J = 8.6 Hz, 2H), 7.06 (s, 1H), 6.83 (d, J 
= 8.7 Hz, 2H), 6.81 (d, J = 8.9 Hz, 1H), 5.86 (s, 1H), 5.14 (d, J = 16.3 Hz, 1H), 5.05 (d, J = 
16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 151.8, 138.8, 136.3, 130.1, 
129.2 (d, J = 4.3 Hz), 129.1, 128.9, 128.1, 127.7 (t, J = 2.8 Hz), 127.7, 127.6, 120.0 (d, J = 
1.8 Hz), 119.2 (qt, J = 289.7, 36.1 Hz), 116.1, 114.4 (tq, J = 266.3, 34.2 Hz), 114.3, 65.3 (t, J 
= 23.6 Hz), 55.2, 45.8. 19F NMR (282 MHz, CDCl3) δ 76.45 (s, 3F, CF3), 114.76 (d, J = 
281.6 Hz, 1F, CF2), 117.40 (d, J = 279.6 Hz, 1F, CF2). HRMS (ESI) m/z calcd for 
C24H18ClF5N2O2Na
+ (M+Na+) 519.0869, found 519.0873. 
 
 
Compound 4-5e: Colorless solid. 92% yield. []25D 4.0 (c 1.00, CHCl3). The ee value was 
99.9%, tR (major) = 5.8 min, tR (minor) = 9.7 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 
9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 7.6 Hz, 2H), 
7.45-7.36 (m, 3H), 7.14 (dd, J = 8.9, 2.3 Hz, 1H), 7.11 (d, J = 8.6 Hz, 2H), 7.06 (s, 1H), 
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6.84-6.77 (m, 3H), 6.23 (s, 1H), 5.11 (d, J = 16.4 Hz, 1H), 5.07 (d, J = 16.7 Hz, 1H), 3.77 (s, 
3H). 13C NMR (125 MHz, CDCl3) δ 158.9, 152.1, 138.6, 136.4, 130.0, 129.1, 129.1, 128.9, 
128.1, 127.7, 127.5, 127.5, 120.0, 117.7 (qt, J = 285.0, 33.1 Hz), 116.1, 116.0 (tt, J = 265.0, 
28.8 Hz ), 114.2, 110.7 (t sextet, J = 267.5, 37.4 Hz), 66.4 (t, J = 23.8 Hz), 55.2, 45.7. 19F 
NMR (282 MHz, CDCl3) δ 80.94 (t, J = 11.4 Hz, CF2CF2CF3), 110.41 (d, J = 289.5 Hz, 1F, 
CF2CF2CF3) 111.62 (d, J = 290.6 Hz, 1F, CF2CF2CF3), 119.66 (br, CF2CF2CF33). HRMS 
(ESI) m/z calcd for C25H18ClF7N2O2Na
+ (M+Na+) 569.0837, found 569.0836. 
 
 
Compound 4-5f: Colorless solid. 70% yield. []25D 36 (c 0.95, CHCl3). The ee value was 
99.2%, tR (major) = 7.7 min, tR (minor) = 10.9 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH 
= 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 7.3 Hz, 2H), 7.47–
7.36 (m, 3H), 7.11 (d, J = 8.7 Hz, 2H), 6.90 (ddd, J = 9.2, 7.5, 2.9 Hz, 1H), 6.866.79 (m, 
4H), 5.72 (s, 1H), 5.15 (d, J = 16.3 Hz, 1H), 5.05 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 158.9, 157.7 (d, J = 242.6 Hz), 151.9, 138.8, 133.9, 129.1, 128.9, 128.2, 
127.6, 127.6, 119.9 (dd, J =7.0, 1.9 Hz), 119.2 (qt, J = 287.8, 35.9 Hz), 117.0 (d, J = 22.5 Hz), 
116.3 (dd, J = 25.2, 3.8 Hz), 116.1 (d, J = 7.9 Hz), 114.4 (tq, J = 266.1, 34.4 Hz), 114.3, 65.3 
(t, J = 23.6 Hz), 55.3, 45.9. 19F NMR (282 MHz, CDCl3) δ 76.48 (s, CF2CF3), 114.75 (d, J 
= 281.4 Hz, 1F, CF2CF3) 117.42 (d, J = 282.8 Hz, 1F, CF2CF3), 120.29 (ddd, J = 8.8, 7.7, 
4.8 Hz, Ar-F). HRMS (ESI) m/z calcd for C24H18F6N2O2Na






Compound 4-5g: Colorless solid. 62% yield. []25D 42 (c 1.00, CHCl3). The ee value was 
99.5%, tR (major) =6.1 min, tR (minor) = 10.5 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH 
= 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 7.5 Hz, 2H), 
7.46-7.37 (m, 3H), 7.11 (d, J = 8.6 Hz, 2H), 6.90 (ddd, J = 9.2, 7.6, 2.9 Hz, 1H), 6.87-6.80 (m, 
4H), 5.80 (s, 1H), 5.14 (d, J = 16.3 Hz, 1H), 5.07 (d, J = 16.3 Hz, 1H), 3.78 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 158.9, 157.7 (d, J = 241.1 Hz), 152.1, 138.6, 134.0, 129.1, 128.9, 128.3, 
127.6, 127.4, 120.3 (d, J =7.2 Hz), 117.7 (qt, J = 286.9, 33.3 Hz), 116.9 (d, J = 22.4 Hz), 
116.3 (d, J = 24.5 Hz), 116.1 (d, J = 7.7 Hz), 116.0 (tt, J = 265.6, 28.5 Hz), 114.3, 110.7 (t 
sextet, J = 267.4, 37.3 Hz), 66.4 (t, J = 23.6 Hz), 55.2, 45.9. 19F NMR (282 MHz, CDCl3) δ 
80.94 (t, J = 11.5 Hz, CF2CF2CF3), 110.49 (d, J = 290.1 Hz, 1F, CF2CF2CF3) 111.64 (d, J 
= 290.7 Hz, 1F, CF2CF2CF3), 119.66 (dd, J = 22.2, 9.4 Hz, CF2CF2CF3), 120.38 (ddd, J = 
9.0, 7.5, 4.7 Hz, Ar-F). HRMS (ESI) m/z calcd for C25H18F8N2O2Na








Derivatization of the Arylation Products. 
 
A Schlenk tube was charged with 4-4a (44.7 mg, 0.10 mmol), anisole (0.5 mL), and 
trifluoroacetic acid (1.0 mL) in this sequence. The mixture was heated to 70 ⁰C for 3 h. Water 
was added and it was extracted with ethyl acetate. The organic layer was washed with 
NaHCO3, dried over Na2SO4, and evaporated under vacuum. The crude product was purified 
by silica gel column chromatography with hexane/ethyl acetate (1:1) to give 4-6 (32.6 mg, 99% 
yield) as colorless solid. Compound 4-6: colorless solid. 99% yield. []25D 53 (c 1.00, 
CHCl3). The ee value was 99.8%, tR (major) = 7.4 min, tR (minor) = 8.8 min (Chiralpak IC, λ 
= 254 nm, hexane/i-PrOH = 19/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 
9.45 (s, 1H), 7.56 (d, J = 7.3 Hz, 2H), 7.46-7.36 (m, 3H), 7.19 (dd, J = 8.6, 2.2 Hz, 1H), 6.81 
(s, 1H), 6.77 (d, J = 8.6 Hz, 1H), 6.12 (s, 1H). 13C NMR (125 MHz, CDCl3) δ 152.9, 137.7, 
135.2, 130.5, 129.3, 129.0, 128.9, 127.7 (q, J = 1.7 Hz), 127.6, 125.2 (q, J = 286.2), 118.3, 
116.2, 66.8 (q, J = 28.8). 19F NMR (282 MHz, CDCl3) δ 74.97. HRMS (ESI) m/z calcd for 
C15H11ClF3N2O
+ (M+H+)327.0507, found 327.0502. 
 
 
To a solution of 4-4a (44.7 mg, 0.10 mmol) in anhydrous THF (2.0 mL), LiAlH4 (1.0 M in 
THF, 0.30 mL, 0.30 mmol) was added dropwise at 0 ⁰C. The mixture was heated to reflux 
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while the reaction was monitored by TLC. The reaction was completed in 12 h, and H2O was 
added at 0 ⁰C to quench the reaction. The mixture was extracted with ethyl acetate. The 
organic layer was dried over Na2SO4 and evaporated under vacuum. The crude product was 
subjected to silica gel column chromatography with hexane/ethyl acetate (10:1) to yield 4-7 
(37.6 mg, 87% yield) as colorless oil. Compound 4-7: Colorless oil. 87% yield. []25D +157 
(c 1.00, CHCl3). The ee value was 99.8%, tR (minor) =8.4 min, tR (major) = 10.4 min 
(Chiralpak IF, λ = 254 nm, hexane/i-PrOH = 199/1, flow rate = 1.0 mL/min). 1H NMR (500 
MHz, CDCl3) δ 7.50-7.45 (m, 2H), 7.39-7.34 (m, 4H), 7.12 (dd, J = 8.9, 2.0 Hz, 1H), 6.95 (d, 
J = 8.3 Hz, 2H), 6.78 (d, J = 8.5 Hz, 2H), 6.61 (d, J = 8.9 Hz, 1H), 4.32 (d, J = 16.5 Hz, 1H), 
4.26 (d, J = 16.5 Hz, 1H), 4.17 (d, J = 11.5 Hz, 1H), 4.02 (d, J = 11.5 Hz, 1H), 3.77 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 158.8, 143.2, 137.4, 129.2, 129.0, 129.0, 128.8, 128.5, 127.7, 
127.5 (q, J = 3.6 Hz), 126.0 (q, J = 283.9 Hz), 121.3, 120.5, 114.3, 114.1, 65.0 (q, J = 26.3 
Hz), 59.4, 55.3, 51.2. 19F NMR (282 MHz, CDCl3) δ 71.16. HRMS (ESI) m/z calcd for 
C23H21ClF3N2O
+ (M+H+) 433.1289, found 433.1294. 
 
 
To a solution of 4-4a (44.7 mg, 0.10 mmol) and NiCl2(dppp) (5.4 mg, 0.01 mmol) in 
benzene (1.0 mL), MeMgBr (3.0 M in Et2O, 0.33 mL, 1.0 mmol) was added dropwise at 0 ⁰C. 
The mixture was heated to reflux for 12 h. NH4Cl (aq) was added at 0 ⁰C and it was extracted 
with ethyl acetate. The organic layer was combined, dried over Na2SO4, and evaporated under 
vacuum. The crude product was purified by silica gel column chromatography with 
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hexane/ethyl acetate (4:1) to give 4-8 (39.2 mg, 92% yield) as colorless solid. Compound 4-8: 
Colorless solid. 92% yield. []25D 33 (c 1.00, CHCl3). The ee value was 99.8%, tR (minor) 
=14.3 min, tR (major) = 16.0 min (Chiralpak IC, λ = 254 nm, hexane/i-PrOH = 9/1, flow rate 
= 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 7.2 Hz, 2H), 7.45-7.36 (m, 3H), 
7.17 (d, J = 8.3 Hz, 2H), 6.99 (d, J = 8.5 Hz, 1H), 6.84 (d, J = 8.4 Hz, 2H), 6.78 (d, J = 8.4 Hz, 
1H), 6.65 (s, 1H), 5.66 (s, 1H), 5.20 (d, J = 16.2 Hz, 1H), 5.07 (d, J = 16.3 Hz, 1H), 3.77 (s, 
3H), 2.13 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 158.7, 152.6, 138.7, 135.5, 131.8, 130.7, 
129.7, 128.9, 128.8, 128.7, 127.9 (q, J =1.9 Hz), 127.7, 125.0 (q, J = 286.7 Hz), 119.0, 114.6, 
114.2, 66.1 (q, J = 28.6 Hz), 55.2, 45.4, 20.5. 19F NMR (376 MHz, CDCl3) δ 74.86. HRMS 
(ESI) m/z calcd for C24H21F3N2O2Na
+ (M+Na+) 449.1447, found 449.1437. 
 
4.4.3 X-ray Crystal Structure of 4-4a 
 
Figure 4.1 Crystal structure of 4-4a  
 
Identification code  E352 
Empirical formula  C23 H18 Cl F3 N2 O2 
Formula weight  446.84 
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Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 10.5894(4) Å a= 90°. 
 b = 13.5143(5) Å b= 90°. 
 c = 28.9569(11) Å g = 90°. 
Volume 4144.0(3) Å3 
Z 8 
Density (calculated) 1.432 Mg/m3 
Absorption coefficient 0.234 mm-1 
F(000) 1840 
Crystal size 0.732 x 0.464 x 0.461 mm3 
Theta range for data collection 2.383 to 28.282°. 
Index ranges -14<=h<=13, -16<=k<=18, -38<=l<=36 
Reflections collected 36385 
Independent reflections 10230 [R(int) = 0.0234] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6851 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10230 / 0 / 569 
Goodness-of-fit on F2 1.039 
Final R indices [I>2sigma(I)] R1 = 0.0299, wR2 = 0.0722 
R indices (all data) R1 = 0.0334, wR2 = 0.0741 
Absolute structure parameter -0.014(11) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.353 and -0.265 e.Å-3 
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Chapter 5 Modified Amino Acid-Derived Phosphine-Imine 
Ligands for Palladium-Catalyzed Asymmetric Arylation of 
Cyclic N-Sulfonyl Imine 
 
5.1 Introduction 
Asymmetric arylation of imines catalyzed by chiral rhodium and palladium catalysts is one 
of the most efficient methods to generate chiral disubstituted and trisubstituted 
methylamines.1,2 Recently, cyclic N-sulfonyl imines have attracted great attention in virtue of 
their general high reactivity and high entioselectivity to the arylation reaction.3-7 Their cyclic 
structures make the enatioface differentiation of imines easier and simpler. The use of 
palladium catalysts in the same reaction is an attractive alternative due to the lower cost of 
palladium than rhodium (Scheme 5.1). The initial study was reported by Zhang using 
Pd(OCOCF3)2/pyridinooxazoline complex to catalyzed the addition of arylboronic acids to 
                                                             
(1) For reviews on the transition metal-catalyzed asymmetric addition of organometallic reagents to imines, see: (a) 
Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter, M. M. Chem. Rev. 2011, 111, 2626. (b) Marques, C. S.; Burke, A. J. 
ChemCatChem 2011, 3, 635. (c) Yamada, K.; Tomioka, K. Chem. Rev. 2008, 108, 2874. (d) Friestad, G. K.; 
Mathies, A. K. Tetrahedron 2007, 63, 2541. 
(2) Selected examples on asymmetric addition of organoboron reagents to acyclic imines. For Rh catalysis, see: (a) 
Kuriyama, M.; Soeta, T.; Hao, X.; Chen, Q.; Tomioka, K. J. Am. Chem. Soc. 2004, 126, 8128. (b) Tokunaga, N.; 
Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 13584. (c) Weix, 
D. J.; Shi, Y.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 1092. (d) Otomaru, Y.; Kina, A.; Shintani, R.; Hayashi, T. 
Tetrahedron: Asymmetry 2005, 16, 1673. (e) Duan, H.-F.; Jia, Y.-X.; Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2006, 8, 
2567. (f) Jagt, R. B. C.; Toullec, P. Y. ; Geerdink, D.; de Vries, J. G.; Feringa, B. L.; Minnaard, A. J. Angew. Chem. 
Int. Ed. 2006, 45, 2789. (g) Wang, Z.-Q.; Feng, C.-G.; Xu, M.-H.; Lin, G.-Q. J. Am. Chem. Soc. 2007, 129, 5336. 
(h) Shintani, R.; Takeda, M.; Tsuji, T.; Hayashi, T. J. Am. Chem. Soc. 2010, 132, 13168. (i) Yang, H.-Y.; Xu, M.-H.; 
Chem. Commun. 2010, 46, 9223. (j) Luo, Y.; Carnell, A. J. Angew. Chem. Int. Ed. 2010, 49, 2750. (k) Chen, C.-C.; 
Gopula, B.; Syu, J.-F.; Pan, J.-H.; Kuo, T.-S.; Wu, P.-Y.; Henschke, J. P.; Wu, H.-L. J. Org. Chem. 2014, 79, 8077. 
For Pd catalysis, see: (l) Dai, H.; Yang, M.; Lu, X. Adv. Synth. Catal. 2008, 350, 249. (m) Dai, H.; Lu, X. 
Tetrahedron Lett. 2009, 50, 3478. (n) Ma, G.-N.; Zhang, T.; Shi, M. Org. Lett. 2009, 11, 875. (o) Marques, C. S.; 
Burke, A. J. Eur. J. Org. Chem. 2010, 1639. (p) Chen, J.; Lu, X.; Lou, W.; Ye, Y.; Jiang, H.; Zeng, W. J. Org. Chem. 
2012, 77, 8541. 
(3) Selected examples on asymmetric addition of organoboron reagents to cyclic imines. For Rh catalysis, see: (a) 
Nishimura, T.; Noishiki, A.; Tsui, G. C.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 5056. (b) Luo, Y.; Carnell, A. J.; 
Lam, H. W. Angew. Chem. Int. Ed. 2012, 51, 6762. (c) Luo, Y.; Hepburn, H. B.; Chotsaeng, N.; Lam, H. W. Angew. 
Chem. Int. Ed. 2012, 51, 8309. (d) Nishimura, T.; Ebe, Y.; Fujimoto, H.; Hayashi, T. Chem. Commun. 2013, 49, 
5504. (e) Nishimura, T.; Noishiki, A.; Ebe, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2013, 52, 1777. (f) Wang, H.; Xu, 
M.-H. Synthesis 2013, 45, 2125. (g) Chen, Y.-J.; Chen, Y.-H.; Feng, C.-G.; Lin, G.-Q. Org. Lett. 2014, 16, 3400. (h) 
Wang, H.; Li, Y.; Xu, M.-H. Org. Lett. 2014, 16, 3962. (i) Kong, J.; McLaughlin, M.; Belyk, K.; Mondschein, R. 
Org. Lett. 2015, 17, 5520. (j) Jiang, T.; Wang, Z.; Xu, M.-H. Org. Lett. 2015, 17, 528. (k) Takechi, R.; Nishimura, 
T. Org. Biomol. Chem. 2015, 13, 4918. (l) Li, Y.; Yu, Y.-N.; Xu, M.-H. ACS Catal. 2016, 6, 661. 
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cyclic N-sulfonyl ketimines.4 Subsequently, palladium phosphinooxazoline catalysts5, 
palladium pyridinohydrazone catalysts6 and ferrocene-derived palladacycle7 emerged as new 
types of catalysts for arylation of ketimine reactions.  
The design and synthesis of new chiral ligands is of essential importance for asymmetric 
metal catalysis. At the design, one of the factors to be considered is their tunability which 
makes the chiral ligands fit in with a given reaction with enantioselectivity as high as possible.  
On the other hand, α-amino acids are known to be most useful chiral pools because a series of 
them are available in enantiomerically pure forms and they are functionalized well with 
amino and carboxylic acid groups which are advantageous for their derivatization. The 
α-amino acids have been used for the synthesis of chiral ligands which coordinate to metals 
with nitrogen and phosphorus atoms. 8,9 These P,N ligands are an important class of ligands as 
they are easily tuning at the both steric and electronic properties.  
                                                             
(4) (a) Yang, G.; Zhang, W. Angew. Chem. Int. Ed. 2013, 52, 7540. (b) Quan, M.; Yang, G.; Xie, F.; Gridnev, I. D.; 
Zhang, W. Org. Chem. Front. 2015, 2, 398. 
(5) Jiang, C.; Lu, Y.; Hayashi, T. Angew. Chem. Int. Ed. 2014, 53, 9936. 
(6) Álvarez-Casao, Y.; Monge, D.;Álvarez, E.; Fernández, R.; Lassaletta, J. M. Org. Lett. 2015, 17, 5104. 
(7) Schrapel, C.; Peters, R. Angew. Chem. Int. Ed. 2015, 54, 10289. 
(8) For reviews on P,N ligands for transition metal catalysis, see: (a) Carroll, M. P.; Guiry, P. J. Chem. Soc. Rev. 
2014, 43, 819. (b) Kostas, I. D. Current Organic Synthesis 2008, 5, 227. (c) Amoroso, D.; Gra-ham, T. W.; Guo, R.; 
Tsang, C.-W.;Abdur-Rashid, K. Aldrichimica Acta 2008, 41, 15. (d) Guiry, P. J. Saunders, C. P. Adv. Synth. Catal. 
2004, 346, 497. (e) Tang, W.; Zhang, X. Chem. Rev. 2003, 103, 3029. 
(9) Selected examples on amino acid-derived P,N ligands for transition metal catalysis, see: (a) Hayashi, T.; 
Fukushima, M.; Konishi, m.; Kumada, M. Tetrahedron. Lett. 1980, 21, 79. (b) Hayashi, T.; Konishi, M.; 
Fukushima, M.; Kanehira, K.; Hioki, T.; Kumada, K. J. Org. Chem. 1983, 48, 2195. (c) Griffin, J. H.; Kellogg, R. 
M. J. Org. Chem. 1985, 50, 3261. (d) Vriesema, B. K.; Kellogg, R. M. Tetrahedron Lett. 1986, 27, 2049. (e) 
Dawson, G. J.; Frost, C. G.; Williams, J. M. J. Tetrahedron Lett. 1993, 34, 3149. (f) Allen, J. V.; Dawson, G. J.; 
Frost, C. G.; Williams, J. M. J. Tetrahedron 1994, 50, 799. (g) Saitoh, A.; Morimoto, T.; Achiwa, K. Tetrahedron 
Asymmetry 1997, 8, 3567. (h) Fang, X.; Johannsen, M.; Yao, S.; Gathergood, N.; Hazell, R. G.;  Jørgensen, K. A.; 
J. Org. Chem. 1999, 64, 4844. (i) Bernardi, L.; Gothelf, A. S.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 2003, 
68, 2583. (j) Blanc, C.; Hannedouche, J.; Agbossou-Niedercorn, F. Tetrahedron Lett. 2003. 44. 6469. (k) Malkov, 
A. V.; Hand, J. B.; Kočovský, P. Chem. Commun.  2003, 1948. (l) Agarkov, A.; Greenfield, S.; Xie, D.; Pawlick, 
R.; Starkey, G.; Gilbertson, S. R. Biopolymers (Peptide Science) 2006, 84, 48. (m) Rönnholm, P.; Södergren, M.; 




Scheme 5.1 Palladium-catalyzed arylation of cyclic N-sulfonyl imine 
 
In 1999, Morimoto and co-workers reported a series of chiral phosphine-imine type P,N 
ligands,
10
 which are readily prepared from amino acids by way of β-aminoalkylphosphines, 
and their successsful use for palladium-catalyzed asymmetric allylic alkylation reactions. We 
realized these amino acid-derived P,N ligands have similar scaffolds to phosphinooxazoline 
ligands which have demonstrated high performance in palladium-catalyzed arylation of 
ketimines.5 Although phosphine imine type P,N ligands have been well developed, they are 
often applied in prototypical transformations such as the palladium-catalyzed asymmetric 
allylic alkylation reactions.11 Here we report the fine tuning of the phosphine-imine ligands 
for the asymmetric arylation of imines by modification of their imino moiety.  
                                                             
(10) (a) Saitoh, A.; Misawa, M.; Morimoto, T. Synlett 1999, 483. (b) Saitoh, A.; Achiwa, K.; Tanaka, K.; Morimoto, 
T. J. Org. Chem. 2000, 65, 4227. 
(11) Selected examples on asymmetric allylic alkylation with phosphine imine P,N ligands, see. (a) Hu, X.; Bai, C.; 
Dai, H.; Chen, H.; Zheng, Z. J. Mol. Catal. A-Chem. 2004, 218, 107. (b) Huang, J.-D.; Hu, X.-P.; Yu, S.-B.; Deng, 
J.; Wang, D.-Y.; Duan, Z.-C.; Zheng, Z. J. Mol. Catal. A-Chem.  2007, 270, 127. (c) Glegola, F.; Johannesen, S. 
A.; Thim, L.; Goux-Henry, C.; Skrydstrup, T.; Framery, E. Tetrahedron Lett. 2008, 49, 6635. (d) Sun, Y.; Jiang, 
J.-J.; Zhao, M.-X.; Wang, F.-J.; Shi. M. J. Organomet. Chem. 2011, 696, 2850. (e) Szulc, I.; Kołodziuk, R.;  
Kryczka, B.; Zawisza, A. Tetrahedron Lett. 2015, 56, 4740. (f) Liu, Q.-L.; Chen, W.; Jiang, Q,-Y.; Bai, X.-F.; Li, Z.; 
Xu, Z.; Xu, L.-W. ChemCatChem 2016, 8, 1495. 
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5.2 Result and Discussion 
5.2.1 Synthesis of Amino Acid-Derived Phosphine-Imine Ligands 
 
Scheme 5.2 Synthesis of phosphine-imine ligands 
 
The chiral phosphine-imines 5-2 (Scheme 5.2), where R is i-Pr and Ar is Ph (5-2a), 
4-MeOC6H4 (5-2b), and 4-MeOOCC6H4 (5-2c), have been reported by Morimoto
10 to be 
synthesized by condensation of β-aminoalkylphosphine 5-1a12 with the corresponding 
aldehydes in refluxing toluene. We have modified the phosphine-imines mainly by 
introducing more bulky aromatic groups on the imine moiety and changing alkyl groups on 
the stereogenic carbon center. A palladium complex PdCl2(5-2l) was isolated by the reaction 
                                                             




of phosphine-imine 5-2l with PdCl2(PhCN)2 in acetone and characterized for its crystal 
structure (Figure 5.1). 
 
5.2.2 Palladium-Catalyzed Arylation of Cyclic N-Sulfonyl Imines 
The cyclic N-sulfonyl aldimines are highly reactive substrates.5 The arylation of 
benzo[e][1,2,3]oxathiazine 2,2-dioxide 5-2a with palladium/phosphine-imine ligand catalysts 
was investigated (Table 5.1). The results revealed that PdCl2(MeCN)2 is not a good choice for 
palladium complex formation, only low yield (38%) was achieved, while PdCl2(PhCN)2 gave 
1,2-adduct 5-5am in high yield (91%) (entries 1 and 2). The generation of a cationic 
palladium complex is essential for the high catalytic activity. In absence of AgBF4, no 
phenylation of 5-3a was observed (entry 3), and using Pd(OCOCF3)2 as palladium precursor 
instead of PdCl2(PhCN)2/AgBF4 resulted in low yield (entry 4). Different phosphine-imine 
ligands were tested, ligand 5-2l gave excellent yield (94%) and the best enatioselectivity (96% 
ee) (entry 15). 
 









1 PdCl2(MeCN)2 5-2a 12 38 77 (S) 
 102 
 
2 PdCl2(PhCN)2 5-2a 12 91 77 (S) 
3d PdCl2(PhCN)2 5-2a 12 0  
4e Pd(OCOCF3)2 5-2a 12 trace  
5 PdCl2(PhCN)2 5-2b 12 41 74 (S) 
6 PdCl2(PhCN)2 5-2c 12 55 78 (S) 
7 PdCl2(PhCN)2 5-2d 12 92 78 (S) 
8 PdCl2(PhCN)2 5-2e 12 65 68 (S) 
9 PdCl2(PhCN)2 5-2f 12 78 84 (S) 
10 PdCl2(PhCN)2 5-2g 12 92 85 (S) 
11 PdCl2(PhCN)2 5-2h 12 93 87 (S) 
12 PdCl2(PhCN)2 5-2i 12 94 89 (S) 
13 PdCl2(PhCN)2 5-2j 12 91 81 (S) 
14 PdCl2(PhCN)2 5-2k 12 92 88 (S) 
15 PdCl2(PhCN)2 5-2l 12 94 96 (S) 
16 PdCl2(PhCN)2 5-2l 1 94 96 (S) 
17f PdCl2(5-2l)  1 98 97 (S) 
aReaction conditions: 5-3a (0.20 mmol), 5-4m (0.40 mmol), Pd precursor (5 mol%), ligand 
(5.5 mol%), AgBF4 (15 mol%) in ClCH2CH2Cl (2.0 mL). 
bIsolated yield of 5-5am. 
cDetermined by HPLC analysis with a chiral stationary phase. The absolute configuration 
of 5-5am was determined by comparison of its optical rotation with literature report. 
dReaction without AgBF4. 
ePd(OCOCF3)2 instead of Pd precursor/AgBF4. 
fIsolated 
palladium complex PdCl2(5-2l) was used in place of in situ generation from PdCl(PhCN)2 
and 5-2l ligand. 
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During modifying the structures of phosphine-imine ligands, different aromatic aldehydes 
were assembled with valine-derived phosphine amine. Ligands with strong electron donating 
group (-OMe 5-2b) or withdrawing group (-COOMe 5-2c) substituted on para position of 
phenyl ring showed low catalytic activity, but the enatioselectivity remained same as 5-2a 
(entries 5,6 vs 2). The substituents on different positions of aldehyde phenyl ring were also 
tested. No better results were obtained with 2-methyl substituted ligand 5-2d and 
3,5-di-tert-butyl substituted ligand 5-2e (entries 7 and 8). In addition, big conjugated aromatic 
ring on ligands were tested, the ee values were increased to 84% (5-2f) and 85% (5-2g) 
(entries 9 and 10). With 2,4,6-trimethylphenyl aldehyde ligand 5-2h, higher ee value was 
obtained (87% ee) (entry 11). It was delight to get the result, which made us further test the 
multiple substituents on imine phenyl ring. The bulky phosphine-imine ligand 5-2i 
synthesized from pentamethylbenzaldehyde gave 89% ee value (entry 12). Moreover, the 
alkyl groups on the stereogenic carbon were modified (entries 12-15), where tert-butyl group 
substituent gave best result 94% yield, 96% ee (entry 15). The reaction is so fast that the 
reaction time is shortened to 1 h without loss of yield of 5-5am (entry 16). With the isolated 
PdCl2(5-2l) complex, the yield and ee value further increased slightly. We found that the 
reaction of 5-3a with 2 equiv of phenylboronic acid 5-4m with isolated PdCl2(5-2l) complex 
(5 mol%) and AgBF4 (15 mol%) in 1,2-dichloroethane at 65 ⁰C for 1 h gave 98% yield and 97% 
ee (entries 17).  
With the best reaction condition, various arylboronic acids were examined for the addition 
to substrate 5-3a (Table 5.2). Excellent yields and enatioselectivities were obtained for most 
of reactions with electron-rich and electron-deficient arylboronic acids. (entries 1-10 and 13). 
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However, a slight decrease in reaction rate was observed when strong electron-deficient 
arylboronic acid 5-4r was used (entry 6), while weak electron-deficient arylboronic acids 
gave good results (entries 3-5 and 9). The enatioselectivities were slightly influenced by 
electron donating group on arylboronic acids. (entry 7). Good results were also observed with 
di-substituted arylboronic 5-4t acid and 2-naphthylboronic acid 5-4y (entries 8 and 13). 
Unfortunately, ortho-substituents on arylboronic acids dramatically decrease the 
enantioselectivities, while high catalytic reactivities remained (entries 11 and 12). In addition, 
aldimines (5-3b to 5-3h) substituted with electron donating or electron withdrawing group in 
various positions on the benzene ring of imines were good substrates, and gave high yields 
and excellent ee values (entries 14-20). 
 









1 H (5-3a) Ph (5-4m) 98 (5-5am) 97 (S) 
2 H (5-3a) 4-MeC6H4 (5-4n) 99 (5-5an) 98 (S) 
3 H (5-3a) 4-FC6H4 (5-4o) 98 (5-5ao) 98 (S) 
4 H (5-3a) 4-ClC6H4 (5-4p) 99 (5-5ap) 98 (S) 





 H (5-3a) 4-CF3C6H4 (5-4r) 88 (5-5ar) 97 (S) 
7 H (5-3a) 4-MeOC6H4 (5-4s) 99 (5-5as) 80 (S) 
8 H (5-3a) 3,4-(OCH2O)C6H3 (5-4t) 97 (5-5at) 92 (S) 
9 H (5-3a) 3-ClC6H4 (5-4u) 99 (5-5au) 98 (S) 
10 H (5-3a) 3-MeC6H4 (5-4v) 99 (5-5av) 97 (S) 
11 H (5-3a) 2-MeC6H4 (5-4w) 99 (5-5aw) 39 (S) 
12 H (5-3a) 1-naphthyl (5-4x) 85 (5-5ax) 12 (S) 
13 H (5-3a) 2-naphthyl (5-4y) 99 (5-5ay) 98 (S) 
14 6-Me (5-3b) Ph (5-4m) 99 (5-5bm) 98 (S) 
15 6-Cl (5-3c) Ph (5-4m) 96 (5-5cm) 97 (S) 
16 6-NO2 (5-3d) Ph (5-4m) 98 (5-5dm) 97 (S) 
17 6-OMe (5-3e) Ph (5-4m) 97 (5-5em) 98 (S) 
18 5,6-(CH=CH)2 (5-3f) Ph (5-4m) 99 (5-5fm) 97 (S) 
19 7-Me (5-3g) Ph (5-4m) 96 (5-5gm) 95 (S) 
20 8-Me (5-3h) Ph (5-4m) 99 (5-5hm) 98 (S) 
a
Reaction conditions: 5-3 (0.20 mmol), 5-4 (0.40 mmol), PdCl2(5-2l) (5 mol %), AgBF4 (15 
mol %) in ClCH2CH2Cl (2.0 mL) at 65 °C for 1 h. 
b
Isolated yield of 5-5. 
c
Determined by HPLC 
analysis with a chiral stationary phase. The absolute configuration of 5-5am was determined by 
comparison of its optical rotation with the literature report, and the other compounds were 
estimated by stereochemical similarity to the reaction giving 5-5am. 
d







Table 5.3 Scope of Cyclic N-Sulfonyl Ketiminesa 
 
 
aReaction conditions: 5-3 (0.20 mmol), 5-4 (0.40 mmol), PdCl2(5-2l) (5 mol%), AgBF4 (15 
mol%) in ClCH2CH2Cl (2.0 mL) at 65 ⁰C for 1 h. The yields were isolated yield of 5-5 and ee 
values were determined by HPLC analysis with achiral stationary phase. The absolute 
configurations of 5-5jm, 5-5kn, 5-5lm, 5-5mm, 5-5om were determined by comparison of 
their optical rotations with literature reports, 5-5im, 5-5nm were estimated by similarity of 
the stereochemical pathway. bBoronic acid 5-4n (1.00 mmol) was used. c5-3h (0.20 mmol), 
5-4m (1.00 mmol), PdCl2(5-2l) (10 mol%), AgBF4 (25 mol%) in ClCH2CH2Cl (2.0 mL) at 65 
⁰C for 12 h 
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The method was also successfully extended to the more challenging substrates, namely 
cyclic N-sulfonyl ketimines (Table 5.3). As results, quantitative yields and high ee values 
were achieved in addition to five membered ring cyclic N-sulfonyl ketimines with different 
substituent groups on imine carbon such as 5-4i (R = COOEt), 5-4j (R = Me), 5-4k (R = Ph). 
For six membered ring cyclic N-sulfonyl ketimines, the substrates substituted with ester 
groups (5-4l, 5-4m, 5-4n) also revealed excellent catalytic activities and enantioselectivities, 
and substrates with smaller substituents on ester groups gave better ee values. However, the 




Scheme 5.3 Stereochemical pathway giving (S)-5-5am with PdCl2(5-2l) 
 
The crystal structure of PdCl2(5-2l) complex helped us to predict the stereochemical model 
and rationalized the product configuration of 5-5am (Scheme 5.3). The imine 5-3a 
coordinates to a phenyl-palladium intermediate with its si-face, resulting to the (S)-5-5am 
through migratory insertion into the phenyl-palladium bond. However, it will suffer from the 
steric hindrance caused by the pentamethylphenyl ring and the sulfonyl group when the 




In summary, a series of amino acid-derived phosphine-imine ligands were designed and 
synthesized for palladium-catalyzed arylation of cyclic N-sulfonyl imines. The easily 
prepared phosphine-imine ligands demonstrated high catalytic activities, useful level of 
enantioselectivities. 
 
5.4 Experimental Section 
5.4.1 General 
All air- and moisture-sensitive manipulations were carried out with standard Schlenk 
techniques under argon. NMR spectra were recorded on Bruker AMX-300, Bruker AMX-400 
or Bruker AMX-500 spectrometer. Chemical shifts were reported in δ (ppm) referenced to the 
residual solvent peak of CDCl3 (δ 7.26), acetone-d6 (δ 2.05) and CD2Cl2 (δ 5.32) for 
1
H NMR 
and CDCl3 (δ 77.0), acetone-d6 (δ 29.84) and CD2Cl2 (δ 53.84) for 
13C NMR. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad). 
Coupling constants were reported in Hertz (Hz). Optical rotations were measured on an Anton 
Paar MCP 200 machine. High resolution mass spectra (HRMS) (ESI) were obtained on a 
Bruker micrOTOF-Q II spectrometer. Enantiomeric excesses (ee) were determined by HPLC 
analysis on Shimadzu HPLC. 
 
1,2-Dichloroethane (HPLC grade) was purchased from Sigma-Aldrich and used without 
further purification. Boronic acids and AgBF4 are commercial available and used as received. 
Phosphine amine intermediate,12 PdCl2(MeCN)2
13 and PdCl2(PhCN)2
14 were prepared by the 
                                                             
(13) Rimoldi, M.; Ragaini, F.; Gallo, E.; Ferretti, F.; Macchi, P.; Casati, N. Dalton Trans. 2012, 41, 3648. 
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known procedures. Substrates (5-3a to 5-3h),15 5-3i,16 5-3j,17 5-3k,3a 5-3l,4 5-3m, 4 5-3n,4 
5-3o
18 were prepared according to the reported procedures. 
 
5.4.2 Experimental Procedures and Characterization Data 
Synthesis of P,N Ligands 5-2a to 5-2l 
 
A 25 mL flask was charged with phosphine amine (0.30 mmol) and aldehyde (0.36 mmol) 
in toluene (15.0 mL). The mixture was heated at reflux for 4 h under argon with Dean-Stark 
trap. The solvent was removed under vacuum. The crude mixture was subjected to a short 
silica gel column with hexane/ethyl acetate (25:1) to give crude product (the column was 
pretreated with 5% Et3N in hexane, and then flashed with hexane). The crude product was 
heated to 200 ⁰C under vacuum to remove excess aldehyde, and gave pure product. 
 
 
Compound 5-2a: (CAS 223438-77-5, S configuration) Colorless oil. 71% yield. []25D +119 
(c 1.00, acetone), S configuration. 1H NMR (500 MHz, acetone-d6) δ 8.14 (s, 1H), 7.68 (dd, J 
                                                                                                                                                                              
(14) Braunstein, P.; Bender, R.; Jud. J. Cyclopentadienylsodium and some mono-, tri-, and tetranuclear metal 
carbonyl derivatives and cluster complexes. In Inorganic Syntheses; Kaesz, H. D., Eds.; Wiley: New York, 1989; 
Vol. 27, pp 341. 
(15) Yu, H.; Zhang, L.; Yang, Z.; Li, Z.; Zhao, Y.; Xiao, Y.; Guo, H. J. Org. Chem. 2013, 78, 8427. 
(16) Wang, H.; Jiang, T.; Xu, M.-H. J. Am. Chem. Soc. 2013, 135, 971. 
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= 7.8, 1.6 Hz, 2H), 7.48 (td, J = 7.5, 1.8 Hz, 2H), 7.44-7.33 (m, 8H), 7.30-7.22 (m, 3H), 3.09 
(tt, J = 9.4, 4.6 Hz, 1H), 2.54 (ddd, J = 13.8, 4.0, 2.2 Hz, 1H), 2.47 (ddd, J = 13.8, 8.9, 0.4 Hz, 
1H), 2.00 (octet, J = 6.7 Hz, 1H), 0.94 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H).  
 
 
Compound 5-2b: (CAS 223438-86-6, S configuration) Colorless oil. 79% yield. []25D +1.5 
× 102 (c 0.98, acetone), S configuration. 1H NMR (500 MHz, acetone-d6) δ 8.06 (s, 1H), 7.62 
(d, J = 8.6 Hz, 2H), 7.48 (t, J = 7.3 Hz, 2H), 7.40 (t, J = 7.4 Hz, 2H), 7.38-7.32 (m, 3H), 
7.30-7.22 (m, 3H), 6.94 (d, J = 8.6 Hz, 2H), 3.83 (s, 3H), 3.08-3.00 (m, 1H), 2.55-2.48 (m, 
1H), 2.45 (dd, J = 13.8, 9.1Hz, 1H), 1.97 (octet, J = 6.6 Hz, 1H), 0.92 (d, J = 6.9 Hz, 3H), 
0.90 (d, J = 6.8 Hz, 3H). 
 
 
Compound 5-2c: (CAS 223438-79-7, S configuration) Colorless oil. 72% yield. []25D +145
 
(c 1.00, acetone), S configuration. 1H NMR (500 MHz, acetone-d6) δ 8.22 (s, 1H), 8.02 (d, J = 
8.4 Hz, 2H), 7.77 (t, J = 8.4 Hz, 2H), 7.51-7.45 (m, 2H), 7.44-7.39 (m, 2H), 7.38-7.33 (m, 
3H), 7.29-7.22 (m, 3H), 3.90 (s, 3H), 3.17 (tt, J = 9.1, 4.9 Hz, 1H), 2.55 (ddd, J = 13.8, 4.6, 
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1.7 Hz, 1H), 2.51 (dd, J = 13.8, 8.4Hz, 1H), 2.05-1.98 (m, 1H), 0.93 (d, J = 6.8 Hz, 3H), 0.92 
(d, J = 6.8 Hz, 3H). 
 
 
Compound 5-2d: Colorless oil. 83% yield. []25D +109
 (c 1.00, acetone), S configuration. 1H 
NMR (400 MHz, acetone-d6) δ 8.41 (s, 1H), 7.71 (d, J = 7.8 Hz, 1H), 7.54-7.46 (m, 2H), 
7.44-7.34 (m, 5H), 7.31-7.24 (m, 4H), 7.22-7.16 (m, 2H), 3.08 (tt, J = 9.5, 4.4 Hz, 1H), 2.56 
(dt, J = 13.7, 3.0 Hz, 1H), 2.50-2.41 (m, 4H), 1.99 (octet, J = 6.5 Hz, 1H), 0.96 (d, J = 6.8 Hz, 
3H), 0.93 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, acetone-d6) δ 159.8, 140.6 (d, J = 14.1 
Hz), 139.8 (d, J = 14.7 Hz), 138.5, 135.3, 134.2 (d, J = 19.9 Hz), 133.3 (d, J = 18.7 Hz), 
131.5, 130.7, 129.6, 129.4 (d, J = 7.0 Hz), 129.10 (d, J = 6.3 Hz), 129.07, 128.9, 126.6, 75.6 
(d, J = 12.8 Hz), 34.9 (d, J = 8.4 Hz), 33.7 (d, J = 12.4 Hz), 20.0, 19.7, 18.5. 31P NMR (162 
MHz, acetone-d6) δ 21.42. HRMS (ESI) m/z calcd for C25H29NP




Compound 5-2e: Colorless oil. 65% yield. []25D +117
 (c 1.00, acetone), S configuration. 1H 
NMR (500 MHz, acetone-d6) δ 8.16 (s, 1H), 7.59 (d, J = 1.8 Hz, 2H), 7.57 (t, J = 1.7 Hz, 1H), 
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7.48 (td, J = 7.5, 2.1 Hz, 2H), 7.42 (td, J = 7.5, 1.5 Hz, 2H), 7.39-7.32 (m, 3H), 7.29-7.21 (m, 
3H), 3.10 (tt, J = 9.5, 4.9 Hz, 1H), 2.53 (ddd, J = 13.9, 4.6, 1.7 Hz, 1H), 2.49 (dd, J = 13.9, 
8.6 Hz, 1H), 2.01 (octet, J = 6.4 Hz, 1H), 1.34 (s, 18H), 0.94 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 
6.9 Hz, 3H). 13C NMR (125 MHz, acetone-d6) δ 161.8, 151.6, 140.7 (d, J = 14.1 Hz), 140.3 (d, 
J = 14.2 Hz), 136.9, 134.1 (d, J = 19.8 Hz), 133.4 (d, J = 18.5 Hz), 129.5, 129.3 (d, J = 6.9 
Hz), 129.1 (d, J = 6.4 Hz), 128.9, 125.5, 123.3, 75.5 (d, J = 13.8 Hz), 35.4, 34.9 (d, J = 8.9 
Hz), 33.9 (d, J = 12.5 Hz), 31.7, 20.1, 18.6. 31P NMR (202 MHz, acetone-d6) δ 20.02. 
HRMS (ESI) m/z calcd for C32H43NP
+ (M+H+)472.3128, found 472.3135. 
 
 
Compound 5-2f: Pale yellow oil. 72% yield. []25D +169
 (c 1.00, acetone), S configuration. 
1H NMR (500 MHz, acetone-d6) δ 9.09 (d, J = 8.2 Hz, 1H), 8.76 (s, 1H), 7.99 (d, J = 8.2 Hz, 
1H), 7.96 (dd, J = 8.3, 1.1 Hz, 1H), 7.81 (dd, J = 7.1, 1.0 Hz, 1H), 7.61-7.48 (m, 5H), 
7.45-7.40 (m, 2H), 7.39-7.34 (m, 3H), 7.26-7.20 (m, 3H), 3.20 (tt, J = 9.3, 4.5 Hz, 1H), 2.63 
(ddd, J = 13.9, 4.1, 2.3 Hz, 1H), 2.56 (ddd, J = 13.9, 9.1, 1.1 Hz, 1H), 2.12-2.06 (m, 1H), 1.03 
(d, J = 6.8 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, acetone-d6) δ 161.1 (d, J = 
5.3 Hz), 140.5 (d, J = 13.9 Hz), 139.8 (d, J = 14.7 Hz), 134.9, 134.2 (d, J = 19.8 Hz), 133.4 (d, 
J = 18.8 Hz), 132.6, 132.3, 131.6, 130.4, 129.6, 129.4 (d, J = 7.0 Hz), 129.3, 129.1 (d, J = 6.4 
Hz), 129.0, 127.8, 126.9, 126.1, 125.9 (d, J = 4.4 Hz), 76.2 (d, J = 12.9 Hz), 35.0 (d, J = 8.5 
Hz), 33.9 (d, J = 12.5 Hz), 20.1, 18.5. 31P NMR (202 MHz, acetone-d6) δ 20.81. HRMS (ESI) 
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m/z calcd for C28H29NP
+ (M+H+) 410.2032, found 410.2038. 
 
 
Compound 5-2g: Yellow gel. 94% yield. []25D +126
 (c 1.04, acetone), S configuration. 1H 
NMR (500 MHz, acetone-d6) δ 9.36 (s, 1H), 8.82 (d, J = 8.5 Hz, 2H), 8.63 (s, 1H), 8.10 (d, J 
= 8.1 Hz, 2H), 7.63 (t, J = 7.5 Hz, 2H), 7.58-7.50 (m, 4H), 7.47 (t, J = 7.5 Hz, 2H), 7.45-7.40 
(m, 3H), 7.32-7.24 (m, 3H), 3.40 (tt, J = 10.0, 4.3 Hz, 1H), 2.82-2.76 (m, 1H), 2.57 (ddd, J = 
13.9, 9.7, 3.2 Hz, 1H), 2.15 (octet, J = 6.6 Hz, 1H), 1.10 (d, J = 7.0 Hz, 3H), 1.09 (d, J = 7.5 
Hz, 3H). 13C NMR (125 MHz, acetone-d6) δ 160.4 (d, J = 0.7 Hz), 140.7 (d, J = 13.5 Hz), 
139.2 (d, J = 14.7 Hz), 134.4 (d, J = 20.0 Hz), 133.2 (d, J = 18.4 Hz), 132.4, 131.0, 130.1, 
129.9, 129.6, 129.5 (d, J = 7.0 Hz), 129.3 (d, J = 6.3 Hz), 129.2, 129.1, 127.3, 126.4 (d, J = 
3.2 Hz), 126.2, 76.9 (d, J = 12.9 Hz), 35.2 (d, J = 8.1 Hz), 33.7 (d, J = 12.2 Hz), 20.2, 18.6. 
31P NMR (202 MHz, acetone-d6) δ 21.57. HRMS (ESI) m/z calcd for C32H31NP
+ (M+H+) 
460.2189, found 460.2192. 
 
 
Compound 5-2h: Colorless oil. 74% yield. []25D + 107
 (c 1.00, acetone), S configuration. 1H 
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NMR (400 MHz, acetone-d6) δ 8.48 (s, 1H), 7.55-7.48 (m, 2H), 7.43-7.34 (m, 5H), 7.32-7.23 
(m, 3H), 6.87 (s, 2H), 3.00 (tt, J = 10.0, 4.0 Hz, 1H), 2.56 (dt, J = 13.8, 3.6 Hz, 1H), 2.43 (s, 
6H), 2.38 (ddd, J = 13.8, 4.4, 2.7 Hz, 1H), 2.26 (s, 3H), 2.02-1.91 (m, 1H), 0.99 (d, J = 6.8 Hz, 
3H), 0.93 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, acetone-d6) δ 160.9, 140.8 (d, J = 13.7 
Hz), 139.5 (d, J = 15.0 Hz), 139.3, 138.6, 134.3 (d, J = 20.0 Hz), 133.2 (d, J = 18.5 Hz), 
131.8, 130.2, 129.7, 129.4 (d, J = 7.0 Hz), 129.2 (d, J = 6.3 Hz), 129.0, 76.3 (d, J = 12.8 Hz), 
34.9 (d, J = 8.1 Hz), 33.8 (d, J = 12.3 Hz), 21.4, 21.1, 20.1, 18.2. 31P NMR (162 MHz, 
acetone-d6) δ 22.21. HRMS (ESI) m/z calcd for C27H33NP




Compound 5-2i: Colorless oil. 71% yield. []25D +106
 (c 1.00, acetone), S configuration. 1H 
NMR (500 MHz, acetone-d6) δ 8.51 (s, 1H), 7.55 (td, J = 7.5, 1.6 Hz, 2H), 7.45-7.36 (m, 5H), 
7.35-7.26 (m, 3H), 3.07 (tt, J = 9.5, 3.9 Hz, 1H), 2.62 (dt, J = 13.9, 3.6 Hz, 1H), 2.37-2.30 (m, 
1H), 2.30 (s, 6H), 2.27 (s, 3H), 2.19 (s, 6H), 2.03-1.95 (m, 1H), 0.99 (d, J = 6.8 Hz, 3H), 0.95 
(d, J = 6.8 Hz, 3H). 13C NMR (125 MHz, acetone-d6) δ 162.5, 139.9 (d, J = 13.8 Hz), 138.6 (d, 
J = 14.4 Hz), 134.9, 133.5, 133.4 (d, J = 19.9 Hz), 132.20, 132.19 (d, J = 18.3 Hz), 131.6, 
128.9, 128.6 (d, J = 7.0 Hz), 128.3 (d, J = 6.2 Hz), 128.1, 74.9 (d, J = 13.4 Hz), 34.1 (d, J = 
8.4 Hz), 32.7 (d, J = 12.6 Hz), 19.2, 17.3, 16.6 (d, J = 3.1 Hz), 16.1, 15.5. 31P NMR (202 MHz, 
acetone-d6) δ 21.48. HRMS (ESI) m/z calcd for C29H37NP






Compound 5-2j: Colorless oil. 70% yield. []25D +91.0
 (c 1.00, acetone), S configuration. 1H 
NMR (500 MHz, acetone-d6) δ 8.51 (s, 1H), 7.52 (t, J = 7.1 Hz, 2H), 7.44 (t, J = 7.1 Hz, 2H), 
7.41-7.28 (m, 6H), 3.47 (septet, J = 6.8 Hz, 1H), 2.49 (dd, J = 13.9, 5.4 Hz, 1H), 2.42 (dd, J = 
13.7, 7.7 Hz, 1H), 2.23 (s, 6H), 2.22 (s, 3H), 2.18 (s, 6H), 1.38 (d, J = 6.3 Hz, 3H). 13C NMR 
(125 MHz, acetone-d6) δ 162.2, 140.6 (d, J = 13.8 Hz), 139.8 (d, J = 14.5 Hz), 135.7, 134.5, 
134.0 (d, J = 19.7 Hz), 133.3 (d, J = 18.7 Hz), 133.0, 132.2, 129.6, 129.4 (d, J = 6.8 Hz), 
129.3 (d, J = 6.3 Hz), 129.2, 65.7 (d, J = 15.6 Hz), 38.3 (d, J = 13.3 Hz), 24.7 (d, J = 8.9 Hz), 
17.3 (d, J = 1.1 Hz), 17.0, 16.3. 31P NMR (202 MHz, acetone-d6) δ 21.77. HRMS (ESI) m/z 
calcd for C27H33NP
+ (M+H+)402.2345, found 402.2350. 
 
 
Compound 5-2k: Colorless oil. 64% yield. []25D +105
 (c 1.01, acetone), (S,S) configuration. 
1H NMR (500 MHz, acetone-d6) δ 8.52 (s, 1H), 7.56 (td, J = 7.3, 1.6 Hz, 2H), 7.44-7.36 (m, 
5H), 7.33-7.23 (m, 3H), 3.17 (tt, J = 10.6, 3.5 Hz, 1H), 2.61 (dt, J = 13.9, 3.7 Hz, 1H), 
2.35-2.30 (m, 1H), 2.30 (s, 6H), 2.23 (s, 3H), 2.19 (s, 6H), 1.75-1.65 (m, 1H), 1.64-1.55 (m, 
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1H), 1.27-1.16 (m, 1H), 0.98 (d, J = 6.8 Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H). 13C NMR (125 
MHz, acetone-d6) δ 163.3, 141.0 (d, J = 14.0 Hz), 139.4 (d, J = 15.2 Hz), 135.8, 134.51 (d, J 
= 20.2 Hz), 134.50, 133.09, 133.01 (d, J = 18.3 Hz), 132.5, 129.9, 129.5 (d, J = 7.1 Hz), 129.2 
(d, J = 6.1 Hz), 129.0, 74.9 (d, J = 13.6 Hz), 42.4 (d, J = 7.8 Hz), 32.8 (d, J = 12.8 Hz), 25.8, 
17.5 (d, J = 3.2 Hz), 17.0, 16.4, 16.1, 12.2. 31P NMR (202 MHz, acetone-d6) δ 21.61. HRMS 
(ESI) m/z calcd for C30H39NP
+ (M+H+)444.2815, found 444.2818. 
 
 
Compound 5-2l: Colorless oil. 85% yield. []25D +150
 (c 1.02, acetone), S configuration. 1H 
NMR (500 MHz, acetone-d6) δ 8.55 (s, 1H), 7.63-7.56 (m, 2H), 7.46-7.40 (m, 3H), 7.40-7.35 
(m, 2H), 7.33-7.23 (m, 3H), 2.83 (dd, J = 13.8, 10.6 Hz, 1H), 2.73 (dd, J = 13.8, 6.5 Hz, 1H), 
2.35 (s, 6H), 2.23 (s, 3H), 2.20 (s, 6H), 2.18-2.13 (m, 1H), 0.93 (s, 9H). 13C NMR (125 MHz, 
acetone-d6) δ 163.5, 141.2 (d, J = 13.6 Hz), 139.0 (d, J = 15.6 Hz), 135.9, 134.9 (d, J = 20.6 
Hz), 134.3, 133.2, 132.83 (d, J = 17.8 Hz), 132.79, 130.1, 129.5 (d, J = 7.3 Hz), 129.2 (d, J = 
5.9 Hz), 128.8, 79.5 (d, J = 12.7 Hz), 35.5 (d, J = 7.3 Hz), 31.2 (d, J = 11.5 Hz), 27.1, 17.6 (d, 
J = 4.2 Hz), 17.1, 16.4. 31P NMR (202 MHz, acetone-d6) δ 20.87. HRMS (ESI) m/z calcd for 
C30H39NP






Synthesis of [PdCl2(5-2l)] Complex 
 
A 25 mL round bottle flask was charged with PdCl2(PhCN)2 (1.00 mmol, 383.6 mg) in 
acetone (5.0 mL) under argon. P,N ligand 5-2l (1.00 mmol, 443.6 mg) in acetone (10.0 mL) 
was added slowly over 5 min at room temperature. The mixture was stirred at room 
temperature for 2 h, while yellow precipitate was formed. The mixture was concentrated to 5 
mL, and filtrated. The residue was washed with hexane (10 mL × 3), and dried under vacuum 
to give pure product (528.0 mg, 85% yield). Compound PdCl2(5-2l): Yellow solid. []
25
D 
+73.2 (c 1.00, CHCl3), S configuration. 
1H NMR (500 MHz, CD2Cl2) δ 8.91 (s, 1H), 8.05-7.91 
(m, 4H), 7.58 (t, J = 7.1 Hz, 1H), 7.53-7.45 (m, 3H), 7.40 (t, J = 6.4, 2H), 4.10 (dd, J = 35.3, 
8.1 Hz, 1H), 3.19 (ddd, J = 15.3, 12.2, 8.6 Hz, 1H), 2.43 (dd, J = 15.2, 11.8 Hz, 1H), 2.23 (s, 
6H), 2.19 (s, 3H), 2.09 (s, 3H), 1.82 (s, 3H), 1.21 (s, 9H). 13C NMR (125 MHz, CD2Cl2) δ 
179.0, 137.5, 134.8 (d, J = 10.5 Hz), 133.0, 132.7, 132.5, 132.4 (d, J = 9.7 Hz), 132.0 (t, J = 
3.1 Hz), 130.9 (d, J = 56.5 Hz), 130.4 (d, J = 49.9 Hz), 129.6, 129.5 (d, J = 11.0 Hz), 128.9 (d, 
J = 11.5 Hz), 88.8 (d, J = 1.5 Hz), 36.0, 30.8 (d, J = 30.4 Hz), 28.4, 19.4 (d, J = 56.3 Hz), 
17.2, 16.3 (d, J = 48.4 Hz). 31P NMR (202 MHz, CD2Cl2) δ 42.18. HRMS (ESI) m/z calcd for 
C30H38ClNPPd






Palladium-Catalyzed Asymmetric Arylation Reaction 
General Procedure for Phenylation of N-Sulfonyl Imine 5-3a with in situ Generated 
Catalyst. 
 
A Schlenk tube was charged with N-sulfonyl imine 5-3a (0.20 mmol, 36.6 mg), 
phenylboronic acid 5-4m (0.40 mmol, 48.8 mg), and palladium precursor (0.01 mmol). The 
mixture was dissolved in 1,2-dichloroethane (1.0 mL), and phosphine-imine ligand (0.011 
mmol) in 1,2-dichloroethane (0.5 mL) was added slowly. After the mixture was stirred at 
room temperature for 10 min, AgBF4 (0.03 mmol, 5.8 mg) in 1,2-dichloroethane (0.5 mL) 
was added. Then the mixture was heated at 65 ⁰C for 12 h, and it was directly subjected to 
flash chromatography on silica gel using hexane/ethyl acetate (5:1) as an eluent to give adduct 
5-5am as a colorless solid. 
 
General Procedure for Asymmetric Arylation of N-Sulfonyl Imines with [PdCl2(5-2l)]. 
 
PdCl2(5-2l) (6.2 mg, 0.01 mmol), N-sulfonyl imine (0.20 mmol), and boronic acid (0.40 
mmol) were placed in a Schlenk tube. To the tube, 1,2-dichloroethane (1.0 mL) was added, 
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and then AgBF4 (5.8 mg, 0.03 mmol) in 1,2-dichloroethane (1.0 mL) was added. The mixture 
was stirred at 65 °C for 1 h, and it was directly subjected to flash chromatography on silica 
gel using hexane/ethyl acetate (5:1) as an eluent to give pure product. 
 
 
Compound 5-5am: (CAS 1025505-92-3, S configuration) Colorless solid. 98% yield. []25D 
18.0 (c 1.01, CHCl3), S configuration. The ee value was 97%, tR (minor) = 15.3 min, tR 
(major) = 17.8 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.48-7.40 (m, 3H), 7.37-7.32 (m, 3H), 7.10 (t, J = 7.9 Hz, 1H), 
7.08 (d, J = 8.2 Hz, 1H), 6.82 (d, J = 7.7 Hz, 1H), 5.91 (d, J = 5.0 Hz, 1H), 4.73 (s, 1H). 
 
 
Compound 5-5an: (CAS 1418635-71-8, R configuration) Colorless solid. 99% yield. []25D 
13.4 (c 1.01, CHCl3), S configuration. The ee value was 98%, tR (minor) = 15.6 min, tR 
(major) = 17.1 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.32 (t, J = 7.7 Hz, 1H), 7.24 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 
8.3 Hz, 2H), 7.08 (t, J = 7.6 Hz, 1H), 7.06 (d, J = 7.6 Hz, 1H), 6.83 (d, J = 7.8 Hz, 1H), 4.67 
 120 
 
(d, J = 6.3 Hz, 1H), 2.39 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 151.5, 139.6, 135.0, 130.1, 
129.6, 128.63, 128.58, 125.2, 122.2, 118.8, 61.7, 21.2. HRMS (ESI) m/z calcd for 
C14H12NO3S
 (M-H+) 274.0543, found 274.0533. 
 
 
Compound 5-5ao: Colorless solid. 98% yield. []25D 28.7 (c 1.00, CHCl3), S configuration. 
The ee value was 98%, tR (minor) = 13.1 min, tR (major) = 17.2 min (Chiralpak IC, λ = 254 
nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.38-7.30 
(m, 3H), 7.16-7.09 (m, 3H), 7.07 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 7.8 Hz, 1H), 5.90 (s, 1H), 
4.77 (br, 1H). 13C NMR (125 MHz, CDCl3) δ 163.2 (d, J = 249.8 Hz), 151.5, 133.8 (d, J = 3.3 
Hz), 130.7 (d, J = 8.5 Hz), 129.9, 128.4, 125.3, 121.7, 119.0, 116.5 (d, J = 21.8 Hz), 61.2. 19F 
NMR (376 MHz, CDCl3) δ 111.10. HRMS (ESI) m/z calcd for C13H9FNO3S
 (M-H+) 
278.0293, found 278.0293. 
 
 
Compound 5-5ap: (CAS 1456548-90-5, R configuration) Colorless solid. 99% yield. []25D 
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8.81 (c 1.01, CHCl3), S configuration. The ee value was 98%, tR (minor) = 13.0 min, tR 
(minor) = 19.6 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.3 Hz, 2H), 7.35 (t, J = 7.8 Hz, 1H), 7.29 (d, J = 
8.3 Hz, 2H), 7.12 (t, J = 7.6 Hz, 1H), 7.09 (d, J = 8.4 Hz, 1H), 6.81 (d, J = 7.8 Hz, 1H), 5.89 
(s, 1H), 4.70 (br, 1H). 13C NMR (125 MHz, CDCl3) δ 151.5, 136.3, 135.7, 130.2, 130.0, 129.7, 
128.4, 125.4, 121.5, 119.0, 61.3. HRMS (ESI) m/z calcd for C13H9ClNO3S




Compound 5-5aq: Colorless solid. 99% yield. []25D 2.70 (c 1.05, CHCl3), S configuration. 
The ee value was 98%, tR (major) = 9.9 min, tR (minor) = 11.7 min (Chiralpak IF, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.4 
Hz, 2H), 7.34 (t, J = 7.8 Hz, 1H), 7.23 (d, J = 8.3 Hz, 2H), 7.11 (t, J = 7.6 Hz, 1H), 7.04 (d, J 
= 8.2 Hz, 1H), 6.80 (d, J = 7.8 Hz, 1H), 5.86 (s, 1H), 4.92 (br, 1H). 13C NMR (125 MHz, 
CDCl3) δ 151.4, 136.7, 132.6, 130.5, 129.9, 128.4, 125.3, 123.7, 121.4, 118.9, 61.3. HRMS 
(ESI) m/z calcd for C13H9BrNO3S





Compound 5-5ar: Colorless solid. 88% yield. []25D 17.7 (c 1.00, CHCl3), S configuration. 
The ee value was 97%, tR (major) = 8.0 min, tR (minor) = 9.1 min (Chiralpak IF, λ = 254 nm, 
hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.1 
Hz, 2H), 7.50 (d, J = 8.2 Hz, 2H), 7.37 (tdd, J = 7.8, 1.6, 0.8 Hz, 1H), 7.13 (td, J = 7.6, 1.1 Hz, 
1H), 7.10 (dd, J = 8.1, 1.0 Hz, 1H), 6.80 (d, J = 7.8 Hz, 1H), 5.97 (d, J = 8.5 Hz, 1H), 4.85 (d, 
J = 8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 151.5, 141.6, 131.8 (q, J = 32.8 Hz), 130.1, 
129.4, 128.3, 126.4 (q, J = 3.6 Hz), 125.5, 123.7 (q, J = 272.4 Hz,), 121.1, 119.1, 61.4. 19F 
NMR (376 MHz, CDCl3) δ 62.86. HRMS (ESI) m/z calcd for C14H9F3NO3S
 (M-H+) 
328.0261, found 328.0268. 
 
 
Compound 5-5as: (CAS 1456548-88-1, R configuration) Colorless solid. 99% yield. []25D 
9.72 (c 1.07, CHCl3), S configuration. The ee value was 80%, tR (minor) = 25.4 min, tR 
(major) = 41.4 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.32 (t, J = 7.5 Hz, 1H), 7.25 (d, J = 8.9 Hz, 2H), 7.09 (t, J = 
7.5 Hz, 1H), 7.05 (d, J = 8.3 Hz, 1H), 6.93 (d, J = 8.3 Hz, 2H), 6.84 (d, J = 7.7 Hz, 1H), 5.86 
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(s, 1H), 4.75 (br, 1H), 3.83 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 160.4, 151.4, 130.1, 129.9, 
129.6, 128.6, 125.1, 122.3, 118.8, 114.7, 61.5, 55.4. HRMS (ESI) m/z calcd for C14H12NO4S
  
(M-H+) 290.0493, found 290.0489. 
 
 
Compound 5-5at: Light yellow solid. 97% yield. []25D 8.81 (c 1.01, CHCl3), S 
configuration. The ee value was 92%, tR (major) = 19.9 min, tR (minor) = 27.0 min (Chiralpak 
IA, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (500 MHz, CDCl3) δ 
7.33 (t, J = 7.6 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.06 (d, J = 8.3 Hz, 1H), 6.87 (d, J = 8.1 Hz, 
1H), 6.85-6.81 (m, 2H), 6.74 (s, 1H), 6.00 (s, 2H), 5.18 (s, 1H), 4.67 (br, 1H). 13C NMR (125 
MHz, CDCl3) δ 151.4, 148.63, 148.58, 131.6, 129.8, 128.6, 125.3, 122.9, 122.1, 118.9, 108.8, 
108.7, 101.6, 61.8. HRMS (ESI) m/z calcd for C14H10NO5S




Compound 5-5au: (CAS 1418635-75-2, R configuration) Colorless solid. 99% yield. []25D 
14.3 (c 1.00, CHCl3), S configuration. The ee value was 98%, tR (major) = 19.3 min, tR 
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(minor) = 29.0 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.44-7.40 (m, 1H), 7.40-7.32 (m, 3H), 7.25 (d, J = 7.4 Hz, 1H), 
7.13 (t, J = 7.6 Hz, 1H), 7.10 (d, J = 8.4 Hz, 1H), 6.83 (d, J = 7.8 Hz, 1H), 5.88 (s, 1H), 4.74 
(br, 1H). 13C NMR (125 MHz, CDCl3) δ 151.4, 139.7, 135.3, 130.7, 130.0, 129.8, 129.0, 
128.4, 127.0, 125.4, 121.2, 119.0, 61.4. HRMS (ESI) m/z calcd for C13H9ClNO3S
 (M-H+) 
293.9997, found 293.9996. 
 
 
Compound 5-5av: (CAS 1456548-95-0, R configuration) Colorless solid. 99% yield. []25D 
10.0 (c 1.03, CHCl3), S configuration. The ee value was 97%, tR (minor) = 14.2 min, tR 
(major) = 16.5 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.36-7.28 (m, 2H), 7.24 (d, J = 7.6 Hz, 1H), 7.14 (s, 1H), 
7.13-7.06 (m, 3H), 6.83 (d, J = 7.5 Hz, 1H), 5.86 (s, 1H), 4.62 (br, 1H), 2.37 (s, 3H). 13C 
NMR (125 MHz, CDCl3) δ 151.5, 139.4, 137.8, 130.3, 129.7, 129.34, 129.34, 128.6, 125.8, 
125.2, 122.2, 118.8, 62.0, 21.4. HRMS (ESI) m/z calcd for C14H12NO3S






Compound 5-5aw: (CAS 1418635-79-6, R configuration) Colorless solid. 99% yield. []25D 
+23.8 (c 1.01, CHCl3), S configuration. The ee value was 39%, tR (major) = 10.6 min, tR 
(minor) = 13.0 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (400 MHz, CDCl3) δ 7.37-7.27 (m, 3H), 7.21 (td, J = 7.0, 2.2 Hz, 1H), 7.14-7.06 (m, 
3H), 6.83 (d, J = 7.6 Hz, 1H), 6.19 (d, J = 7.7 Hz, 1H), 4.59 (br, 1H), 2.48 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ 151.8, 137.5, 136.0, 131.4, 129.6, 129.5, 128.6, 128.3, 127.0, 125.3, 
122.1, 119.0, 58.6, 19.2. HRMS (ESI) m/z calcd for C14H12NO3S




Compound 5-5ax: (CAS 1456548-92-7, R configuration) Colorless solid. 85% yield. []25D 
11 (c 0.84, CHCl3), S configuration. The ee value was 12%, tR (minor) = 12.2 min, tR (major) 
= 13.5 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H 
NMR (400 MHz, CDCl3) δ 8.02 (s, 1H), 7.98-7.91 (m, 2H), 7.60-7.52 (m, 2H), 7.51-7.41 (m, 
2H), 7.35 (td, J = 7.9, 0.7 Hz, 1H), 7.14 (dd, J = 8.3, 1.0 Hz, 1H), 7.07 (td, J = 7.3, 0.9 Hz, 
1H), 6.83 (d, J = 7.8 Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 4.95 (d, J = 8.3 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) δ 151.5, 134.3, 133.1, 130.8, 130.5, 129.7, 129.3, 128.2, 128.0, 127.4, 
126.4, 125.4, 125.3, 122.7, 122.1, 119.1, 59.2. HRMS (ESI) m/z calcd for C17H12NO3S
 (M-H+) 





Compound 5-5ay: (CAS 1456548-93-8, R configuration) Colorless solid. 99% yield. []25D 
+46.5 (c 1.02, CHCl3), S configuration. The ee value was 98%, tR (major) = 14.9 min, tR 
(minor) = 20.3 min (Chiralpak ID, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 
1H NMR (500 MHz, CDCl3) δ 7.91 (d, J = 8.6 Hz, 1H), 7.90-7.84 (m, 3H), 7.60-7.53 (m, 2H), 
7.39-7.33 (m, 2H), 7.13 (dd, J = 8.3, 0.9 Hz, 1H), 7.09 (td, J = 7.6, 1.0 Hz, 1H), 6.86 (d, J = 
7.8 Hz, 1H), 6.08 (s, 1H), 4.76 (br, 1H). 13C NMR (125 MHz, CDCl3) δ 151.5, 134.9, 133.5, 
133.2, 129.8, 129.7, 128.8, 128.6, 128.1, 127.8, 127.2, 127.0, 125.3, 125.2, 122.0, 118.9, 62.1. 
HRMS (ESI) m/z calcd for C17H12NO3S
 (M-H+) 310.0543, found 310.0545. 
 
 
Compound 5-5bm: (CAS 1025505-94-5 for S configuration). Colorless solid, 99% yield. 
[]25D 49.3 (c 1.01, CHCl3), S configuration. The ee value was 98%, tR (minor) = 17.9 min, 
tR (major) = 19.6 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (500 MHz, CDCl3) δ 7.47-7.41 (m, 3H), 7.37-7.32 (m, 2H), 7.12 (dd, J = 
8.5, 1.8 Hz, 1H), 6.96 (d, J = 8.4 Hz 1H), 6.60 (s, 1H), 5.85 (d, J = 8.6 Hz, 1H), 4.72 (d, J = 





Compound 5-5cm: (CAS 1456548-99-4 for R configuration). Colorless solid, 96% yield. 
[]25D 71.3 (c 1.00, CHCl3), S configuration. The ee value was 97%, tR (minor) = 11.3 min, 
tR (major) = 12.1 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (500 MHz, CDCl3) δ 7.49-7.44 (m, 3H), 7.35-7.32 (m, 2H), 7.30 (ddd, J = 
8.8, 2.5, 0.6 Hz, 1H), 7.04 (d, J = 8.8 Hz 1H), 6.81 (dd, J = 2.5, 0.8 Hz, 1H), 5.86 (d, J = 8.7 
Hz, 1H), 4.69 (d, J = 8.7 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 150.0, 137.1, 130.6, 129.95, 
129.93, 129.7, 128.7, 128.3, 123.6, 120.3, 61.8. HRMS (ESI) m/z calcd for C13H9ClNO3S
 
(M-H+) 293.9997, found 294.0002. 
 
 
Compound 5-5dm: Colorless solid, 98% yield. []25D 131 (c 1.04, CHCl3), S configuration. 
The ee value was 97%, tR (minor) = 17.3 min, tR (major) = 21.6 min (Chiralpak AD-H, λ = 
254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (300 MHz, CDCl3) δ 8.22 
(dd, J = 9.0, 2.5 Hz, 1H), 7.75 (d, J = 2.3 Hz, 1H), 7.56-7.42 (m, 3H), 7.39-7.29 (m, 2H), 7.24 
(d, J = 9.1 Hz, 1H), 5.96 (d, J = 8.6 Hz, 1H), 4.95 (d, J = 8.7 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) δ 155.6, 144.6, 136.3, 130.4, 130.0, 128.6, 125.2, 124.6, 123.4, 120.1, 61.8. HRMS 
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(ESI) m/z calcd for C13H9N2O5S
 (M-H+) 305.0238, found 305.0244. 
 
 
Compound 5-5em: (CAS 1456548-97-2 for R configuration). Colorless solid, 97% yield. 
[]25D 58.5 (c 1.00, CHCl3), S configuration. The ee value was 98%, tR (minor) = 22.7 min, 
tR (major) = 24.7 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (500 MHz, CDCl3) δ 7.46-7.41 (m, 3H), 7.37-7.32 (m, 2H), 7.01 (d, J = 
9.1 Hz, 1H), 6.86 (dd, J = 9.0, 3.0 Hz, 1H), 6.30 (d, J = 2.9 Hz, 1H), 5.85 (d, J = 8.6 Hz, 1H), 
4.69 (d, J = 8.3 Hz, 1H), 3.65(s, 3H). 13C NMR (125 MHz, CDCl3) δ 156.5, 145.3, 137.8, 
129.6, 129.5, 128.8, 122.8, 119.7, 115.2, 113.2, 61.2, 55.6. HRMS (ESI) m/z calcd for 
C14H12NO4S
 (M-H+) 290.0493, found 290.0500. 
 
 
Compound 5-5fm: (CAS 1418635-83-2 for R configuration). Colorless solid, 99% yield. 
[]25D 38.6 (c 1.00, CHCl3), S configuration. The ee value was 97%, tR (major) = 12.1 min, 
tR (minor) = 15.0 min (Chiralpak ID, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (300 MHz, CDCl3) δ 7.91 (d, J = 9.0 Hz, 1H), 7.85 (d, J = 8.1 Hz, 1H), 
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7.46-7.38(m, 1H), 7.37-7.30 (m, 5H), 7.30-7.22 (m, 3H), 6.36 (d, J = 6.8 Hz, 1H), 4.84 (d, J = 
6.8 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 150.2, 138.6, 131.4, 131.3, 130.1, 129.3, 129.1, 
128.9, 128.3, 127.4, 125.6, 124.2, 118.7, 114.2, 60.8. HRMS (ESI) m/z calcd for C17H12NO3S
 
(M-H+) 310.0543, found 310.0542. 
 
 
Compound 5-5gm: (CAS 1025505-95-6 for S configuration). Colorless solid, 96% yield. 
[]25D 29.4 (c 1.02, CHCl3), S configuration. The ee value was 95%, tR (minor) = 16.2 min, 
tR (major) = 17.6 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 19/1, flow rate = 1.0 
mL/min). 1H NMR (500 MHz, CDCl3) δ 7.45-7.40 (m, 3H), 7.36-7.31 (m, 2H), 6.90 (d, J = 
8.3 Hz, 1H), 6.89 (s, 1H), 6.69 (d, J = 7.8 Hz, 1H), 5.86 (d, J = 8.6 Hz, 1H), 4.65 (d, J = 8.6 
Hz, 1H), 2.35 (s, 3H).  
 
 
Compound 5-5hm: (CAS 1456549-04-4 for R configuration). Colorless solid, 99% yield. 
[]25D +2.28 (c 1.01, CHCl3), S configuration. The ee value was 98%, tR (minor) = 13.2 min, 
tR (major) = 14.5 min (Chiralpak IC, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (300 MHz, CDCl3) δ 7.47-7.38 (m, 3H), 7.37-7.30 (m, 2H), 7.17 (d, J = 
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7.5 Hz, 1H), 6.97 (t, J = 7.7 Hz, 1H), 6.64 (d, J = 7.8 Hz, 1H), 5.88 (d, J = 8.6 Hz, 1H), 4.74 
(d, J = 8.6 Hz, 1H), 2.31 (s, 3H). 13C NMR (125 MHz, CDCl3) δ 150.0, 138.1, 131.1, 129.5, 
129.4, 128.7, 128.1, 126.0, 124.5, 121.8, 62.0, 15.5. HRMS (ESI) m/z calcd for C14H12NO3S
 
(M-H+) 274.0543, found 274.0547. 
 
 
Compound 5-5im: (CAS 1418634-27-1, R configuration) Colorless solid. 98% yield. []25D 
11.0 (c 1.00, CHCl3), S configuration. The ee value was 92%, tR (major) = 12.9 min, tR 
(minor) = 16.6 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 7/3, flow rate = 1.0 mL/min). 
1H NMR (400 MHz, CDCl3) δ 7.82-7.78 (m, 1H), 7.75 (d, J = 7.4 Hz, 1H), 7.66 (td, J = 7.6, 
1.4 Hz, 1H), 7.61 (td, J = 7.5, 1.2 Hz, 1H), 7.43-7.32 (m, 5H), 6.11 (s, 1H), 4.36 (q, J = 7.1 H, 
2H), 1.31 (t, J = 7.1 H, 3H). 13C NMR (100 MHz, CDCl3) δ 169.1, 138.8, 137.4, 135.4, 133.1, 
130.5, 128.91, 128.89, 127.2, 126.4, 121.2, 70.9, 63.8, 13.9. HRMS (ESI) m/z calcd for 
C16H14NO4S
 (M-H+) 316.0649, found 316.0643. 
 
 
Compound 5-5jm: (CAS 1815601-80-9, S configuration) Colorless solid. 99% yield. []25D 
+55.6 (c 1.00, CHCl3), S configuration. The ee value was 91%, tR (major) = 9.9 min, tR (minor) 
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= 12.9 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 7/3, flow rate = 1.0 mL/min). 1H 
NMR (400 MHz, CDCl3) δ 7.80 (d, J = 7.4 Hz, 1H), 7.58 (td, J = 7.5, 1.3 Hz, 1H), 7.53 (td, J 
= 7.5, 1.2 Hz, 1H), 7.50-7.45 (m, 2H), 7.41-7.28 (m, 3H), 7.21 (d, J = 7.2 Hz, 1H), 4.79 (br, 
1H), 2.07 (s, 3H).  
 
 
Compound 5-5kn: (CAS 1365284-28-1, S configuration) Colorless solid. 99% yield. []25D 
16.0 (c 1.00, CHCl3), S configuration. The ee value was 96%, tR (minor) = 22.9 min, tR 
(majorr) = 31.4 min (Chiralpak AD-H, λ = 254 nm, hexane/iPrOH = 8/2, flow rate = 1.0 
mL/min). 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 7.8 Hz, 1H), 7.61 (td, J = 7.6, 1.3 Hz, 
1H), 7.55 (td, J = 7.5, 1.1 Hz, 1H), 7.42 (d, J = 7.7 Hz, 1H), 7.40-7.31 (m, 5H), 7.21 (d, J = 
8.4 Hz, 2H), 7.14 (d, J = 8.1 Hz, 2H), 4.89 (s, 1H), 2.34 (s, 3H).  
 
 
Compound 5-5lm: (CAS 1802550-03-3, R coniguration) Colorless solid. 98% yield. []25D 
39.7 (c 1.00, CHCl3), S configuration. The ee value was 94.3%, tR (minor) = 11.6 min, tR 
(majorr) = 15.2 min (Chiralpak AD-H, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
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mL/min). 1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 8.0, 1.6 Hz, 1H), 7.43 (ddd, J = 8.3, 7.5, 
1.6 Hz, 1H), 7.39-7.34 (m, 3H), 7.25-7.20 (m, 3H), 7.14 (dd, J = 8.3, 1.2 Hz, 1H), 6.43 (s, 
1H), 3.90 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 170.5, 151.0, 139.1, 130.9, 130.5, 129.0, 
128.6, 127.5, 125.0, 119.7, 118.9, 71.2, 54.5. HRMS (ESI) m/z calcd for C15H12NO5S
 (M-H+) 
318.0442, found 318.0447. 
 
 
Compound 5-5mm: (CAS 1682647-58-0, S configuration) Colorless solid. 97% yield. []25D 
38 (c 0.99, CHCl3), S configuration. The ee value was 93.5%, tR (minor) = 12.2 min, tR 
(major) = 16.0 min (Chiralpak AD-H, λ = 254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 
mL/min). 1H NMR (400 MHz, CDCl3) δ 7.51 (dd, J = 8.0, 1.6 Hz, 1H), 7.43 (ddd, J = 8.3, 7.4, 
1.6 Hz, 1H), 7.38-7.33 (m, 3H), 7.25-7.20 (m, 3H), 7.14 (dd, J = 8.3, 1.2 Hz, 1H), 6.46 (s, 
1H), 4.37 (qd, J = 7.1, 1.6 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
 
 
Compound 5-5nm: Colorless solid. 97% yield. []25D 35.8 (c 1.00, CHCl3), S configuration. 
The ee value was 92.7%, tR (minor) = 10.7 min, tR (major) = 13.5 min (Chiralpak AD-H, λ = 
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254 nm, hexane/iPrOH = 9/1, flow rate = 1.0 mL/min). 1H NMR (400 MHz, CDCl3) δ 7.52 
(dd, J = 8.0, 1.6 Hz, 1H), 7.43 (ddd, J = 8.3, 7.4, 1.6 Hz, 1H), 7.37-7.32 (m, 3H), 7.25-7.19 
(m, 3H), 7.13 (dd, J = 8.3, 1.2 Hz, 1H), 6.50 (s, 1H), 5.20 (septet, J = 6.3 Hz, 1H), 1.27 (d, J = 
6.3 Hz, 3H), 1.25 (d, J = 6.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.4, 151.1, 139.5, 
130.7, 130.5, 128.8, 128.4, 127.6, 124.7, 119.6, 119.0, 72.6, 71.0, 21.31, 21.27. HRMS (ESI) 
m/z calcd for C17H16NO5S
 (M-H+) 346.0755, found 346.0755. 
 
 
Compound 5-5om: (CAS 1504627-60-4, R coniguration) Colorless solid. 46% yield. []25D 
17.6 (c 1.00, CHCl3), S configuration. The ee value was 93%, tR (major) = 14.1 min, tR 
(minor) = 15.9 min (Chiralpak IF, λ = 254 nm, hexane/iPrOH = 19/1, flow rate = 1.0 mL/min). 
1H NMR (400 MHz, CDCl3) δ 7.40-7.30 (m, 6H), 7.18 (td, J = 7.7, 1.2 Hz, 1H), 7.10 (dd, J = 
8.2, 1.1 Hz, 1H), 7.03 (dd, J = 7.9, 1.5 Hz, 1H), 4.96 (br, 1H), 2.15 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ 150.2, 143.5, 129.5, 128.9, 128.64, 128.63, 127.4, 126.7, 125.5, 119.4, 65.3, 
28.9. HRMS (ESI) m/z calcd for C14H12NO3S








5.4.3 X-ray Crystal Structure of PdCl2(5-2l) Complex 
 
 
Figure 5.1 Crystal structure of PdCl2(5-2l) 
 
Identification code  G265 
Empirical formula  C30.50 H39 Cl3 N O0.50 P Pd 
Formula weight  671.34 
Temperature  114(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  C2221 
Unit cell dimensions a = 16.8218(7) Å = 90°. 
 b = 18.7535(7) Å = 90°. 
 c = 40.9334(17) Å  = 90°. 
Volume 12913.2(9) Å3 
Z 16 
Density (calculated) 1.381 Mg/m3 
Absorption coefficient 0.894 mm-1 
F(000) 5520 
Crystal size 0.344 x 0.271 x 0.263 mm3 
Theta range for data collection 2.421 to 25.035°. 
Index ranges -19<=h<=20, -21<=k<=21, -47<=l<=37 
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Reflections collected 22888 
Independent reflections 10359 [R(int) = 0.0338] 
Completeness to theta = 25.035° 96.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6522 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10359 / 463 / 714 
Goodness-of-fit on F2 1.128 
Final R indices [I>2sigma(I)] R1 = 0.0530, wR2 = 0.1216 
R indices (all data) R1 = 0.0580, wR2 = 0.1242 
Absolute structure parameter 0.026(12) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.908 and -0.778 e.Å-3 
 
 
